MAXIMUS

11419 Sunset Hills Road

Reston VA 20190

 

July 29, 2010

 

United States Securities and Exchange Commission

Division of Corporate Finance — Mail Stop 3010

Washington DC 20549

 

Dear Ms. Monick,

 

In response to a telephone call from Howard Efron, we have been asked to provide further examples of analysts’ reports from fiscal year 2008, focusing on the unusual and infrequent events which occurred in that year and the charge of $2.2 million disclosed and recorded in the first quarter of that year.

 

In addition, we acknowledge that:

 

·                  The Company is responsible for the adequacy and accuracy of the disclosure in the filing;

·                  Staff comments or changes to disclosure in response to staff comments do not foreclose the Securities and Exchange Commission from taking any action with respect to the filing;

·                  The Company may not assert staff comments as a defense in any proceeding initiated by the Securities and Exchange Commission or any person under the federal securities laws of the United States.

 

There were no significant, unusual events during the first quarter of fiscal year 2008.

 

However, during the quarter, the Company did record a pre-tax charge of $2.2 million ($1.3 million after tax) reflecting the correction of an understatement of stock compensation expense in 2006 and 2007.  As previously noted in our letter of June 18, 2010, this item was mentioned in our earnings call and was the subject of questions at the time.

 

Following the call, reports were prepared by a number of analysts, including the following:

 

·                  CJS Securities, whose report is included in Appendix 1.  This report mentions the $2.2 million charge on page 1, “normalizing” EPS for the effect of the charge.  In addition, there is no evidence that CJS Securities considered the charge so significant that it affected their understanding of the Company’s results in any of the years between 2006 and 2008.

 

1



 

·                  Jefferies & Co (Appendix 2).  This report mentions the charge on page 1 and summarizes it (along with a temporary increase in tax rates) as “transitory”.  The charge is excluded in preparing a pro forma calculation of EPS.

 

·                  UBS and GARP Research & Securities published reports, but did not mention the charge.  The GARP report is included at Appendix 3.

 

The Company recorded some legal expenses in the second and third quarter and a gain on sale of a building in the third quarter.  However, the most significant unusual events occurred in the fourth quarter, where the Company recorded a $7.5 million pre-tax ($4.6 million after-tax) goodwill impairment charge and a $37.5 million pre-tax ($23.2 million after-tax) legal and settlement charge related to the settlement with Accenture over the Texas subcontract.

 

At the time of the Company’s initial earnings call on November 13, 2008, the details of the legal settlement were not known.  However, all analysts’ reports focused either on EBITDA (excluding the impairment charge) or “pro forma” results with the impairment charge reversed out.  We believe this is significant evidence that the analysts are focused on adjusted income.  For example, in Appendix 4 we have included the report of Stifel Nicolaus.  We note that:

 

·                  The report acknowledges the goodwill impairment charge on page 2;

 

·                  The report prepares an analysis of fourth quarter EBIT margin, which excludes goodwill impairment and legal expenses.

 

Following settlement of the Accenture matter, Stifel Nicolaus released a follow-up note on December 15 ,2008, included as Appendix 5.  This note focuses on the legal and settlement charge, in itself a reflection of the nature of this charge to the analyst community.  As well as analyses similar to those performed in the previous note, this report also includes a section called “FY08 EPS Restated From Prior Periods” which mentions pro forma EPS of $0.71 for the quarter and $2.83 for the fiscal year.  These pro forma numbers are consistent with those used by the Company in its press release of December 12, 2008 and include adjustments for legal and settlement expense, goodwill impairment and the sale of the building.

 

It remains our opinion that the error in stock compensation expense is immaterial to the Company both in the aggregate and within each year affected.  This is based upon the magnitude of the adjustment, the nature of the charge and the comprehensive disclosure of the correction by management in the Company’s Form 10-Q in the first quarter of 2008.  We feel that the review of the analyst reports in 2008 confirms this view as:

 

·                  The focus of the analysts appears to be on an earnings figure adjusted for unusual events, such as the legal and settlement charge or the goodwill impairment.  As a consequence, any adjustments must be viewed in the context of a net income based upon a larger earnings figure than that recorded under GAAP;

 

2



 

·                  Unlike the goodwill impairment or legal and settlement expense, which are greater in scale and significance to the Company, analysts did not place a significant amount of interest in the stock-compensation correction, with some analysts omitting mention of it entirely.

·                  We are not aware of any shareholder viewing the correction of the error as a materially misleading adjustment, notwithstanding the disclosure of the adjustment in the financial statements, earnings call and certain of the analyst reports.

 

Please do not hesitate to contact us if you need further information or clarification.

 

Sincerely

 

 

/s/ David N. Walker

 

 

 

David N. Walker

 

Chief Financial Officer

 

 

3



 

Appendix 1

 

CJS SECURITIES

 

50 MAIN ST
WHITE PLAINS
NY 10606

 

Telephone

(914) 287-7600

 

MAXIMUS

 

MARKET OUTPERFORM

 

FEBRUARY 7, 2008

(MMS-$39.91:NYSE)

 

 

 

P-TARGET:$49

 

COMPANY UPDATE

 

·                  GOOD START TO THE YEAR,  EPS EX-CHARGE $0.07 BETTER THAN EXPECTED

·                  STRONG MARGINS IN OPERATIONS SEG. MORE THAN OFFSET WEAK SYSTEMS

·                  ECONOMIC DOWNTURN NOT EXPECTED TO IMPACT CO. AS EVIDENCED BY GROWING BACKLOG

·                 EPS GUIDANCE RAISED TO ACCOUNT FOR BUYBACK ACCRETION

·                 RAISING FY09 ESTIMATES, REITERATE  MKT. OUTPERFORM RATING

 

The core operations business continues to drive solid results at MAXIMUS making up for poor results in its systems segment. Overall top line sales of 202mm were 1mm shy of our model for FQ1 08 but again can be attributed to the troubled systems unit which was over 2mm below our estimate.  Operating margins were 90bps better than expected as the operations unit delivered nearly 300bps higher profitability. Consulting was 80bps above our model and Systems showed a loss of $3mm vs our just above break even expectation. The company has struggled to turn this unit around as it appears software development costs have been mounting and a couple of contracts may be operating at a loss. While MMS tries to rework these contracts this segment remains a drag on earnings, masking the strong performance of its core health and human services business and it now appears that systems will not be profitable this year. Despite this the other businesses are more than making up for this shortfall and we are maintaining our prior estimates for the year.

 

Excluding a $2.2mm charge for the forfeiture of options EPS would have been approximately $0.07 better than our estimate. Cash flow from operations was strong at $20.8mm and FCF was $16.7mm.  The company has done an excellent job focusing on reducing DSOs, which were 77 days in the quarter within the targeted 75-85 day range. Guidance for FY08 CFFO remains at $50-60mm with FCF expected to be $30-40mm. Overall guidance for sales remains unchanged at $850mm to $880mm but EPS guidance is now higher at $2.60 to $2.85 (was $2.40 to $2.65

 

 

 

 

 

Financial Metrics

 

GAAP Earnings Per Share

 

Current Price

 

$35.82

 

Cash $(MM)

 

$62

 

FY (Sep)

 

2008e

 

was

 

2009e

 

was

 

52 Week Range

 

$26.65 - $48.33

 

Total Debt $(MM)

 

$0

 

Q1 Dec

 

$0.51 a

 

$0.50

 

 

 

 

 

Shares Out FD (MM)

 

19.0

 

Net Debt/Cap

 

0%

 

Q2 Mar

 

$0.62

 

 

 

 

 

 

 

Float (MM)

 

19

 

Return on Equity

 

-2%

 

Q3 Jun

 

$0.78

 

 

 

 

 

 

 

Average Daily Vol.

 

405 K

 

Est. 3-5 yr Rev growth

 

10-15%

 

Q4 Sep

 

$0.85

 

 

 

 

 

 

 

Market Cap ($MM)

 

$681

 

Est. 3-5 yr EPS growth

 

13-17%

 

Year

 

$2.75

 

 

 

$3.30

 

$3.15

 

Enterprise Value ($MM)

 

$618

 

Dividend Yield

 

1%

 

P/E

 

13.0X

 

 

 

10.9X

 

 

 

Mgmt/Director Ownership

 

1.6%

 

Book Value per Share

 

$18.49

 

EV/ EBITDA

 

27.7 X

 

 

 

5.5X

 

 

 

 

Charles Strauzer

cstrauzer@cjs-securities.com

PLEASE REFER TO THE LAST PAGE OF THIS REPORT FOR IMPORTANT DISCLOSURES, ANALYST CERTIFICATION AND PRICE CHART.

 



 

but excluded the buyback) given the previously announced $150mm accelerated share repurchase and will likely net more shares given the lower share price.

 

Backlog continues to grow even though there are some investors who may have the perception that a tough economic climate will impact MMS.  The total pipeline now stands at $1.5bln vs. 1.3bln in FY07. There are several reasons we believe MMS can weather a challenging economic environment;

 

·                  60% of its business are BPO type services which are typically driven and funded by the federal government,

·                  States tend to outsource more in tougher budgetary environments to try and save money,

·                  Focus of services on cost reductions and efficiencies, which is appealing to its customer base during tougher times,

·                  Privatization services typically are attractive during tighter fiscal cycles because MMS can do the same job as government more efficiently and often with less expense.

·                  Lastly case loads usually increase in more difficult times, as there are more people in need of help increasing the need for the work performed by MMS.

 

We are maintaining our FY 08 estimates but raising our FY 09 EPS for continued progress in growing its core operations margins. Our $49 valuation is based on 8X our FY08E EBITDA (below takeout multiples and inline with comparable public company valuations).      If MMS can rid themselves of unprofitable businesses it would help further expand margins and could use cash proceeds received to further enhance value. Accordingly, we reiterate our market outperform rating.

 



 

MAXIMUS

Actual vs. Estimates for Q1 12/07e (in MMs except EPS)

 

 

 

Year Ago Actual

 

Current Quarter Actual

 

Current Q Estimate

 

Better/

 

 

 

Q1 12/06

 

% Revs

 

Q1 12/07

 

% Revs

 

Y/Y

 

Q1 12/07e

 

% Revs

 

(Worse)

 

Segment Revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consulting

 

24.7

 

15.3

%

22.2

 

11.0

%

-10.1

%

22.2

 

10.9

%

-0.2

%

Systems

 

34.5

 

21.4

%

34.0

 

16.8

%

-1.6

%

36.3

 

17.8

%

-6.3

%

Operations

 

101.9

 

63.3

%

145.8

 

72.2

%

43.0

%

144.8

 

71.2

%

0.7

%

Total Revenue

 

161.1

 

100.0

%

202.0

 

100.0

%

25.3

%

203.2

 

100.0

%

-0.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from Operations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consulting

 

2.8

 

11.4

%

1.2

 

5.2

%

-59.1

%

1.0

 

4.4

%

16.8

%

Systems

 

(1.6

)

-4.6

%

(3.1

)

-9.2

%

96.7

%

0.6

 

1.5

%

-661.9

%

Operations

 

(16.0

)

-15.7

%

18.7

 

12.8

%

-216.8

%

12.8

 

8.9

%

46.0

%

Consolidating Adjustments

 

0.5

 

 

 

(0.2

)

 

 

-151.0

%

0.5

 

 

 

-146.0

%

Total Income from Operations

 

(14.4

)

-8.9

%

16.5

 

8.2

%

-214.9

%

14.9

 

7.3

%

11.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Profit

 

20.3

 

12.6

%

52.8

 

26.1

%

160.2

%

51.5

 

25.3

%

2.5

%

Selling, General & Administrative

 

(34.7

)

-21.5

%

(36.3

)

-18.0

%

4.6

%

(36.6

)

-18.0

%

0.9

%

EBIT

 

(17.4

)

-10.8

%

16.5

 

8.2

%

NM

 

14.9

 

7.3

%

11.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest Income

 

1.6

 

1.0

%

1.5

 

0.7

%

-6.9

%

0.3

 

0.1

%

400.3

%

Pretax Income

 

(15.8

)

-9.8

%

18.0

 

8.9

%

NM

 

15.2

 

7.5

%

18.7

%

Taxes

 

5.8

 

3.6

%

(7.4

)

-3.7

%

NM

 

(5.9

)

-2.9

%

-20.1

%

Tax Rate

 

36.9

%

NA

 

41.1

%

NA

 

4.2

%

39.0

%

NA

 

-2.1

%

Net Income

 

$

(9.9

)

-6.2

%

$

10.6

 

5.3

%

NM

 

$

9.3

 

4.6

%

14.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EPS (Fully Diluted)

 

$

(0.48

)

NA

 

$

0.51

 

NA

 

-205.9

%

$

0.50

 

NA

 

 

 

EPS (Fully Diluted) Ex Items

 

 

 

 

 

$

0.57

 

 

 

 

 

$

0.50

 

 

 

 

 

Fully Diluted Shares

 

21.6

 

NA

 

20.9

 

NA

 

-3.4

%

18.7

 

NA

 

-10.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBITDA

 

(10.9

)

-6.7

%

22.7

 

11.2

%

-308.5

%

21.5

 

10.6

%

5.5

%

Depreciation & Amortization

 

5.1

 

3.1

%

5.1

 

2.5

%

0.0

%

5.5

 

2.7

%

8.8

%

 

Source: CJS Securities Estimates, Company Documents

 



 

MAXIMUS, Inc. (MMS)

Income Statement

All Figures $MM, except per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FY 2004a

 

FY 2005a

 

FY 2006e

 

Q1 12/06

 

Q2 3/07

 

Q3 6/07

 

Q4 9/07

 

FY 2007e

 

Q1 12/07

 

Q2 3/08e

 

Q3 6/08e

 

Q4 9/08e

 

FY 2008e

 

FY 2009e

 

Revenue

 

603.8

 

647.5

 

700.9

 

161.1

 

179.1

 

196.6

 

201.9

 

738.6

 

202.0

 

210.0

 

226.0

 

230.1

 

868.0

 

950.9

 

% growth year-to-year

 

8.1

%

7.2

%

8.2

%

-1.0

%

-0.4

%

5.3

%

17.5

%

5.4

%

25.3

%

17.3

%

15.0

%

14.0

%

17.5

%

9.5

%

Cost of Revenue

 

(427.7

)

(467.6

)

(547.4

)

(140.9

)

(136.2

)

(138.1

)

(146.4

)

(561.6

)

(149.2

)

(153.3

)

(160.8

)

(161.8

)

(625.1

)

(675.5

)

% of Revenue

 

70.8

%

72.2

%

78.1

%

87.4

%

76.1

%

70.3

%

72.5

%

76.0

%

73.9

%

73.0

%

71.2

%

70.3

%

72.0

%

71.0

%

% growth year-to-year

 

9.2

%

9.3

%

17.1

%

19.4

%

1.3

%

-13.0

%

7.5

%

2.6

%

5.9

%

12.6

%

16.4

%

10.6

%

11.3

%

8.0

%

Gross Profit

 

176.0

 

180.0

 

136.3

 

20.3

 

42.9

 

58.4

 

55.5

 

177.1

 

52.8

 

56.7

 

65.2

 

68.3

 

242.9

 

275.4

 

Gross Margin

 

29.2

%

27.8

%

19.5

%

12.6

%

23.9

%

29.7

%

27.5

%

24.0

%

26.1

%

27.0

%

28.8

%

29.7

%

28.0

%

29.0

%

% growth year-to-year

 

7.0

%

2.2

%

-24.2

%

-54.7

%

-5.4

%

449.1

%

55.8

%

29.9

%

160.2

%

32.2

%

11.5

%

23.0

%

37.2

%

13.4

%

Selling, General & Administrative

 

(113.0

)

(116.7

)

(129.7

)

(34.7

)

(34.5

)

(35.4

)

(31.1

)

(135.6

)

(36.3

)

(37.8

)

(40.7

)

(41.4

)

(156.1

)

(171.2

)

% of Revenue

 

18.7

%

18.0

%

18.5

%

21.5

%

19.2

%

18.0

%

18.0

%

18.4

%

18.0

%

18.0

%

18.0

%

18.0

%

18.0

%

18.0

%

% Growth Year-to-Year

 

5.2

%

3.3

%

11.1

%

9.8

%

11.5

%

9.5

%

-10.9

%

4.6

%

4.6

%

9.7

%

15.1

%

33.1

%

15.2

%

9.6

%

Write off of deferred contract costs

 

 

 

 

 

(17.1

)

(28.0

)

(6.5

)

 

 

0.2

 

 

 

(2.2

)

 

 

 

 

 

 

 

 

 

 

Legal Expense

 

0.0

 

(7.0

)

(9.4

)

(3.0

)

(6.1

)

(33.0

)

(2.5

)

(44.6

)

 

 

 

 

 

 

 

 

0.0

 

0.0

 

Operating Profit

 

63.0

 

56.3

 

(2.8

)

(17.4

)

2.3

 

(9.9

)

21.8

 

(3.1

)

16.5

 

18.9

 

24.5

 

26.8

 

86.7

 

104.3

 

% of Revenue

 

10.4

%

8.7

%

-0.4

%

-10.8

%

1.3

%

-5.1

%

10.8

%

-0.4

%

8.2

%

9.0

%

10.8

%

11.7

%

10.0

%

11.0

%

% Growth Year-to-Year

 

10.5

%

-10.7

%

-105.0

%

-237.0

%

-83.1

%

-67.8

%

1281.0

%

11.0

%

-195.0

%

714.6

%

-346.6

%

22.8

%

-2865.9

%

20.2

%

Net Interest Income & Other

 

1.0

 

3.3

 

6.9

 

1.6

 

1.6

 

0.9

 

2.1

 

6.3

 

1.5

 

0.4

 

0.3

 

0.3

 

2.5

 

1.8

 

Pretax Income

 

64.1

 

59.6

 

4.0

 

(15.8

)

3.9

 

(9.0

)

24.0

 

3.1

 

18.0

 

19.3

 

24.8

 

27.1

 

89.2

 

106.1

 

% of Revenue

 

10.6

%

9.2

%

0.6

%

-9.8

%

2.2

%

-4.6

%

11.9

%

0.4

%

8.9

%

9.2

%

11.0

%

11.8

%

10.3

%

11.2

%

% Growth Year-to-Year

 

9.7

%

-7.0

%

-93.2

%

-207.1

%

-73.2

%

-68.4

%

633.9

%

-22.7

%

-214.3

%

390.4

%

-374.5

%

13.2

%

2761.2

%

18.9

%

Taxes

 

(25.3

)

(23.6

)

(1.6

)

5.8

 

(1.6

)

(5.4

)

(10.3

)

(11.4

)

(7.4

)

(7.6

)

(9.7

)

(10.6

)

(35.3

)

(41.4

)

Tax Rate

 

39.5

%

39.5

%

39.0

%

36.9

%

40.0

%

-59.4

%

42.8

%

364.7

%

41.1

%

39.4

%

39.0

%

39.0

%

39.5

%

39.0

%

Net Income

 

38.8

 

36.1

 

2.5

 

(9.9

)

2.4

 

(14.4

)

13.7

 

(8.3

)

10.6

 

11.7

 

15.1

 

16.6

 

54.0

 

64.7

 

% of Revenue

 

6.4

%

5.6

%

0.4

%

-6.2

%

1.3

%

-7.3

%

6.8

%

-1.1

%

5.3

%

5.6

%

6.7

%

7.2

%

6.2

%

6.8

%

% Growth Year-to-Year

 

9.7

%

-7.0

%

-93.2

%

-211.7

%

-73.4

%

-16.9

%

588.3

%

-435.6

%

-206.6

%

395.1

%

-205.1

%

20.7

%

-753.8

%

19.9

%

Net Earnings per Share fd

 

$

1.76

 

$

1.67

 

$

0.11

 

$

(0.48

)

$

0.11

 

$

(0.65)

 

$

0.63

 

$

(0.38

)

$

0.51

 

$

0.62

 

$

0.78

 

$

0.85

 

$

2.75

 

$

3.30

 

% Growth Year-to-Year

 

6.3

%

-5.4

%

-93.2

%

-218.1

%

-73.5

%

-18.8

%

589.3

%

-435.0

%

-205.9

%

472.6

%

-219.8

%

36.0

%

-827.7

%

20.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (Charges)/Income

 

0.0

 

(4.2

)

(23.8

)

(17.3

)

(7.6

)

(28.6

)

(1.2

)

(54.7

)

(1.3

)

0.0

 

0.0

 

0.0

 

(1.3

)

0.0

 

Pro-Forma Net Income(ex one time items)

 

38.8

 

40.3

 

26.2

 

7.3

 

10.0

 

14.2

 

14.9

 

46.4

 

11.9

 

11.7

 

15.1

 

16.6

 

55.3

 

64.7

 

Pro-Forma EPS (ex one time items)

 

$

1.76

 

$

1.86

 

$

1.20

 

$

0.34

 

$

0.45

 

$

0.65

 

$

0.68

 

$

2.12

 

$

0.57

 

$

0.62

 

$

0.78

 

$

0.85

 

$

2.82

 

$

3.30

 

% Growth Year-to-Year

 

6.3

%

5.7

%

-35.4

%

-19.2

%

6.9

%

-1044.8

%

62.2

%

76.6

%

68.4

%

35.4

%

21.2

%

25.4

%

32.6

%

17.2

%

FAS 123R Options expense pre-tax**

 

0.0

 

0.0

 

5.8

 

1.5

 

1.5

 

0.8

 

0.8

 

4.5

 

1.1

 

1.1

 

1.1

 

1.1

 

4.4

 

4.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FD EPS before options exp.

 

$

1.76

 

$

1.86

 

$

1.36

 

$

0.38

 

$

0.49

 

$

0.70

 

$

0.70

 

$

1.58

 

$

0.60

 

$

0.65

 

$

0.82

 

$

0.89

 

$

2.95

 

$

3.44

 

% Growth Year-to-Year

 

6.3

%

5.7

%

-26.7

%

-17.4

%

6.2

%

-2656.0

%

52.5

%

15.7

%

58.6

%

31.7

%

16.2

%

26.6

%

87.0

%

16.5

%

Weighted Avg. S/O (mil)-fd

 

22.0

 

21.7

 

21.8

 

21.6

 

22.0

 

22.0

 

21.9

 

21.9

 

20.9

 

19.0

 

19.3

 

19.4

 

19.6

 

19.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBITDA

 

76.2

 

71.4

 

20.6

 

(10.9

)

8.7

 

29.3

 

30.7

 

22.3

 

22.7

 

25.5

 

31.1

 

33.4

 

112.7

 

128.7

 

% of Revenue

 

12.6

%

11.0

%

2.9

%

-6.7

%

4.9

%

14.9

%

15.2

%

3.0

%

11.2

%

12.1

%

13.8

%

14.5

%

13.0

%

13.5

%

% Growth Year-to-Year

 

11.6

%

-6.3

%

-71.1

%

-159.5

%

-54.8

%

-216.4

%

274.6

%

8.3

%

-308.5

%

191.7

%

6.1

%

9.0

%

404.6

%

14.2

%

Depreciation & Amortization

 

13.2

 

15.1

 

17.6

 

5.1

 

5.0

 

5.4

 

5.5

 

21.0

 

5.1

 

5.5

 

5.5

 

5.5

 

21.6

 

20.0

 

% of Revenue

 

2.2

%

2.3

%

2.5

%

3.1

%

2.8

%

2.8

%

2.7

%

2.8

%

2.5

%

2.6

%

2.4

%

2.4

%

2.5

%

2.1

%

% Growth Year-to-Year

 

17.1

%

15.2

%

16.5

%

21.9

%

19.2

%

30.2

%

6.9

%

18.8

%

0.0

%

10.6

%

1.3

%

-0.3

%

2.8

%

-7.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Source: Company Reports and CJS Securities Estimates

 


Notes:

 

(1) Pro-forma to include FAS 123 R option expense for years FY 05 and beyond

 



 

COMPANY : MAXIMUS INC

CURRENCY : USD

 

HISTORY OF RECOMMENDATION AND PRICE TARGET CHANGES

 

DATE

 

CLOSING PRICE

 

RECOMMENDATION CHANGE

 

PRICE TARGET

16-Nov-2007

 

39.92

 

 

 

49.00

10-May-2007

 

39.93

 

 

 

46.00

12-Feb-2007

 

29.34

 

 

 

38.00

22-Dec-2006

 

29.77

 

 

 

31.00

07-Aug-2006

 

27.85

 

 

 

34.00

29-Jun-2006

 

23.79

 

 

 

30.00

29-Jun-2006

 

23.79

 

MARKET OUTPERFORM

 

 

23-Nov-2005

 

37.00

 

 

 

44.00

19-Sep-2005

 

37.43

 

MARKET PERFORM

 

 

01-Jul-2005

 

36.00

 

 

 

41.00

 

Source: Firstcall & CJS Sec.

 

Charles Strauzer    cstrauzer@cjs -securities.com

 

IMPORTANT DISCLOSURES

 

Valuation Methodology: 8X 2008E EV/EBITDA

 

Investment Risks: TX contract resolution and potential liability claims, State budget cuts/reductions, management execution, competition, general macro economic factors, timing of contracts, inability to reduce costs in underperforming units, cost over-runs in fixed price contracts, penalties for non-performance, acquisitions.

 

CJS Securities, Inc. Equity Research rating system

 

Market Outperform (MO): a stock that should perform at least 15% better than the Russell 2000 index over the next 6-18 months Market Perform (MP): a stock that should perform in line with or slightly better than the Russell 2000 index

 

Market Under-Perform (MU): a stock expected to under-perform the Russell 2000 index

 

We will continue to have some stocks on a Monitor List, where we are indicating to clients not to expect a similar level of research coverage as companies on our active coverage list. Hence, we do not have investment opinions, nor do we intend to publish estimates, on Monitor list names.

 

As of 1/2/08, CJS Securities provides active research on 66 companies, of which 42 (64%) are rated MO(buy) and 24 (36%) are rated MP(hold) and 0 (0%) are rated MU(sell), we also have two additional companies on our Monitor List (no rating, estimates or price target).

 

The information and statistics in this report have been obtained from sources we believe are reliable but we do not warrant their accuracy or completeness. Prices and opinions concerning the composition of market sectors included in this report reflect the judgments as of this date and are subject to change without notice. This material is for your information only and does not constitute an offer to buy or sell, or the solicitation of any offer to buy or sell any securities. CJS Securities Inc., its affiliates, directors, officers, stockholders, employees (or members of their families), and accounts with respect to which the forgoing have investment discretion, may have long or short positions in, and may, as principal or agent, buy or sell the securities mentioned herein. Occasionally, CJS Securities, Inc. may receive sales credits or fees, directly or indirectly, when an individual company under research coverage or a related peer company does an underwritten offering.  CJS intends to seek commission related non-investment banking services over the next 3 months. Accordingly, the firm may have a conflict of interest that could effect the objectivity of this report.

 

ANALYST CERTIFICATION

 

The Research Analyst(s) who prepared the document / email hereby certify that the views expressed in this document / email

 



 

Appendix 2

 

Jefferies & Company, Inc.

 

February 7, 2008

 

Technology IT Services

 

United States of America

 

MAXIMUS (NYSE: MMS)

 

Quarter Offers Proof Point of Improved Health

 

Company Update Estimate Change

 

Rating:

 

BUY

 

Price:

 

$35.82

 

Price Target:

 

$55.00

 

Bloomberg:

 

NYSE: MMS

 

 

Market Data

 

52-Week Range:

 

$48.33-$26.65

 

Total Entprs. Value (MM):

 

$689.9

 

Market Cap. (MM):

 

$750.7

 

Insider Ownership:

 

1.7

%

Institutional Ownership:

 

97.0

%

Shares Out. (MM):

 

20.9

 

Float (MM):

 

18.2

 

Avg. Daily Vol.:

 

190,017

 

 

Financial Summary

 

Book Value (MM):

 

$

273.0

 

Book Value/Share:

 

$

13.07

 

Net Debt (MM):

 

$

(60.8

)

Net Debt/Capital:

 

0.0

%

ROE:

 

15.3

%

3-5 Yr. Est. EPS Growth Rate:

 

15.0

%

ROIC:

 

16.5

%

Lg-Trm Debt to Eqty:

 

0.0

%

 

ROE: Estimate for FYE 2008

ROIC: Estimate for FYE 2008

 

USD

 

2005A

 

2006A

 

2007A

 

2008E

 

Rev. (MM)

 

 

700.9

 

738.6

 

877.7

 

Prev.

 

 

 

 

865.0

 

EV/Rev.

 

NM

 

1.0x

 

0.9x

 

0.8x

 

EPS

 

 

 

 

 

 

 

 

 

Cal.

 

1.66

 

(0.79

)

0.59

 

3.00

 

Prev. Cal.

 

 

 

 

2.88

 

Cal. P/E

 

21.6x

 

NM

 

60.7x

 

11.9x

 

EPS Diluted

 

 

 

 

 

 

 

 

 

EPS

 

 

 

 

 

 

 

 

 

Dec

 

 

0.41

 

(0.48

)

 

Mar

 

 

0.41

 

0.11

 

 

Jun

 

 

(0.81

)

(0.65

)

 

Sep

 

 

0.09

 

0.63

 

 

FY Sep

 

 

0.11

 

(0.37

)

2.81

 

Prev. FY

 

 

 

(0.38

)

2.80

 

FY P/E

 

NM

 

NM

 

NM

 

12.7x

 

GAAP EPS.

 

 

 

 

 

 

 

 

 

Consensus

 

 

0.11

 

(0.38

)

2.73

 

 

Investment Summary

MMS should outperform the market in C08 due to accelerating top-line growth to the upper teens, an expanding operating margin likely in the double digits, and lowered operating risks due to improved control systems. We remain bullish and highlight the healthy quarter was actually even stronger than the results imply.

 

Event

Maximus reported revenue and EPS of $202 million and $0.51. Revenue was ahead of consensus based on healthy growth in the Operations segment. EPS met consensus expectations, though was negatively impacted by a $2.2 million non-cash charge and temporarily higher tax rate that veiled the upside in operating results.

 

Key Points

·             Raising our fiscal 2008 estimates to reflect new guidance. Our fiscal year 2008 revenue and EPS estimates move to $877.7 million and $2.81 from $865 million and $2.80. Management reiterated revenue guidance of $850–880 million, though made an upward revision to EPS guidance to $2.60–2.85 from $2.35–2.65 to reflect accretion from the accelerated share repurchase program. Supporting the increased guidance is $324 million of new awards during the quarter, representing a book-to-bill of 1.6x. New awards, including multi-hundred million dollar contracts in California and Texas, and a healthy sales pipeline lend confidence to our raise.

 

·             Strong quarter obscured by transitory events. Maximus reported a 25% increase in revenue and the operating margin improved from negative 8.9% a year-ago to 9.3%, after excluding a $2.2 million non-cash charge related to a forfeiture calculation on previous years’ stock-based compensation. Results were fueled by strong performance in the Operations segment (72% of revenue), which grew its top-line by a normalized 24% and swung to a 13% operating margin compared to a loss in the same quarter the previous year. The normalized growth within Operations excludes a negative $15.7 million revenue impact from the termination of the Ontario contract and reduction of the Texas contract last year.  Excluding this impact from overall results reduces top line growth by about 10%. On the other hand, the company reported a $2.2 million non-cash charge related to prior years’ stock-based compensation and a more than 100 bp temporary increase in the tax rate from a change in Canadian tax law. We note that the impact of these events combined to impact EPS by approximately $0.07, exceeding our estimate by 8 cents.

 

Valuation/Risks

At 12x our raised C08 EPS estimate, MMS is trading at nearly a 30% discount to its 10-year median forward P/E of 18x. Key risks include the impact of discretionary spending cuts in a softening economy and execution on improving the performance of the Systems segment. Please refer to the attached DCF to understand the operating assumptions supporting our $55 one-year price target.

 

Matthew G. McKay, CFA

(617) 342-7909, mmckay@Jefferies.com

 

Please see important disclosure information on pages 7 - 9 of this report.

 



 

A softening economy will potentially have a mixed impact on Maximus. Despite definitive undercurrents of concern regarding a recession, the National Association of State Budget Officers is still projecting fiscal year 2008 spending growth near 5% overall. Furthermore, approximately 65–70% of the company’s revenue currently comes from state run but federally mandated and largely federally funded programs that are relatively insulated from changes in the level of tax receipts at the state level. In past economic downturns, the company was more leveraged to the economic cycle given that the Consulting and Systems segments represented 40% of revenue, compared to approximately 28% today. The current mix is heavily weighted to services outsourcing from the Operations segment and the nature of the work being done on the Systems and Consulting side carries a stickier revenue stream than before. That said, discretionary spending cuts at the state level remain a risk, more so in fiscal 2009, though it likely does not have a material impact on Maximus’ core book of business.

 

Maximus repurchased $150 million of stock during the quarter, retiring approximately 3.8 million shares at a share price of $39.91. The company used UBS as its broker. While the interests of confidentiality precluded full disclosure of details, management was able to confirm that the bank is continuing to purchase shares and has not completely covered its position to date. Contractual obligations call for UBS to complete its transactions by August 15, 2008. Given an outlook for improving stock performance in FY08, we are keeping a keen eye on the impact on cash flow from UBS potentially having to purchase shares at a higher VWAP and subsequently requiring Maximus to make a cash outlay for the difference. That said, the stock has underperformed recently and therefore UBS may be able to purchase shares below the initial price, resulting in excess cash with which management can choose to repurchase additional shares. The share repurchase has been accretive to EPS and has not been detrimental to Maximus’ ability to meet future liquidity requirements and investment opportunities. Furthermore, Maximus continues to be significantly cash generative and management has also arranged a $50 million credit facility that carries the potential to increase to $75 million.

 

Revenue for fiscal 1Q was $202 million, a 25% increase y/y. Revenue growth was primarily driven by the Operations segment, which increased 43% y/y. Operating income was $16.5 million, representing an 8.2% operating margin that met expectations. Operating margins showed substantial improvement y/y though declined sequentially due to some 4Q seasonality in the Operations segment, investments made in the Consulting segment, and losses related to legacy contracts and product build-outs in the Systems segment. Management still expects total company operating margins of approximately 10% for the fiscal year. Net income for the quarter was $10.6 million or $0.51 per diluted share. Backing out a temporary increase in the overall tax rate and a $2.2 million non-cash charge related to stock based compensation from previous years, we estimate that EPS could have been $0.07 higher. Cash flow from operations for the quarter was $20.8 million, with free cash flow of $16.7 million. Management expects full fiscal year cash flow from operations of $50–60 million and free cash flow of $30–40 million.

 

Operations segment revenue for the quarter increased 43% y/y to $145.8 million. The segment accounted for 72% of total company revenue for the quarter. Gross margin for the segment was 24.2% . Operating margin was 12.8%, compared to an operating loss during the same quarter last year. The segment growth and improved profitability was largely due to increased activity in health and workforce services and execution of a project portfolio optimization. Management indicated that operating margins for the segment should be sustainable in the 12% to 15% range for the remainder of fiscal 2008.

 

Consulting segment revenue for the quarter was $22.2 million or approximately 11% of total company revenue. Gross margin for the segment was 38.3%. Operating margin was 5.2%, a 300 bp improvement y/y. The improved performance reflects the company’s transition away from the contingent fee federal healthcare claim market and entry into new markets. Performance was tempered somewhat by required investments in state Medicaid fraud prevention services.

 

Systems segment revenue for the quarter was $34 million or approximately 17% of total company revenue. Gross margin for the segment was 26.3%. The segment reported an operating loss of $3.1 million. Results were negatively impacted by losses related to legacy project issues and losses related to the product build-out of some web-based applications. Management indicated that the same optimization process successfully used to turnaround performance in the Operations segment is now being applied to the Systems segment. However, management also indicated that it will likely be 9–12 months before the segment will turn profitable. During that time period, management also intends to evaluate strategic alternatives for the aspects of the segment that were the root of the underperformance.

 

2



 

Company Description

MAXIMUS was incorporated in 1975, has been publicly traded since 1997, and is based in Reston, Virginia. The company offers services primarily to state and local governments, as well as the federal government. In fiscal 3Q04 management reorganized the company into three business segments: health services, human services, and technical services. The main drivers of the business are program management and outsourcing of health and human services that are federally mandated and funded. In addition, the company is positioned to take advantage of legislative actions encouraging state and local spending on modernization of voting technology, improving port security, and offering improved educational services. MAXIMUS is a member of the Russell 2000 and S&P 600 SmallCap index.

 

3



 

Maximus, Inc.

2006-2009E Profit and Loss Model

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

($ in millions, except per share)

 

 

 

F2007A

 

 

 

F2008E

 

 

 

 

 

 

 

 

 

 

 

(FY End September)

 

F2006A

 

Q1A

 

Q2A

 

Q3A

 

Q4A

 

F2007A

 

Q1A

 

Q2E

 

Q3E

 

Q4E

 

F2008E

 

F2009E

 

C2006A

 

C2007A

 

C2008E

 

Income Statement Data

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

700.9

 

161.1

 

179.1

 

196.6

 

201.9

 

738.6

 

202.0

 

208.6

 

231.0

 

236.2

 

877.7

 

991.8

 

699.3

 

779.5

 

904.0

 

Cost of revenue

 

547.5

 

140.9

 

136.2

 

138.1

 

146.4

 

561.6

 

149.2

 

154.8

 

167.4

 

171.5

 

642.9

 

722.8

 

570.4

 

569.9

 

658.0

 

Gross Income

 

153.4

 

20.3

 

42.9

 

58.4

 

55.5

 

177.1

 

52.8

 

53.8

 

63.5

 

64.7

 

234.8

 

269.1

 

128.9

 

209.6

 

246.0

 

Selling, general & administrative

 

129.7

 

34.7

 

34.5

 

35.4

 

31.1

 

135.6

 

34.1

 

35.5

 

37.0

 

37.8

 

144.3

 

169.6

 

132.8

 

135.0

 

153.1

 

Amortization of intangibles

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

Other

 

26.5

 

3.0

 

6.1

 

33.0

 

2.5

 

44.6

 

2.2

 

0.0

 

0.0

 

0.0

 

2.2

 

0.0

 

29.0

 

43.8

 

0.0

 

Total operating expenses

 

703.7

 

178.5

 

176.8

 

206.5

 

180.0

 

741.8

 

185.4

 

190.3

 

204.4

 

209.3

 

789.4

 

892.3

 

732.2

 

748.7

 

811.1

 

Op Inc - Exc Options & One-time

 

23.7

 

(14.4

)

8.4

 

23.1

 

24.4

 

41.5

 

18.7

 

18.4

 

26.6

 

26.9

 

90.6

 

99.5

 

(3.9

)

74.6

 

92.8

 

Interest income, net

 

6.9

 

0.5

 

1.6

 

1.1

 

2.6

 

5.8

 

1.5

 

0.4

 

0.5

 

0.5

 

2.9

 

2.5

 

5.3

 

6.8

 

1.9

 

Other, net

 

0.0

 

0.7

 

0.0

 

(0.2

)

0.0

 

0.5

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.7

 

(0.2

)

0.0

 

Pretax income - Operating

 

30.5

 

(13.2

)

10.0

 

24.0

 

27.0

 

47.8

 

20.2

 

18.8

 

27.0

 

27.4

 

93.4

 

102.0

 

2.1

 

81.2

 

94.7

 

Taxes - Operating

 

11.9

 

(4.7

)

4.0

 

9.5

 

11.3

 

20.1

 

8.3

 

7.4

 

10.7

 

10.8

 

37.2

 

40.3

 

1.3

 

33.1

 

37.4

 

Cumulative effect accounting change

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

N.I. - Exc. One-time, Options & Div

 

18.6

 

(8.5

)

6.0

 

14.5

 

15.6

 

27.7

 

11.9

 

11.3

 

16.3

 

16.6

 

56.2

 

61.7

 

0.8

 

48.1

 

57.3

 

Diluted EPS - Operating

 

$

 

0.85

 

$

 

(0.39

)

$

 

0.27

 

$

 

0.65

 

$

 

0.69

 

$

 

1.26

 

$

 

0.57

 

$

 

0.60

 

$

 

0.86

 

$

 

0.87

 

$

 

2.88

 

$

 

3.20

 

$

 

0.03

 

$

 

2.19

 

$

 

3.00

 

Diluted EPS - Reported

 

$

 

0.11

 

$

 

(0.48

)

$

 

0.11

 

$

 

(0.65

)

$

 

0.63

 

$

 

(0.37

)

$

 

0.51

 

$

 

0.60

 

$

 

0.86

 

$

 

0.87

 

$

 

2.81

 

$

 

3.20

 

$

 

(0.79

)

$

 

0.59

 

$

 

3.00

 

Diluted Shares Outstanding

 

21.8

 

21.6

 

22.0

 

22.0

 

22.6

 

22.0

 

20.9

 

19.0

 

19.1

 

19.2

 

19.5

 

19.3

 

21.5

 

21.8

 

19.1

 

Growth

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

8.2

%

(1.0

)%

(0.4

)%

5.3

%

17.5

%

5.4

%

25.3

%

16.5

%

17.5

%

17.0

%

18.8

%

13.0

%

6.3

%

11.5

%

16.0

%

Operating income

 

(62.6

)%

N/A

 

(41.7

)%

N/A

 

3521.4

%

75.3

%

N/A

 

117.9

%

15.1

%

10.5

%

118.2

%

9.9

%

N/A

 

N/A

 

24.5

%

Net income

 

(53.7

)%

N/A

 

(35.3

)%

N/A

 

986.8

%

48.7

%

N/A

 

88.3

%

12.6

%

6.1

%

103.0

%

9.8

%

(98.0

)%

5782.5

%

19.3

%

EPS - Operating

 

(54.0

)%

N/A

 

(35.6

)%

N/A

 

911.9

%

47.3

%

N/A

 

118.3

%

31.2

%

25.0

%

129.2

%

11.1

%

(98.2

)%

6448.1

%

37.0

%

Margin Analysis

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

78.1

%

87.4

%

76.1

%

70.3

%

72.5

%

76.0

%

73.9

%

74.2

%

72.5

%

72.6

%

73.2

%

73.1

%

81.6

%

73.1

%

72.8

%

Gross income

 

21.9

%

12.6

%

23.9

%

29.7

%

27.5

%

24.0

%

26.1

%

25.8

%

27.5

%

27.4

%

26.8

%

27.1

%

18.4

%

26.9

%

27.2

%

S,G&A

 

18.5

%

21.5

%

19.2

%

18.0

%

15.4

%

18.4

%

16.9

%

17.0

%

16.0

%

16.0

%

16.4

%

17.1

%

19.0

%

17.3

%

16.9

%

Amortization

 

0.0

%

0.0

%

0.0

%

0.0

%

0.0

%

0.0

%

0.0

%

0.0

%

0.0

%

0.0

%

0.0

%

0.0

%

0.0

%

0.0

%

0.0

%

Operating Income

 

3.4

%

(8.9

)%

4.7

%

11.7

%

12.1

%

5.6

%

9.3

%

8.8

%

11.5

%

11.4

%

10.3

%

10.0

%

(0.6

)%

9.6

%

10.3

%

Pretax Income

 

4.4

%

-8.2

%

5.6

%

12.2

%

13.4

%

6.5

%

10.0

%

9.0

%

11.7

%

11.6

%

10.6

%

10.3

%

0.3

%

10.4

%

10.5

%

Tax rate

 

39.0

%

35.9

%

40.0

%

-59.4

%

42.0

%

364.7

%

41.1

%

39.5

%

39.5

%

39.5

%

39.8

%

39.5

%

61.1

%

40.8

%

39.5

%

Net Income

 

2.7

%

(5.3

)%

3.4

%

7.4

%

7.7

%

3.7

%

5.9

%

5.4

%

7.1

%

7.0

%

6.4

%

6.2

%

0.1

%

6.2

%

6.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Source: Company reports and Jefferies & Company estimates

Note: Operating EPS excludes one-time gains and charges.

 

4


 


 

Maximus, Inc.

2006-2009E Balance Sheet and Cash Flow Model

 

($ in millions, except per share)

 

 

 

 

 

F2008E

 

 

 

 

 

 

 

 

 

 

 

(FY End September)

 

2006A

 

2007A

 

Q1A

 

Q2E

 

Q3E

 

Q4E

 

2008E

 

2009E

 

C2006A

 

C2007A

 

C2008E

 

Balance Sheet Summary

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and Cash Equivalents

 

$

158.4

 

$

197.0

 

$

62.7

 

$

51.7

 

$

59.4

 

$

70.9

 

$

70.9

 

$

104.7

 

$

164.1

 

$

62.7

 

$

96.7

 

Receivables

 

201.1

 

175.2

 

169.0

 

203.3

 

222.2

 

218.7

 

218.7

 

250.1

 

166.9

 

169.0

 

191.0

 

Other

 

24.2

 

26.6

 

19.0

 

21.3

 

19.4

 

22.0

 

22.0

 

23.4

 

30.2

 

19.0

 

20.0

 

Total Current Assets

 

383.7

 

398.7

 

250.6

 

276.3

 

301.0

 

311.6

 

311.6

 

378.2

 

361.2

 

250.6

 

307.6

 

Property, Equipment & Software, Net

 

67.4

 

65.4

 

64.9

 

64.6

 

64.1

 

63.9

 

63.9

 

65.6

 

64.6

 

64.9

 

64.6

 

Investments

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

Goodwill & Other Intangibles

 

92.4

 

89.7

 

89.3

 

89.3

 

89.3

 

89.3

 

89.3

 

89.3

 

90.9

 

89.3

 

89.3

 

Other

 

15.1

 

10.6

 

11.3

 

13.4

 

13.4

 

13.0

 

13.0

 

14.3

 

12.7

 

11.3

 

12.3

 

Total Assets

 

558.5

 

564.5

 

416.1

 

443.6

 

467.8

 

477.8

 

477.8

 

547.3

 

529.4

 

416.1

 

473.8

 

Accounts Payable

 

54.5

 

54.4

 

52.4

 

58.5

 

60.7

 

63.8

 

63.8

 

72.5

 

44.4

 

52.4

 

57.8

 

Accrued Expenses

 

24.4

 

29.4

 

25.8

 

28.1

 

32.8

 

34.5

 

34.5

 

38.9

 

22.2

 

25.8

 

29.1

 

Current Portion Long-term Debt

 

1.7

 

1.6

 

1.6

 

1.6

 

1.6

 

1.6

 

1.6

 

1.6

 

1.7

 

1.6

 

1.6

 

Deferred Revenue

 

54.4

 

38.5

 

37.5

 

48.3

 

52.8

 

45.1

 

45.1

 

51.0

 

48.3

 

37.5

 

42.3

 

Other

 

1.6

 

7.5

 

2.7

 

3.3

 

3.5

 

3.5

 

3.5

 

3.8

 

1.1

 

2.7

 

3.5

 

Total Current Liabilities

 

136.6

 

131.6

 

120.0

 

139.8

 

151.3

 

148.5

 

148.5

 

167.9

 

117.6

 

120.0

 

134.3

 

Long-term Debt

 

2.0

 

0.4

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

1.6

 

0.0

 

0.0

 

Other

 

14.9

 

23.1

 

23.5

 

23.5

 

23.5

 

23.5

 

23.5

 

23.5

 

13.7

 

23.5

 

23.5

 

Total Liabilities

 

153.6

 

155.1

 

143.5

 

163.3

 

174.9

 

172.0

 

172.0

 

191.4

 

133.0

 

143.5

 

157.8

 

Minorty Interest

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

Total Shareholders’ Equity

 

404.9

 

409.4

 

272.6

 

280.2

 

292.9

 

305.8

 

305.8

 

355.9

 

396.5

 

272.6

 

315.9

 

Total Liabilities and Owners Equity

 

$

558.5

 

$

564.5

 

$

416.1

 

$

443.6

 

$

467.8

 

$

477.8

 

$

477.8

 

$

547.3

 

$

529.4

 

$

416.1

 

$

473.8

 

Balance Sheet Metrics

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

DSO

 

80

 

66

 

56

 

69

 

69

 

68

 

73

 

74

 

72

 

56

 

55

 

DSO (Unbilled)

 

25

 

21

 

22

 

20

 

19

 

17

 

18

 

18

 

23

 

22

 

21

 

DPO

 

36

 

35

 

32

 

34

 

33

 

34

 

36

 

37

 

29

 

32

 

32

 

ROE

 

0.6

%

(2.0

)%

0.6

%

6.4

%

15.3

%

15.3

%

15.3

%

18.7

%

(4.2

)%

0.6

%

19.5

%

ROIC (incl GW)

 

(4.8

)%

(3.4

)%

5.9

%

7.1

%

16.9

%

16.5

%

16.5

%

15.5

%

(12.1

)%

5.9

%

16.2

%

Debt/ Capital

 

0.9

%

0.5

%

0.6

%

0.6

%

0.6

%

0.5

%

0.5

%

0.5

%

0.8

%

0.6

%

0.5

%

Debt/ TTM EBITDA

 

0.3x

 

0.1x

 

0.0x

 

0.0x

 

0.0x

 

0.0x

 

0.0x

 

0.0x

 

(0.2)x

 

0.0x

 

0.0x

 

Net Cash/ Share

 

$

7.02

 

$

8.84

 

$

2.91

 

$

2.62

 

$

3.02

 

$

3.60

 

$

3.53

 

$

5.33

 

$

7.43

 

$

2.91

 

$

4.93

 

Book Value/Share

 

$

18.56

 

$

18.59

 

$

13.07

 

$

14.79

 

$

15.37

 

$

15.97

 

$

15.68

 

$

18.46

 

$

18.36

 

$

13.07

 

$

16.45

 

Invested Capital (in GW)

 

355.8

 

358.4

 

353.9

 

365.8

 

352.1

 

376.2

 

376.2

 

424.2

 

354.6

 

353.9

 

375.8

 

Cash Flow Summary

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Sources

 

679.3

 

782.3

 

210.7

 

169.9

 

214.0

 

237.4

 

832.0

 

957.8

 

727.1

 

793.1

 

880.0

 

Operating Uses

 

689.8

 

748.9

 

194.0

 

175.9

 

201.4

 

221.1

 

792.4

 

904.3

 

731.6

 

748.4

 

826.4

 

Free Cash Flow

 

(10.4

)

33.4

 

16.7

 

(6.1

)

12.6

 

16.3

 

39.5

 

53.5

 

(4.5

)

44.7

 

53.6

 

Acquisitions/ LT Investments

 

0.0

 

1.9

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

0.0

 

2.2

 

(0.3

)

0.0

 

Non-operating Cash Flow

 

(9.1

)

(4.3

)

(24.9

)

(4.9

)

(4.9

)

(4.9

)

(39.5

)

(19.6

)

(12.3

)

(4.0

)

(19.5

)

Reported CFO

 

15.7

 

51.2

 

20.8

 

(1.0

)

17.7

 

21.5

 

59.1

 

77.2

 

18.3

 

64.4

 

74.9

 

NOPAT

 

(17.2

)

(12.1

)

15.2

 

12.2

 

17.2

 

17.5

 

62.2

 

65.6

 

(43.0

)

20.7

 

61.0

 

EBITDA

 

14.8

 

17.8

 

21.6

 

23.8

 

32.2

 

32.3

 

109.8

 

121.6

 

(14.3

)

51.7

 

114.4

 

Annual Growth

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Sources

 

8.4

%

15.2

%

5.4

%

(6.5

)%

4.8

%

20.8

%

6.3

%

15.1

%

15.4

%

9.1

%

11.0

%

Operating Uses

 

19.6

%

8.6

%

(0.3

)%

4.9

%

16.6

%

3.3

%

5.8

%

14.1

%

24.8

%

2.3

%

10.4

%

Free Cash Flow

 

N/A

 

N/A

 

209.1

%

N/A

 

(60.1

)%

N/A

 

18.5

%

35.3

%

N/A

 

N/A

 

20.0

%

Reported CFO

 

(78.8

)%

226.1

%

172.6

%

N/A

 

(48.3

)%

N/A

 

15.4

%

30.7

%

(73.5

)%

252.2

%

16.4

%

Cash Flow per Share Data

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Free Cash Flow

 

$

(0.48

)

$

1.51

 

$

0.80

 

$

(0.32

)

$

0.66

 

$

0.85

 

$

2.03

 

$

2.77

 

$

(0.23

)

$

2.09

 

$

2.79

 

Reported CFO

 

$

0.72

 

$

2.32

 

$

1.00

 

$

(0.05

)

$

0.93

 

$

1.12

 

$

3.03

 

$

4.00

 

$

0.84

 

$

2.99

 

$

3.91

 

EBITDA

 

$

0.68

 

$

0.81

 

$

1.03

 

$

1.26

 

$

1.69

 

$

1.69

 

$

5.63

 

$

6.31

 

$

(0.67

)

$

2.37

 

$

5.99

 

 

Notes:

Operating Sources defined as Revenue + Decrease in operating assets + Adjustments for acquisitions and reclassifications

Operating Use defined as Cash expenses + Decrease in operating liabilities + Capital expenditures & capitalized software

Free Cash Flow = Operating Sources - Operating Uses

Source: Company Reports and Jefferies & Co. estimates

 

5



 

 

 

One-Year Price Target

Discounted Cash Flow Analysis (10-Year)

($ in millions, except per share)

 

Projection Period Assumptions

 

Last Actual FY End:

 

9/30/2007

 

Exit Multiple FY End:

 

9/30/2017

 

Price Target Date:

 

2/7/2009

 

Calendar Adjustment Factor:

 

-1.36

 

 

Discount Assumptions

 

Base discount rate:

 

10.5

%

Incremental discount rate:

 

2

%

Derived WACC

 

13.1

%

 

Operating Assumptions

 

 

 

F2008E

 

F2009E

 

Organic Growth

 

18.8

%

13.0

%

Acquired Revenue

 

0.0

%

0.0

%

Operating Margin

 

10.3

%

10.0

%

DSO

 

91

 

92

 

ROIC (In GW)

 

16.5

%

15.5

%

 

Balance Sheet Adjustments

 

Dec-07

 

Cash & ST Investments

 

62

 

ST & LT Debt

 

2

 

 

Miscellaneous

 

5-Year Normal Growth

 

15

%

10-Year Treasury Yield

 

3.6

%

Estimated Beta

 

1.68

 

Debt Interest Rate

 

7.0

%

Expected S&P 500 Performance

 

9.0

%

Diluted Shares Outstanding

 

19.0

 

 

Exit Multiple Assumptions

 

FCF exit multiple

 

10.7x

 

Incremental exit multiple

 

0.5x

 

 

 

 

F2007A

 

F2008E

 

F2009E

 

F2010E

 

F2011E

 

F2012E

 

F2013E

 

F2014E

 

F2015E

 

F2016E

 

F2017E

 

Free cash flow

 

33.4

 

39.5

 

53.5

 

61.5

 

70.7

 

81.4

 

91.9

 

102.0

 

111.2

 

119.0

 

125.0

 

Growth Rate

 

 

 

19

%

35

%

15

%

15

%

15

%

13

%

11

%

9

%

7

%

5

%

 

Note: FCF equals CFO minus Capital Expenditures and Capitalized Software

 

 

 

10.5% Discount Rate

 

12.5% Discount Rate

 

14.5% Discount Rate

 

FCF Multiple

 

10.7x

 

11.2x

 

11.7x

 

10.7x

 

11.2x

 

11.7x

 

10.7x

 

11.2x

 

11.7x

 

Terminal Value

 

1,334

 

1,396

 

1,459

 

1,334

 

1,396

 

1,459

 

1,334

 

1,396

 

1,459

 

Present Value of Terminal Value

 

562

 

589

 

615

 

482

 

504

 

527

 

414

 

433

 

452

 

Present Value of Cash Flows

 

515

 

515

 

515

 

478

 

478

 

478

 

445

 

445

 

445

 

Asset Value

 

1,077

 

1,103

 

1,130

 

959

 

982

 

1,004

 

858

 

877

 

897

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

62

 

62

 

62

 

62

 

62

 

62

 

62

 

62

 

62

 

Debt

 

2

 

2

 

2

 

2

 

2

 

2

 

2

 

2

 

2

 

Implied Equity Value

 

1,138

 

1,164

 

1,191

 

1,020

 

1,042

 

1,065

 

919

 

938

 

958

 

Implied Equity Value per Share

 

$

60.03

 

$

61.42

 

$

62.81

 

$

53.81

 

$

55.00

 

$

56.19

 

$

48.47

 

$

49.50

 

$

50.52

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Implied Perpetual Growth Rate

 

1.0

%

1.4

%

1.8

%

2.9%

 

3.3

%

3.6

%

4.7%

 

5.1

%

5.5

%

 

Source: Jefferies & Company, Inc.

 

6



 

ANALYST CERTIFICATIONS

I, Matthew McKay, CFA, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) and subject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed in this research report.

 

I, Jason O’Connell, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) and subject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed in this research report.

 

Important Disclosures

 

As is the case with all Jefferies employees, the analyst(s) responsible for the coverage of the financial instruments discussed in this report receive compensation based in part on the overall performance of the firm, including investment banking income. We seek to update our research as appropriate, but various regulations may prevent us from doing so. Aside from certain industry reports published on a periodic basis, the large majority of reports are published at irregular intervals as appropriate in the analyst’s judgement.

 

Meanings of Jefferies & Company, Inc, Ratings

Buy - Describes stocks that we expect to provide a total return (price appreciation plus yield) of 15% or more within a 12-month period.

 

Hold - Describes stocks that we expect to provide a total return (price appreciation plus yield) of plus or minus 15% within a 12-month period.

 

Underperform - Describes stocks that we expect to provide a total negative return (price appreciation plus yield) of 15% or more within a 12-month period.

 

Our focus on mid-capitalization and growth companies implies that many of the companies we cover are typically more volatile than the overall stock market, which can be amplified for companies with an average stock price consistently below $10. For companies in this category only, the expected total return (price appreciation plus yield) for Buy rated stocks is 20% or more within a 12-month period. For Hold rated stocks with an average stock price consistently below $10, the expected total return (price appreciation plus yield) is plus or minus 20% within a 12-month period. For Underperform rated stocks with an average stock price consistently below $10, the expected total return (price appreciation plus yield) is minus 20% within a 12-month period.

 

NR - The investment rating and price target have been temporarily suspended. Such suspensions are in compliance with applicable regulations and/or Jefferies & Company, Inc. policies.

 

CS - Coverage Suspended. Jefferies & Company, Inc. has suspended coverage of this company.

 

NC - Not covered. Jefferies & Company, Inc. does not cover this company.

 

Speculative Buy - Describes stocks we view with a positive bias, whose company fundamentals and financials are being monitored, but for which there is insufficient information for Jefferies & Company, Inc. to assign a Buy, Hold or Underperform Rating. At the discretion of the analyst, a Speculative buy-rated stock could also include stocks with a price under $5, or where the company is not investment grade to highlight the risk of the situation.

 

Speculative Underperform - Describes stocks we view with a negative bias, whose company fundamentals and financials are being monitored, but for which there is insufficient information for Jefferies & Company, Inc. to assign a Buy, Hold or Underperform Rating. At the discretion of the analyst, a Speculative underperform-rated stock could also include stocks with a price under $5, or where the company is not investment grade to highlight the risk of the situation.

 

Restricted - Describes issuers where, in conjunction with Jefferies engagement in certain transactions, company policy or applicable securities regulations prohibit certain types of communications, including investment recommendations.

 

Monitor - Describes stocks whose company fundamentals and financials are being monitored, and for which no financial projections or opinions on the investment merits of the company are provided.

 

7



 

Valuation Methodology

Jefferies’ methodology for assigning ratings may include the following: market capitalization, maturity, growth/value, volatility and expected total return over the next 12 months. The price targets are based on several methodologies, which may include, but are not restricted to, analyses of market risk, growth rate, revenue stream, discounted cash flow (DCF), EBITDA, EPS, cash flow (CF), free cash flow (FCF), EV/EBITDA, P/E, PE/growth, P/CF, P/FCF, premium (discount)/average group EV/EBITDA, premium (discount)/average group P/E, sum of the parts, net asset value, dividend returns, and return on equity (ROE) over the next 12 months.

 

Risk which may impede the achievement of our Price Target

This report was prepared for general circulation and does not provide investment recommendations specific to individual investors. As such, the financial instruments discussed in this report may not be suitable for all investors and investors must make their own investment decisions based upon their specific investment objectives and financial situation utilizing their own financial advisors as they deem necessary. Past performance of the financial instruments recommended in this report should not be taken as an indication or guarantee of future results. The price, value of, and income from, any of the financial instruments mentioned in this report can rise as well as fall and may be affected by changes in economic, financial and political factors. If a financial instrument is denominated in a currency other than the investor’s home currency, a change in exchange rates may adversely affect the price of, value of, or income derived from the financial instrument described in this report. In addition, investors in securities such as ADRs, whose values are affected by the currency of the underlying security, effectively assume currency risk.

 

 

Distribution of Ratings

 

 

 

 

 

 

 

IB Serv./Past 12 Mos.

 

Rating

 

Count

 

Percent

 

Count

 

Percent

 

BUY [BUY/ SB]

 

509

 

58.71

 

60

 

11.79

 

 

 

 

 

 

 

 

 

 

 

HOLD [HOLD]

 

337

 

38.87

 

28

 

8.31

 

 

 

 

 

 

 

 

 

 

 

SELL [SU/ UNPF]

 

21

 

2.42

 

3

 

14.29

 

 

OTHER DISCLOSURES

This material has been prepared by Jefferies & Company, Inc. a U.S.-registered broker-dealer, employing appropriate expertise, and in the belief that it is fair and not misleading. The information upon which this material is based was obtained from sources believed to be reliable, but has not been independently verified, therefore, we do not guarantee its accuracy. Additional and supporting information is available upon request. This is not an offer or solicitation of an offer to buy or sell any security or investment. Any opinion or estimates constitute our best judgment as of this date, and are subject to change without notice. Jefferies & Company, Inc. and Jefferies International Limited and their

 

8



 

affiliates and their respective directors, officers and employees may buy or sell securities mentioned herein as agent or principal for their own account.

 

Additional information for UK and Canadian investors

This material is approved for distribution in the United Kingdom by Jefferies International Limited which is authorized and regulated by the Financial Services Authority (“FSA”). While we believe this information and materials upon which this information was based are accurate, except for any obligations under the rules of the FSA, we do not guarantee its accuracy. This material is intended for use only by a person or entity that qualifies as an authorised person or exempt person within the meaning of section 19 of the UK Financial Services and Markets Act 2000 (the “Act”) or qualifies as a person to whom the financial promotion restrictions imposed by the Act does not apply by virtue of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, or is a person classified as an “intermediate customer” for the purposes of the Conduct of Business Rules of the FSA. None of the investments or investment services mentioned or described herein are available to other persons in the UK and in particular are not available to “private customers” as defined by the rules of the FSA. For Canadian investors, this material is intended for use only by professional or institutional investors. None of the investments or investment services mentioned or described herein are available to other persons or to anyone in Canada who is not a “Designated Institution” as defined by the Securities Act (Ontario).

 

This material does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Clients should consider whether any advice or recommendation in this report is suitable for their particular circumstances and, if appropriate, seek professional advice, including tax advice. The price and value of the investments referred to herein and the income from them may fluctuate. Past performance is not a guide to future performance, future returns are not guaranteed, and a loss of original capital may occur. Fluctuations in exchange rates could have adverse effects on the value or price of, or income derived from, certain investments.

 

Jefferies & Company, Inc. research reports are disseminated and available primarily electronically, and, in some cases, in printed form. Electronic research is simultaneously available to all clients. This report or any portion hereof may not be reprinted, sold or redistributed without the written consent of Jefferies & Company, Inc. Jefferies International Limited has adopted a conflicts management policy in connection with the preparation and publication of research, the details of which are available upon request in writing to: The Compliance Officer, Jefferies International Limited, Vintners Place, 68 Upper Thames Street, London EC4V 3BJ; telephone +44 (0)20 7029 8000; facsimile +44 (0)20 7029 8010. Jefferies International Limited is authorised and regulated by the Financial services Authority.

 

© 2008 Jefferies & Company, Inc,

 

9


 


 

Appendix 3

 

GARP Research & Securities

 

Quarterly Summary

 

Jeff Burnett

410.318.5014
burnett@garpresearch.com

 

February 7, 2008

 

 

 

MAXIMUS (MMS)

 

Buy

 

 

MMS - $36

 

Market Cap: $660 million

 

 

Company Description:

MAXIMUS provides outsourced program management support, IT services, and consulting primarily to state & local governments.  The company’s competitive edge is its 30-year operating history, which provides an embedded knowledge base of arcane government regulations and program administration and support needs.

 

Operating & Financial Highlights

($ Millions, Adjusted for Certain Items, Sept. FY)

 

 

 

2007

 

2008F

 

2009F

 

2010F

 

Sales

 

739

 

865

 

985

 

1,125

 

Operating Income

 

(3

)

84

 

114

 

133

 

 

 

 

 

 

 

 

 

 

 

Diluted Shares

 

22

 

20

 

20

 

20

 

EPS

 

$

(0.38

)

$

2.75

 

$

3.63

 

$

4.20

 

EPS (ex 123R)

 

$

(0.26

)

$

2.87

 

$

3.75

 

$

4.32

 

 

 

 

 

 

 

 

 

 

 

P/E

 

n/a

 

13

 

10

 

9

 

 

 

 

 

 

 

 

 

 

 

Operating Margins

 

n/a

 

10

%

12

%

12

%

Capital Employed

 

210

 

242

 

252

 

253

 

Pretax ROCE

 

n/a

 

35

%

45

%

53

%

Pretax ROTCE

 

n/a

 

55

%

70

%

82

%

 

FY 2008 Estimated Quarterly Results

 

 

 

Q1

 

Q2F

 

Q3f

 

Q4F

 

Sales

 

202

 

210

 

223

 

230

 

EPS

 

$

0.51

 

$

0.63

 

$

0.72

 

$

0.88

 

EPS (ex. 123R)

 

$

0.54

 

$

0.66

 

$

0.75

 

$

0.91

 

 

GARP’s Quintile Ranking System

 

 

MMS scores in GARP’s most attractive growth quintile and most attractive valuation quintile. See disclaimer for additional information.

 

Summary Points

 

Growth:

·                  Continued solid backlog of sales opportunities and contract wins, and strong record of re-bid wins.

 

Quality:

·                  Leading position in its core outsourcing businesses, with intellectual & operational barriers to entry.

 

·                  Strong balance sheet; net cash of $3/share. Solid cash generation. Pre-tax tangible ROCE is targeted to exceed 80% within our 3-year investment horizon.

 

Control of Risk:

·                  MAXIMUS repurchased $150 million in stock in Q1 FY08 under its Accelerated Share Repurchase (ASR) program; $40 million remains available for repurchase from prior authorizations.

 

·                  MMS trades at 9x our out-year (FY 2010F) EPS estimate of $4.20.

 

Recent Developments

MAXIMUS’ fiscal Q108 results were driven by its Operations segment (72% of Q1 sales), with normalized revenues up 24%, driven by the Texas health & human services contract and workforce services business. Operations recorded a 13% operating margin, up from a loss in Q207. Consulting (11%) contributed sales of $22 million and a modest 5% operating margin reflecting the transition from the contingent fee business and investment in new markets such as Medicaid fraud. Systems’ (17%) sales of $34 million were below expectations, and flattish with last year, with an operating loss of $3 million versus a loss of $1.6 million last year. The problems stemmed from education systems and justice businesses which required significant IT spending; we are targeting profitability here by fiscal Q4 (September) 2008. The company’s cash position remains strong. MAXIMUS used $150 million to repurchase stock in Q1 (retiring ~3.8 million shares), enjoyed free cash flow of $17 million, and ended the quarter with $63 million in net cash (~$3/share). Management expects free cash flow of $30-40 million in FY 2008. Driving both the top-line and margins going forward will be the company’s core Operations segment, we believe. MAXIMUS’ sales pipeline remains robust, and should reasonably support mid-teens revenue gains going forward. That said, the state fiscal environment is mixed and could negatively impact discretionary spending. But nearly 70% of MAXIMUS’ revenue is driven by state run, federally-funded programs that should be largely resilient to budgetary issues at the state level. Health care reform is a particularly promising opportunity for MAXIMUS and its core outsourcing business.

 

Please refer to important disclosures on final page. The information contained herein has been obtained from sources believed reliable but is not necessarily complete and accuracy is not guaranteed. Opinions do not constitute solicitation of orders.

 



 

Recommendation Rationale

MAXIMUS is the leader in several niche service markets in the state & local government outsourcing sector including Medicaid eligibility and welfare-to-work. Management is focusing on the company’s core health & human services outsourcing strengths. Historically, MAXIMUS enjoyed high double-digit organic growth because states outsource only a fraction of their services and the trend is to do more. The past several years unveiled a marked slowing of new government programs, yet MAXIMUS managed to grow its top line in the mid-single digits and weather the budgetary storm. In calendar year 2005, MAXIMUS strengthened its organization by adding senior managers, cutting underperforming businesses, and investing in quality control and technology. CEO Rich Montoni has installed financial discipline in the company; MAXIMUS is focused on profitability, selectivity regarding its assignments, and dispositions of non-strategic units. MAXIMUS announced in June 2006 that it was amending its $370 million, 5-year Texas integrated eligibility & enrollment subcontract with Accenture because of significant operational and planning difficulties. This was the first time that MAXIMUS had agreed to subcontract for a large scale assignment, and it proved to be a costly mistake. In May 2007, then company announced that it extricated itself from a contractor role on this project and now works as a prime contractor directly with the Texas health & human services agency. We believe management’s distraction with Texas is now behind us, and we anticipate a more discriminating acceptance of new projects. Meanwhile, MAXIMUS generates cash, enjoys a strong balance sheet ($3/share in net cash), and possesses a powerful brand in the government sector based on its imbedded knowledge and 30-year operating history. The company’s contract wins, strong re-bid wins, and robust pipeline give us confidence that MAXIMUS can revert to its growth trajectory in FY 2008.

 

Operations

With the exception of a rather unusual FY 2007, MAXIMUS has been profitable every year since its founding in 1975. The company employs minimal capital and can achieve a pretax return on tangible capital (ROCE) exceeding 80% by FY (September) 2010F, according to our estimate. However, deep problems associated with the company’s Texas subcontract decimated reported earnings (and hence ROCE) beginning in FY 2006, but we project that this metric will rise again to strong levels within our 3-year investment horizon.

 

MAXIMUS has three business lines: Operations (68% of FY 2007 revenues), Consulting (13%), and Systems (19%). The Operations segment includes health services such as project management services for Medicaid and the Children’s Health Insurance Plan (CHIP). MAXIMUS plugs in to state welfare records and assists states in making sure that those who are eligible for Medicaid actually receive it. In addition to Medicaid outreach, education and enrollment services, MAXIMUS customizes information systems for state Medicaid programs, collects and analyses data, and produces program materials. The company also administers programs for uninsured and underinsured children as part of the CHIP in various states. In November 2004, MAXIMUS signed a 10-year, $268 million health benefit administration contract with the government of British Columbia (BC). The implementation of this complex contract has been troublesome and MAXIMUS had been fined for certain non-compliance issues. MAXIMUS appears to have its controls now in place and we anticipate that it will be profitable in FY 2008. Human services-related functions are included in the Operations segment, including child support enforcement and welfare-to-work programs. The child care business is driven by rigid federal performance standards. MAXIMUS typically recovers funds from deadbeat dads and is compensated versus performance benchmarks. In addition to enforcement services, MAXIMUS also performs collections, customer service, payment processing, and systems consulting. MAXIMUS manages welfare-to-work programs (typically 3-year contracts) and Workforce Investment Act programs (state administered, federal job training funds for adults, youth, and dislocated workers). The company’s Texas subcontract referenced above also falls in the Operations segment. The company’s prowess in handling large contracts had justifiably been called into question, but management has pledged to avoid situations such as this going forward and will pursue prime contractor roles on manageable assignments. Operating margins reached 8.2% in Q1 FY 08 and management targets 10% as the corporate goal. MAXIMUS will focus on growing its core health & human services opportunities going forward and expects this segment to drive overall revenues in FY 08.

 

The Consulting segment includes traditional management consulting and information technology (IT) consulting to state & local governments in planning, design, procurement, and implementation of IT systems. Beginning in FY 2004, MAXIMUS experienced lower-than-anticipated profitability in Consulting due to increased competition and reduced reimbursement levels from the federal government. MAXIMUS is in the process of turning this division around but the process will likely not be achieved in the short term.

 

The Systems business assists clients with enterprise resource planning (ERP) implementations, including PeopleSoft software for a wide range of tasks and Smart Card implementations for federal and state/local governments. MAXIMUS also provides specialized software programs for state court systems and jury management, and creates and manages IT systems for state criminal justice systems. The company considered FY07 as a ‘transition year’ for Systems, as it continues to resolve unprofitable legacy contracts.

 

2



 

Competition

MAXIMUS has several rivalries in its outsourcing businesses. We estimate that MAXIMUS has 70% of the market for health care services, with Benova (a subsidiary of FleetBoston Financial) being the next major competitor. In child support, MAXIMUS competes against Affiliated Computer Services and privately-held Policy Studies Incorporated (PSI). GARP believes that MAXIMUS has half of the welfare services market, with non-profit organizations like United Way and Goodwill offering similar services. The markets for the company’s other services are considerably more competitive. In consulting, competitors include Accenture, the Big 4 accounting firms and several boutiques. In Systems, MAXIMUS competes against a large number of players including Unisys, SAP, Oracle, BearingPoint, Accenture, Deloitte, Northrop Grumman (NOC - Neutral), and Electronic Data Systems.

 

Market

Governments are increasingly outsourcing key functions to the private sector to enable performance-based management. That said, only a tiny percentage of these expenditures are currently outsourced and MAXIMUS still commands the leading market share in its space. We believe the trend towards outsourcing will only grow over time as fiscal pressures, changing regulations, and increased accountability compel state & local governments to rationalize programs and improve quality and efficiency. Importantly, outsourcing continues to be a low cost alternative that has barely penetrated this market. Demographics within the state workforce point to the likelihood of increased secular demand for MAXIMUS’ services over the long term, given the pervasive graying of the state and local government workforce, implying increased opportunities for contractors. Meanwhile, 60% of the federal workforce alone will become eligible for retirement over the next 10 years. The potential market for state operated support programs exceeds $29 billion and is driven by legislation to reform federal, state, and local welfare and health and human services programs.

 

Risks

We believe that most of MAXIMUS’s businesses are ultimately tied to federally-mandated programs that would likely continue despite fiscal issues at the state level. However, pressures such as potential reductions in federal assistance and increased costs from entitlement programs such as Medicaid could subdue discretionary spending by states, in our opinion. We continue to believe in the merits of this outsourcing trend, and MAXIMUS is well-positioned to benefit from new opportunities that will arise as budgets continue to stabilize and programs are expanded. Beginning in late FY 2004, the company experienced increased competition across its businesses, though MAXIMUS’s solid sales and backlog statistics, combined with its deep experience & quality reputation in serving state & local governments, will likely translate into reasonable growth opportunities.

 

MAXIMUS evolved in 2005-2006 as a bidder for larger outsourcing contracts, with a corresponding extension of its sales cycles. However, the company’s negative experience in this area -— particularly with its Texas health & human services subcontract with Accenture — has refocused senior management on more appropriate assignments. MAXIMUS currently is prime contractor with the Texas on a renegotiated contract.

 

3



 

Maximus, Inc.

Fiscal Year Sep 30

 

Operating & Financial Highlights

($ Millions, Adjusted for Certain Items)

 

 

 

2003

 

2004

 

2005

 

2006

 

2007

 

2008F

 

2009F

 

2010F

 

Revenue

 

558.3

 

603.8

 

647.5

 

700.8

 

738.6

 

865.0

 

985.0

 

1,125.0

 

Operating Income

 

57.0

 

63.0

 

63.3

 

(2.8

)

(2.7

)

83.9

 

114.0

 

133.0

 

Net Income

 

35.3

 

38.8

 

36.9

 

2.5

 

(8.3

)

54.2

 

72.6

 

84.0

 

Avg Shares Outstanding- Diluted

 

21.3

 

22.0

 

21.7

 

21.8

 

21.9

 

19.7

 

20.0

 

20.0

 

EPS - Diluted

 

$

1.66

 

$

1.76

 

$

1.70

 

$

0.11

 

$

(0.38

)

$

2.75

 

$

3.63

 

$

4.20

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted EPS Without FAS 123R

 

 

 

 

 

$

1.86

 

$

0.22

 

$

(0.26

)

$

2.87

 

$

3.75

 

$

4.32

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital Employed

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Property Plant & Equipment

 

40.9

 

44.0

 

55.1

 

67.3

 

67.0

 

67.0

 

67.0

 

67.0

 

Operating Working Capital

 

84.6

 

91.9

 

69.4

 

91.9

 

52.5

 

85.0

 

95.0

 

96.0

 

Other / Intangibles

 

94.8

 

105.2

 

106.0

 

89.3

 

90.0

 

90.0

 

90.0

 

90.0

 

total

 

220.3

 

241.0

 

230.5

 

248.5

 

209.5

 

242.0

 

252.0

 

253.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financing

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt

 

4.6

 

6.7

 

5.1

 

2.0

 

2.0

 

2.0

 

2.0

 

2.0

 

Shareholders Equity

 

333.2

 

373.5

 

406.0

 

404.9

 

404.6

 

316.8

 

377.4

 

429.4

 

(Less: Cash)

 

(117.5

)

(139.3

)

(180.6

)

(158.4

)

(197.1

)

(76.8

)

(127.4

)

(178.4

)

total

 

220.3

 

241.0

 

230.5

 

248.5

 

209.5

 

242.0

 

252.0

 

253.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ratios (%)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Margin

 

10.2

%

10.4

%

9.8

%

n/a

 

n/a

 

9.7

%

11.6

%

11.8

%

Return on Capital Employed

 

25.9

%

26.2

%

27.5

%

n/a

 

n/a

 

34.7

%

45.2

%

52.6

%

Return on Tangible Capital

 

43.4

%

43.1

%

46.6

%

n/a

 

n/a

 

55.2

%

70.4

%

81.6

%

Shareholders Equity / Capital

 

151.2

%

155.0

%

176.2

%

162.9

%

193.1

%

130.9

%

149.8

%

169.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Valuation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Price Earnings Multiple

 

 

 

 

 

 

 

 

 

n/a

 

13.1

 

9.9

 

8.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Segment Estimates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consulting

 

102.6

 

103.3

 

107.3

 

93.7

 

93.7

 

88.0

 

100.0

 

110.0

 

Systems

 

133.4

 

139.1

 

137.1

 

141.3

 

141.3

 

137.0

 

145.0

 

165.0

 

Operations

 

322.2

 

361.4

 

403.1

 

503.6

 

503.6

 

640.0

 

740.0

 

850.0

 

Other

 

0.0

 

0.0

 

0.0

 

(37.8

)

0.0

 

0.0

 

0.0

 

0.0

 

total

 

558.3

 

603.8

 

647.5

 

700.8

 

738.6

 

865.0

 

985.0

 

1,125.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consulting

 

15.6

 

11.0

 

10.7

 

14.5

 

6.4

 

5.0

 

6.0

 

8.0

 

Systems

 

15.3

 

15.4

 

11.4

 

(0.9

)

(4.7

)

(4.5

)

3.0

 

5.0

 

Operations

 

25.1

 

35.1

 

38.5

 

(9.5

)

39.1

 

84.0

 

104.0

 

119.0

 

Corporate / Other

 

1.1

 

1.6

 

2.7

 

(7.0

)

(43.5

)

(0.6

)

1.0

 

1.0

 

total

 

57.0

 

63.0

 

63.3

 

(2.8

)

(2.7

)

83.9

 

114.0

 

133.0

 

 

4



 

Copyright © 2008, GARP Research & Securities Co. All rights reserved.

 

GARP Research & Securities Co. (“GARP Research”) is a dually registered broker dealer and investment adviser, a member organization of FINRA and SIPC, and accredited member of the Investorside Research Association. GR&S is an independent research firm that provides research to institutional investors. Weedflower, Inc., a registered investment adviser, serves as the investment manager to the Gaineswood Fund, LP (the “Partnership”) and has discretionary investment authority over the Partnership’s assets. GARP Capital, LLC is the general partner for Partnership. GARP Research & Securities Co., Weedflower, Inc., GARP Capital, LLC, and the Gaineswood Fund, LP (collectively “GARP”) are under common ownership and control.

 

 

The Investorside Research Association certifies its
members have no investment
banking conflicts.

 

 

GARP Research, its advisory clientele, their partners, principals, officers, employees and affiliates may hold positions in or options on the securities discussed.

 

The information contained herein has been obtained from sources believed reliable but is not necessarily complete and accuracy is not guaranteed. Opinions expressed are subject to change without notice and do not constitute solicitation of orders. Within the body of this and previous reports GARP Research & Securities Co. attempts to examine competitive threats, secular and cyclical demand shifts, or financial considerations which can impose risk upon its clients.

 

The table below lists all holdings by GARP Research analysts and/or their family members of GARP-rated stocks. Outside of this ownership disclosed in the table below, the analysts are not aware of any other material conflict of interest. Likewise, GARP Research & Securities Co. does not hold a position in any stocks. GARP Research & Securities Co. does not make a market in any securities.

 

Analyst Ownership in GARP Recommended Securities

 

Analyst

 

Ownership

Jeff Burnett

 

None

Brett Carson

 

Cosi, ICON Plc., International Rectifier, PPD Inc., Synopsys

Seth Dadds

 

Ameritrade, Cree, E*Trade, Illumina

Rob Furlong

 

Analog Devices, Cosi, Flextronics, Sangamo, Taser International, ZipRealty

Alastair Mackay

 

None

George Sakellaris

 

Gevity HR, ZipRealty, Cree, EW Scripps, International Rectifier, Sangamo, Cosi, Gemstar-TV Guide

 

Additional information is available upon request by contacting GARP Research & Securities Co.’s Chief Compliance Officer at (410) 318-5018.

 

GARP Research is mostly a fundamental equity research product. We utilize a BUY, NEUTRAL, and AVOID (SELL) rating system based on an approach balancing growth against valuation with a proprietary matrix. The percentage of BUY, NEUTRAL, and AVOID ratings was recently 70-75%, 20-30%, and 0-5%, respectively. GARP Research does not conduct corporate finance activities in the stocks it covers, and does not plan to conduct such activities in the foreseeable future. The model keys off of projections of per diluted share earnings over a three year time horizon, which in some cases involves the use of certain pro forma adjustments to GAAP. Another important consideration is whether the underlying company possesses

 

5



 

characteristics consistent with GARP’s investment philosophy, in particular the firm’s methods of assessing quality (through competitive assessment and current or projected return on invested capital) and control of risk (technical analysis and quantitative measures). Ratings may also take into account growth beyond terminus years and capital gains taxation.

 

Reasonable valuation is essential to BUY recommendations. Companies with annual growth rates as low as 9% if valuation is 10x out-year earnings or lower could qualify, but faster growing firms are permitted higher valuations, such as a multiple of less than 16x out-year EPS for a 17% growth rate. There are other combinations of growth rates and earnings multiples that represent a frontier that delineates attractive versus unattractive equities, but our model is not purely linear. For example, near the “middle” of these outliers would be firms that trade at 10x to 12x out-year earnings whose earnings growth rate approaches 12% or better. A NEUTRAL rating occurs when valuation lies below this EPS-growth frontier, or our assessment of quality or risk elicits caution. A rating of AVOID is defined by a boundary whose maximum constraint is having a PE multiple of over 16x out-year EPS, and growth of less than 12%. Also, substantive non-quantitative risks may be a requisite before an AVOID rating is assigned. In our valuation analysis, we may take into account cash per share, new accounting standards, pro forma earnings or cash flow adjustments, or other items that create deviation from standard calculations. Ratings are also often maintained once equity shifts into a higher or lower quintile in order to avoid excessive reclassifications due to volatility near break points. Ratings of appreciated securities might also be maintained because we are aware that our “out-year” could shift, thereby reestablishing an attractive quintile score simply through the passage of time. Moreover, long-term technical analysis may be used to aid in decisions regarding the classification of a stock, particularly when volatility near a break point has been experienced. Additional information is available upon request.

 

Past performance is not indicative of future results.

 

Analyst Certification

 

All of the views expressed in the report accurately reflect the personal views of the research analyst about any and all of the subject companies. No part of the compensation of the research analyst named herein was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by the research analyst in this report. Neither the research analyst nor a member of the analyst’s household serves as an officer, director or advisory board member of any company mentioned in the report.

-Jeff Burnett

 

 

6



 

GARP Research & Securities Co.

 

Main: (410) 764-1300

2800 Quarry Lake Drive, Suite 140

 

Fax: (410) 318-5048

Baltimore, Maryland 21209

 

www.garpresearch.com

 

INVESTMENT RESEARCH & INSTITUTIONAL SALES

 

Jeff Burnett

 

burnett@garpresearch.com

 

410-318-5014

Brett Carson, CFA

 

carson@garpresearch.com

 

410-318-5031

Seth Dadds

 

dadds@garpresearch.com

 

410-318-5021

Robert Furlong, CFA

 

furlong@garpresearch.com

 

410-318-5015

Alistair Mackay, Ph.D.

 

mackay@garpresearch.com

 

410-318-5022

Seth Moshman, CPA

 

moshman@garpresearch.com

 

410-318-5017

George Sakellaris, CFA

 

sakellaris@garpresearch.com

 

410-318-5016

 

PUBLICATIONS

 

More information about our firm, our coverage our research and our performance history can be found on our website, or by typing GRCO <Go> on Bloomberg.

 

Entitled clients can access our research on Thomson, Reuters, Bloomberg, Capital IQ, Factset and Zacks Investment Research. Please contact us should you need proper entitlement for access.

 

INSTITUTIONAL EQUITY TRADING INSTRUCTIONS

 

GARP Research, Inc., a FINRA-registered broker dealer and a member of the SIPC. We offer several ways to facilitate the payment of our investment research services.

 

Commission Sharing Agreements:

 

GARP Research has Commission Sharing Agreements (CSA’s) with Lehman Brothers, Citigroup, Goldman Sachs, and Instinet. Institutional clients can place orders through their normal trading contacts at these firms and direct commission dollars to our firm in payment for our research services.

 

Our primary contact(s) at Lehman Brothers are:

 

Chris Caras

 

Kevin Petrello

Vice President

 

SVP-Head of US Commission Management

212-526-9490

 

212-526-9459

chcaras@lehman.com

 

kpetrell@lehman.com

 

Bear Stearns & Co.:

GARP Research also clears through Bear Stearns Securities Corp. on a fully-disclosed basis. Orders can be placed through any existing coverage at Bear Stearns institutional trading desks. When placing orders, please specify that the order is for the “credit of GARP Research — Office 504”. Please use DTC number 352. Our Broker/Dealer number is 58712.

 

If you have any questions, please call Seth Moshman or Jeff Burnett.

 

7



 

Appendix 4

 

 

Maximus, Inc.
MMS — NYSE
Hold

Commercial IT Services

 

 

 

November 14, 2008

 

 

 

From

 

To

 

Changes

 

(Previous)

 

(Current)

 

Rating

 

 

Hold

 

FY09E EPS

 

$

3.07

 

$3.11

 

(Net)

 

 

 

 

 

FY10E EPS

 

 

$3.35

 

(Net)

 

 

 

Stock Data

 

 

 

Price (11/13/08):

 

$31.02

 

52-Week Range:

 

$48 – $26

 

Market Cap.($mm):

 

$580.1

 

Shr.O/S-Diluted (mm):

 

18.7

 

Enterprise Val. ($mm):

 

$460.8

 

Avg Daily Vol (3 Mo):

 

226,463

 

LT Debt/Total Cap.:

 

0.0

%

Net Cash/Share:

 

$6.45

 

Dividend ($):

 

$0.40

 

Yield (%):

 

1.3

%

Book Value/Share:

 

$15.95

 

S&P Index:

 

911.29

 

 

EPS (Net)

 

2008 A

 

2009 E

 

2010 E

 

1Q

 

$

0.59A

 

$

0.67

 

$

0.74

 

2Q

 

0.75A

 

0.77

 

0.83

 

3Q

 

0.81A

 

0.80

 

0.85

 

4Q

 

0.71A

 

0.88

 

0.93

 

FY Sep

 

$

2.86A

 

$

3.11

 

$

3.35

 

P/E

 

10.8x

 

10.0x

 

9.3x

 

 

F3Q07 per share results do not include legal settlement charges. 2007 EPS is proforma.

 

FY08 quarterly EPS estimates are pro forma from continuing operations, and exclude one-time, nonrecurring items; include $0.03 of

pre-ASR interest income.

 

Revenue (Net)

 

$

807.9

M

$

765.8

M

$

818.0

M

EV/Revenue

 

0.6

x

0.6

x

0.6

x

 

FY08 revenue estimates are from continuing operations.

 

 

Sloppy F4Q08 Results; Guidance Impacted By Currency;

 

Maintain Hold

 

 

 

 

George A. Price

 

(443) 224-1323

 

gaprice@stifel.com

Shlomo Rosenbaum

 

(443) 224-1322

 

shrosenbaum@stifel.com

Richard Eskelsen

 

(443) 224-1366

 

eskelsenr@stifel.com

 

 

 

 

Analysis of Sales/Earnings

 

·        MMS reported generally disappointing F4Q08 results relative to our and consensus estimates. While MMS’ outlook remains generally consistent with prior view (excluding currency impacts), the state & local fiscal situation is deteriorating, and timing/magnitude of federal assistance is uncertain. While we believe MMS shares admittedly appear attractively valued, we maintain our Hold rating.

·        F4Q08 results. Revenue of $189.1M (up 8.8% YOY on cont. ops. basis) was below our $194.4M estimate and the $193.2M consensus estimate.  Earnings results were sloppy due to several one-time puts and takes, but at the end of the day, pro forma EPS came in below our expectations. Margins were also light. The Operations segment performed well (up 14% YOY, nicely profitable), while the Consulting segment continued to be a drag on results (down 17% YOY, with a loss, largely due to contract execution).

·        Guidance maintained, though currency impacting. FY09 revenue guidance was taken down ~3% due to currency (AUD and CAD depreciating against US$), but otherwise was intact. FY09 EPS of $3.00 -$3.15 was maintained, though MMS had to make a sizable share repurchase to offset the lower expected revenue. Additional share repurchases are planned but incremental to guidance.

·        State and local fiscal conditions deteriorating. State revenues are declining and the number of states facing budget deficits is increasing, driven by the weak U.S. economy. While health and social programs often see an uptick in enrollment during downturns, states are under considerable pressure, and some have indicated that cuts even in these programs are being considered. The Obama administration has expressed interest in giving assistance to states, but timing and magnitude are uncertain.

·        MMS shares cheap, but... We acknowledge that MMS shares appear cheap, trading at 10.5x our new CY08 EPS estimate of $2.94 and 9.7x our new CY09 EPS estimate of $3.18 (up 8.2%), and especially noting MMS has $121.0M in cash, which comprises almost 21% of the stock’s current market cap. Still, we remain cautious around the deterioration in S&L fiscal conditions and uncertainty as to whether and when states will get federal assistance.

 

All relevant disclosures and certifications appear on pages 10 - 11 of this report.

 

1



 

F4Q08 Results: Still A Bit Sloppy

 

MMS reported disappointing F4Q08 results, showing that while progress has been made in de-risking the business, there is still some work to be done. Revenue was slightly below us, consensus, and prior guidance, and pro forma EPS from continuing operations was also below our estimate and in the middle of guidance. Included in the quarter was a $0.02 per share benefit from insurance reimbursement for legal and settlement costs (primarily relating to the ongoing ACN arbitration), ~$1M in severance ($0.03 per share) due to corporate headcount reductions resulting from the prior Systems segment divestiture, and a $0.25 goodwill impairment charge related to the ERP division of the Systems segment that MMS did not divest. Margins were below our expectations, driven by weakness in the Consulting segment (see below). FCF was modestly below our estimate.

 

RESULTS VERSUS OUR EXPECTATIONS AT TIME OF EARNINGS ANNOUNCEMENT

 

KEY METRICS

 

F4Q08

 

SN Est.

 

Actual

 

Year Ago

 

Comment

 

Revenue ($M)

 

$

194.4

 

$

189.1

 

$

201.9

 

Below us and consensus, and slightly below prior guidance of $190M - $195M, following Systems divestiture.

 

YOY Growth (as reported)

 

-3.7

%

-6.3

%

17.5

%

 

 

YOY Growth (cont. ops.)

 

11.9

%

8.8

%

NA

 

 

 

Consensus Revenue ($M)

 

$

193.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Margin (reported)

 

28.8

%

26.9

%

27.5

%

Below our estimate.

 

EBIT Margin (GAAP)

 

11.4

%

6.9

%

10.8

%

Below our estimate, do to several unexpected and one-time expenses.

 

EBIT Margin (pro forma, excl. one time and legal)

 

11.8

%

11.0

%

12.1

%

Excludes reimbursed legal and settlement expenses, goodwill impairment, and severance; our estimate excl. ~$900K in legal expenses that we previously modeled, whereas MMS reported a gain from insurance/legal reimbursement.

 

Tax Rate

 

39.0

%

37.1

%

42.0

%

Lower than our estimate; added $0.02 to EPS, by our calculation.

 

EPS (GAAP)

 

$

(0.09

)

$

(0.09

)

$

0.63

 

In line.

 

YOY Growth

 

NM

 

NM

 

NM

 

 

 

EPS (cont. ops., pro forma)

 

$

0.73

 

$

0.71

 

NA

 

Below our estimate.

 

YOY Growth

 

NA

 

NA

 

NA

 

 

 

EPS (cont. ops., pro forma, excl. legal)

 

$

0.76

 

$

0.71

 

NA

 

In the middle of prior guidance of $0.68 - $0.76; our estimate in this case excludes ~$900K in legal expenses that we previously modeled.

 

YOY Growth

 

NA

 

NA

 

NA

 

 

 

Consensus EPS

 

$

(0.10

)

 

 

 

 

 

 

Share count (M)

 

18.9

 

18.7

 

22.6

 

Slightly below us; no impact to EPS by itself, but with lower tax rate would round up extra $0.01.

 

A/R DSO (days)

 

76

 

76

 

78

 

In line.

 

Free Cash Flow ($M), cont. ops.

 

$

7.4

 

$

5.2

 

$

(15.7

)

Modestly below our estimate. Including discontinued ops, FCF was $16.9M.

 

 

Source: Company Filings, FirstCall Estimates, and Stifel Nicolaus Estimates.

 

Segments: Operations Strong, Consulting Leaves Room For Improvement

 

While the Operations segment continued to perform well, posting YOY revenue growth of 14.4% and an operating margin of 13.6% (towards top-end of company’s stated range of 10%-15%), the Consulting segment continues to be a drag. Revenues declined 16.8% YOY and the operating margin was a negative 8.3% . MMS noted that the majority of the Consulting loss was as a result of a $2.7M year-end adjustment on a fixed-price ERP contract that is taking longer

 

2



 

than MMS originally thought. This is a legacy Systems segment contract (not divested) that moved into the Consulting segment as a result of the ERP division moving into Consulting at the time of the Systems divestiture. This is a negative in our view, as it is yet another unexpected contract issue that pops up (MMS has a mixed track record over time in this regard), and management noted that there are still several legacy ERP contracts in MMS’ Consulting portfolio. While we applaud MMS management for the many steps it has taken to (and progress shown in) de-risking the business (e.g., recent Systems divestiture), it appears that some operational risk still remains with legacy contracts.

 

Outlook: Beyond Currency, Guidance Reiterated

 

OUR ESTIMATES VERSUS UPDATED GUIDANCE FOLLOWING DIVESTITURE ANNOUNCEMENT

 

GUIDANCE

 

F1Q09

 

SN Ests.

 

Guidance

 

Comment

 

Revenue ($M, cont. ops.)

 

$

183.8

 

No guidance

 

MMS did not give F1Q09 guidance.

 

Consensus Revenue ($M)

 

$

184.6

 

 

 

 

 

EPS (cont. ops., pro forma)

 

$

0.67

 

No guidance

 

MMS did not give F1Q09 guidance.

 

Consensus EPS

 

$

0.68

 

 

 

 

 

 

FY09

 

 

 

 

 

 

 

Revenue ($M, cont. ops.)

 

$

788.6

 

$750M - $775M

 

Reduced prior guidance of $775M - $800M due to currency (appreciation of US$ against AUD and CAD).

 

Consensus Revenue ($M)

 

$

786.1

 

 

 

 

 

EPS

 

$

3.07

 

$3.00 - $3.15

 

Reaffirmed prior guidance of $3.00 - $3.15.

 

Consensus EPS

 

$

3.03

 

 

 

 

 

FCF ($M)

 

$

51.1

 

$40M - $50M

 

Includes cash from ops of $60M - $70M, but excludes $11M payment due to divestiture, so reported FCF will be lower than the $40M-$50M range, all else being equal.

 

 

Source: Company Filings, FirstCall Estimates, and Stifel Nicolaus Estimates.

 

Positives

 

·        New Democratic regime in Washington should favor programs (ex. , SCHIP) that benefit MMS.

·        Additionally, in a recession, volumes of people enrolled in public social and health programs (such as Medicaid and welfare-to-work) tends to increase, which could benefit MMS as a provider of enrollment, eligibility, and welfare-to-work services, among others.

·        Signings, backlog, and pipeline appear to remain healthy for MMS.

·        MMS has $62.1M remaining on its share repurchase program, and has been active in September and October, buying a total of one million shares for ~$34.1M since September. Incremental repurchases could offer potential upside to guidance (current guidance does not factor in any additional share repurchases, beyond material repurchases made after the end of F4Q08), but we believe that currency and any continuing execution issues could offset potential repurchase upside.

 

Concerns

 

·        The state and local fiscal situation continues to deteriorate. Recent data released by the Nelson A. Rockefeller Institute of Government (www. rockinst. org) indicate that C3Q08 state tax revenues were virtually unchanged year-over-year on a nominal basis, and declined 2.6% nationally on a real basis. The Institute expects tax revenues to continue to trend down, as the two largest taxes (income and sales tax) have generally been trending down since C2Q07. The report also noted that corporate tax collections, while a small part of total tax revenue, declined by 15.3% YOY.

·        S&L fiscal pressures (as described above), combined with credit markets that remain tight and increasing federal

 

3



 

government debt and financial system guarantees, could create budget delays or even cuts in programs that were previously thought to be “sacred cows” (such as SCHIP).

·        Legacy Systems contracts that are now included in the Consulting segment could remain a near-term issue and drag to margins throughout the year.

·        FCF was a bit below our previous estimate and could be viewed by some investors as a negative, especially considering that guidance does not include an additional $11M outflow in FY09 due to the divestiture (this will show up in reported FCF).

·        Currency is becoming an increasing issue for MMS, as ~16% of its revenue comes from overseas (primarily Australia and Canada). We estimate that currency could create a ~3.5% headwind for MMS in FY09, based on current spot prices.

 

Additionally, MMS mentioned that the U.K. is looking to revamp their current welfare-to-work system and MMS has submitted a bid. We view such a contract very cautiously, given the problems, delays, and setbacks (some of which remain ongoing) from the last sizable U.K. health and social program, the NHS Connecting for Health program.

 

Estimates

 

Basic Assumptions:

 

·        Revenue growth impacted by currency (~3.5% headwind, based on current spot prices) and S&L fiscal pressures.

·        MMS utilizes half of their current $62.1M repurchase authorization pro rata over the next four quarters, with an average share price assumption of $30.

·        Operations segment continues to perform well, although growth is impacted by currency. Consulting remains a revenue drag throughout FY09.

·        Tax rate remains constant at ~37%.

 

4



 

ESTIMATES

 

F1Q09

 

Current

 

Prior

 

Variance

 

YOY Change

 

Comment

 

Revenue ($M, as reported)

 

$

180.7

 

$

183.8

 

$

(3.1

)

-10.5

%

Revenue increases 2.0% on a continuing operations basis.

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Margin

 

27.4

%

28.5

%

- 110 bps

 

+ 130 bps

 

 

 

Operating Margin (excl. charges)

 

10.4

%

11.1

%

- 70 bps

 

+ 110 bps

 

Expect lingering issues with legacy ERP contracts to continue.

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted EPS (pro forma, cont. ops.)

 

$

0.67

 

$

0.67

 

$

0.00

 

13.6

%

Unchanged from our previous estimate.

 

FCF ($M)

 

$

11.3

 

$

10.8

 

$

0.5

 

$

27.0

 

Flow through from lower revenue and margins.

 

 

FY09

 

Current

 

Prior

 

Variance

 

YOY Change

 

Comment

 

Revenue ($M, as reported)

 

$

765.8

 

$

788.6

 

$

(22.8

)

-5.2

%

Revenue increases 2.8% YOY on continuing operations basis. Near the middle of revised guidance of $750M - $775M.

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Margin

 

28.0

%

29.2

%

- 120 bps

 

+ 170 bps

 

 

 

Operating Margin (excl. charges)

 

11.1

%

11.8

%

- 70 bps

 

+ 200 bps

 

Margins show nice expansion YOY, as Operations segment makes up majority of business; expect Consulting to be a margin drag.

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted EPS (pro forma, cont. ops.)

 

$

3.11

 

$

3.07

 

$

0.04

 

8.7

%

Slightly above the midpoint of guidance of $3.05 - $3.15. Share repurchases boost EPS.

 

FCF ($M)

 

$

39.2

 

$

51.1

 

$

(11.9

)

$

5.9

 

Guidance of $40M - $50M excludes $11M payment in FY09 due to divestiture; including that, assume FCF near high end of range.

 

 

FY10

 

Current

 

Prior

 

Variance

 

YOY Change

 

Comment

 

Revenue ($M, as reported)

 

$

818.0

 

No prior FY10 estimates

 

6.8

%

Expect MMS to post mid to upper single digit growth going forward.

 

Gross Margin

 

27.7

%

 

 

 

 

- 30 bps

 

 

 

Operating Margin (excl. charges)

 

10.8

%

 

 

 

 

- 30 bps

 

Assume margins see some pressure due to S&L fiscal conditions and price pressure.

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted EPS (pro forma)

 

$

3.35

 

 

 

 

 

7.6

%

 

 

FCF ($M)

 

$

50.8

 

 

 

 

 

$

11.6

 

FCF is ~87% of net income.

 

 

Calendar Year

 

Current

 

Prior

 

Variance

 

YOY Change

 

Comment

 

CY08 Revenue ($M, as reported)

 

$

786.7

 

$

795.2

 

$

(8.5

)

0.9

%

 

 

CY08 Pro forma EPS

 

$

3.18

 

$

2.96

 

$

0.22

 

NM

 

 

 

CY09 Revenue ($M, as reported)

 

$

778.0

 

$

796.3

 

$

(18.4

)

-1.1

%

 

 

CY09 Pro forma EPS

 

$

3.49

 

$

3.09

 

$

0.40

 

9.6

%

 

 

 

Source: Company data and Stifel Nicolaus.

 

Valuation

 

MMS shares are currently trading at 10.5x our new CY08 EPS estimate of $2.94 and 9.7x our new CY09 EPS estimate of $3.18 (up 8.2%) . These are historically very low multiples, as the last time MMS shares were trading near these valuations was late 2002/early 2003, during the last downturn when the S&L fiscal situation was also bad (actually further along in the downcycle). Additionally, with $121.0M in cash currently on the balance sheet, cash comprises almost 21% of stock’s current market cap.

 

MMS shares ended up 17.6% yesterday, versus the S&P 500 up 6.9% . We suspect some short covering, as some investors may have been expecting an impact to MMS’ business from the difficult S&L budget environment, as well as buyers in an up market of a relatively inexpensive stock that has been weak recently.

 

However, the S&L backdrop remains concerning, in our view. While MMS indicates it has not seen any broad fundamental impacts from the poor S&L fiscal environment, we are still early in the downcycle, and S&L fiscal conditions appear to be deteriorating on a weekly basis (we note that MMS was impacted during the last downturn later in the macro cycle, in early 2003). The Center on Budget and Policy Priorities (www.cbpp.org), which tracks state and locality finances, notes that 41 states have already either reported or projected budget problems for the current fiscal year (which began July 1 for most states) or next fiscal year, and are responding in some cases by cutting spending in areas such as health care for children, families, seniors, and the disabled. The Rockefeller Institute of Government (www.rockinst.org) indicates that state revenues dropped in the last quarter. While the incoming Obama administration has expressed some interest in fiscal relief for the states, the timing and magnitude of any aid is uncertain, given large expenditures by the federal government in areas such as the financial industry and housing. We remain concerned about the S&L fiscal environment and potential lingering issues in MMS’ legacy ERP contracts, and would wait for

 

5



 

either a more attractive entry point or incremental details about potential federal aid for the states before revisiting our rating. Maintain Hold.

 

Company Description

 

Founded in 1975, Maximus is a leader in providing program management support (including both IT services and business process outsourcing) and consulting services primarily to health and human services agencies in state and local governments. Maximus utilizes technology combined with its strong program management skills and understanding of government agencies’ business processes to result in an operation that is more efficient than governments could achieve on their own at similar costs. Maximus is based in McLean, Virginia.

 

6



 

Maximus, Inc.

Income Statement

($ in thousands, except per share)

 

Fiscal year ends September 30

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income Statement

 

2007

 

1Q08

 

2Q08

 

3Q08

 

4Q08

 

2008

 

1Q09E

 

2Q09E

 

3Q09E

 

4Q09E

 

2009E

 

1Q10E

 

2Q10E

 

3Q10E

 

4Q10E

 

2010E

 

Revenue (as reported)

 

$

738,646

 

$

201,950

 

$

210,584

 

$

206,324

 

$

189,069

 

$

807,927

 

$

180,713

 

$

196,515

 

$

193,787

 

$

194,792

 

$

765,807

 

$

192,869

 

$

210,037

 

$

206,799

 

$

208,332

 

$

818,037

 

Year-over-year % Change (as reported)

 

5.4

%

25.3

%

17.6

%

5.0

%

-6.3

%

9.4

%

-10.5

%

-6.7

%

-6.1

%

3.0

%

-5.2

%

6.7

%

6.9

%

6.7

%

7.0

%

6.8

%

Year-over-year % Change (continuing ops.)

 

 

 

34.4

%

25.7

%

11.4

%

8.8

%

19.0

%

2.0

%

3.6

%

2.3

%

3.0

%

2.8

%

 

 

 

 

 

 

 

 

 

 

Sequential % Change

 

5.4

%

0.0

%

4.3

%

-2.0

%

-8.4

%

9.4

%

-4.4

%

8.7

%

-1.4

%

0.5

%

-5.2

%

-1.0

%

8.9

%

-1.5

%

0.7

%

6.8

%

Salaries, wages and other

 

561,563

 

149,183

 

156,694

 

151,086

 

138,260

 

595,223

 

131,198

 

142,277

 

138,364

 

139,471

 

551,310

 

140,601

 

152,697

 

148,275

 

149,790

 

591,364

 

Gross Profit

 

177,083

 

52,767

 

53,890

 

55,238

 

50,809

 

212,704

 

49,515

 

54,238

 

55,423

 

55,321

 

214,498

 

52,267

 

57,340

 

58,524

 

58,541

 

226,673

 

Gross Margin

 

24.0

%

26.1

%

25.6

%

26.8

%

26.9

%

26.3

%

27.4

%

27.6

%

28.6

%

28.4

%

28.0

%

27.1

%

27.3

%

28.3

%

28.1

%

27.7

%

Selling Gen & Admin

 

131,752

 

33,033

 

35,019

 

35,213

 

29,126

 

132,391

 

30,011

 

32,286

 

33,073

 

30,982

 

126,352

 

32,030

 

34,508

 

35,294

 

33,135

 

134,967

 

Stock Option Expense

 

3,829

 

1,020

 

2,154

 

1,595

 

1,774

 

6,543

 

800

 

800

 

800

 

800

 

3,200

 

800

 

800

 

800

 

800

 

3,200

 

Consolidating Adjustment & Other

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Charges/Nonrecurring Items

 

44,638

 

2,200

 

931

 

3,737

 

6,827

 

13,695

 

 

 

 

 

 

 

 

 

 

 

Total Operating Expense

 

180,219

 

36,253

 

38,104

 

40,545

 

37,727

 

152,629

 

30,811

 

33,086

 

33,873

 

31,782

 

129,552

 

32,830

 

35,308

 

36,094

 

33,935

 

138,167

 

% of Revenue

 

24.4

%

18.0

%

18.1

%

19.7

%

20.0

%

18.9

%

17.0

%

16.8

%

17.5

%

16.3

%

16.9

%

17.0

%

16.8

%

17.5

%

16.3

%

16.9

%

Operating Income (GAAP)

 

(3,136

)

16,514

 

15,786

 

14,693

 

13,082

 

60,075

 

18,704

 

21,152

 

21,550

 

23,539

 

84,945

 

19,438

 

22,032

 

22,430

 

24,606

 

88,506

 

% Change

 

11.0

%

-195.0

%

580.4

%

-248.0

%

-40.1

%

-2015.7

%

13.3

%

34.0

%

46.7

%

79.9

%

41.4

%

-67.6

%

17.8

%

6.0

%

14.2

%

4.2

%

Oper. Margin (GAAP)

 

-0.4

%

8.2

%

7.5

%

7.1

%

6.9

%

7.4

%

10.4

%

10.8

%

11.1

%

12.1

%

11.1

%

10.1

%

10.5

%

10.8

%

11.8

%

10.8

%

Oper. Margin (Continuing Ops.)

 

 

 

10.9

%

11.7

%

14.3

%

6.9

%

10.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Margin (excl. charges)

 

5.6

%

9.3

%

7.9

%

8.9

%

10.5

%

9.1

%

10.4

%

10.8

%

11.1

%

12.1

%

11.1

%

10.1

%

10.5

%

10.8

%

11.8

%

10.8

%

Investment Income

 

5,804

 

1,501

 

107

 

490

 

325

 

2,423

 

613

 

608

 

598

 

617

 

2,435

 

1,005

 

1,077

 

1,135

 

1,227

 

4,443

 

Minority Interest

 

451

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income Before Income Taxes

 

3,119

 

18,015

 

15,893

 

15,183

 

13,407

 

62,498

 

19,317

 

21,759

 

22,148

 

24,156

 

87,381

 

20,443

 

23,109

 

23,565

 

25,833

 

92,949

 

Pretax Margin

 

0.4

%

8.9

%

7.5

%

7.4

%

7.1

%

7.7

%

10.7

%

11.1

%

11.4

%

12.4

%

11.4

%

10.6

%

11.0

%

11.4

%

12.4

%

11.4

%

% Change

 

-22.7

%

-211.1

%

303.9

%

-268.1

%

-45.1

%

1903.8

%

7.2

%

36.9

%

45.9

%

80.2

%

39.8

%

-67.3

%

19.6

%

8.3

%

16.6

%

6.4

%

Provision for Income Taxes

 

11,374

 

7,410

 

6,266

 

5,379

 

4,979

 

24,034

 

7,174

 

8,081

 

8,225

 

8,971

 

32,451

 

7,592

 

8,582

 

8,751

 

9,594

 

34,519

 

Tax Rate

 

364.7

%

41.1

%

39.4

%

35.4

%

37.1

%

38.5

%

37.1

%

37.1

%

37.1

%

37.1

%

37.1

%

37.1

%

37.1

%

37.1

%

37.1

%

37.1

%

Income from Continuing Ops.

 

(8,255

)

12,268

 

13,489

 

17,296

 

8,428

 

51,481

 

12,143

 

13,678

 

13,923

 

15,185

 

54,930

 

12,851

 

14,527

 

14,813

 

16,239

 

58,430

 

Margin

 

-1.1

%

6.1

%

6.4

%

8.4

%

4.5

%

6.4

%

6.7

%

7.0

%

7.2

%

7.8

%

7.2

%

6.7

%

6.9

%

7.2

%

7.8

%

7.1

%

Income from Discontinued Ops.

 

 

(1,663

)

(3,862

)

(5,891

)

(10,188

)

(21,604

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income

 

(8,255

)

10,605

 

9,627

 

11,405

 

(1,760)

 

29,877

 

12,143

 

13,678

 

13,923

 

15,185

 

54,930

 

 

 

 

 

 

 

 

 

 

 

Net Margin

 

-1.1

%

5.3

%

4.6

%

5.5

%

-0.9

%

3.7

%

6.7

%

7.0

%

7.2

%

7.8

%

7.2

%

 

 

 

 

 

 

 

 

 

 

Earnings Per Share (GAAP)

 

$

(0.40

)

$

0.51

 

$

0.51

 

$

0.61

 

$

(0.09

)

$

1.55

 

$

0.67

 

$

0.77

 

$

0.80

 

$

0.88

 

$

3.12

 

$

0.74

 

$

0.83

 

$

0.85

 

$

0.93

 

$

3.35

 

% Change

 

NM

 

NM

 

NM

 

NM

 

NM

 

NM

 

31.4

%

51.0

%

31.1

%

NM

 

101.3

%

-52.2

%

23.7

%

10.0

%

16.5

%

7.4

%

Earnings Per Share (Continuing Ops.)

 

 

 

$

0.59

 

$

0.72

 

$

0.92

 

$

0.45

 

$

2.67

 

$

0.67

 

$

0.77

 

$

0.80

 

$

0.88

 

$

3.11

 

$

0.74

 

$

0.83

 

$

0.85

 

$

0.93

 

$

3.35

 

% Change

 

 

 

 

 

 

 

 

 

 

 

 

 

13.6

%

6.9

%

-13.0

%

95.6

%

16.5

%

10.4

%

7.8

%

6.3

%

5.7

%

7.7

%

Earnings Per Share (Continuing Ops., pro forma)

 

 

 

$

0.59

 

$

0.75

 

$

0.81

 

$

0.71

 

$

2.86

 

$

0.67

 

$

0.77

 

$

0.80

 

$

0.88

 

$

3.11

 

$

0.74

 

$

0.83

 

$

0.85

 

$

0.93

 

$

3.35

 

% Change

 

 

 

 

 

 

 

 

 

 

 

 

 

13.6

%

2.7

%

-1.2

%

23.9

%

8.7

%

10.4

%

7.8

%

6.3

%

5.7

%

7.7

%

Shares Outstanding (000s)

 

22,029

 

20,854

 

18,763

 

18,819

 

18,742

 

19,295

 

18,008

 

17,749

 

17,490

 

17,318

 

17,641

 

17,368

 

17,418

 

17,468

 

17,518

 

17,443

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Calendar Year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CY08

 

CY09

 

CY010

 

EPS (Continuing Ops., pro forma)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

2.94

 

$

3.18

 

$

3.49

 

% Change YOY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8.2

%

9.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ratios

 

2007

 

1Q08

 

2Q08

 

3Q08

 

4Q08

 

2008

 

1Q09E

 

2Q09E

 

3Q09E

 

4Q09E

 

2009E

 

1Q10E

 

2Q10E

 

3Q10E

 

4Q10E

 

2010E

 

A/R in Days Sales

 

85

 

75

 

75

 

77

 

76

 

71

 

76

 

77

 

77

 

77

 

78

 

75

 

76

 

76

 

76

 

77

 

A/P and Accrued Days Op. Exp.

 

28

 

26

 

25

 

25

 

26

 

24

 

25

 

25

 

25

 

25

 

25

 

24

 

24

 

24

 

24

 

24

 

Current Ratio

 

3.03

 

2.1

 

2.3

 

2.4

 

2.4

 

2.45

 

2.6

 

2.5

 

2.5

 

2.6

 

2.61

 

2.7

 

2.7

 

2.9

 

3.0

 

2.99

 

Return on Assets, avg

 

-1.5

%

8.7

%

9.1

%

9.1

%

7.8

%

41.7

%

11.2

%

12.4

%

12.5

%

13.4

%

49.3

%

11.1

%

12.2

%

12.0

%

12.8

%

48.2

%

Return on Equity, avg.

 

-2.0

%

12.4

%

13.8

%

13.5

%

11.3

%

14.7

%

16.0

%

17.7

%

17.7

%

18.9

%

17.6

%

15.5

%

16.9

%

16.5

%

17.4

%

16.5

%

NOPAT/Capital*

 

1.9

%

10.8

%

13.0

%

12.4

%

10.5

%

13.5

%

14.7

%

16.3

%

16.4

%

17.5

%

16.2

%

14.0

%

15.3

%

15.0

%

15.9

%

15.0

%

Book Value, end

 

$

18.36

 

$

13.07

 

$

15.18

 

$

15.78

 

$

15.95

 

$

15.49

 

$

17.04

 

$

17.56

 

$

18.12

 

$

18.83

 

$

18.48

 

$

19.46

 

$

20.18

 

$

20.92

 

$

21.73

 

$

21.82

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Some calculations may vary due to rounding.

 

 

 

Source: Maximus, Inc. data and Stifel Nicolaus estimates

 

 

 

 

11/13/2008

 

 

 

 

 

 

George A. Price, Jr.

Shlomo H. Rosenbaum

Richard M. Eskelsen

 

(443) 224-1323

(443) 224-1322

(443) 224-1366

 

gaprice@stifel.com

shrosenbaum@stifel.com

eskelsenr@stifel.com

 

 

7



 

Maximus, Inc.

Balance Sheet and Cash Flow

($ in thousands)

 

FY ends September 30

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance Sheet

 

FY07

 

1Q08

 

2Q08

 

3Q08

 

4Q08

 

FY08

 

1Q09E

 

2Q09E

 

3Q09E 4

 

4Q09E

 

FY09 E

 

1Q10E

 

2Q10E

 

3Q10E

 

4Q10E

 

FY10 E

 

Cash and short-term investments

 

 

 

$

62,654

 

$

63,747

 

$

78,271

 

$

120,957

 

 

 

$

124,235

 

$

118,767

 

$

120,524

 

$

126,162

 

 

 

$

141,809

 

$

145,427

 

$

157,133

 

$

169,958

 

 

 

Accounts receivable, net

 

 

 

119,267

 

122,692

 

126,793

 

128,819

 

 

 

112,444

 

124,459

 

120,579

 

119,040

 

 

 

117,864

 

130,690

 

126,377

 

124,999

 

 

 

Unbilled receivables

 

 

 

49,771

 

52,314

 

49,721

 

30,695

 

 

 

40,158

 

43,670

 

45,217

 

47,616

 

 

 

42,860

 

46,675

 

48,253

 

50,926

 

 

 

Prepaid and other current assets

 

 

 

7,688

 

15,719

 

11,649

 

10,215

 

 

 

10,215

 

10,215

 

10,215

 

10,215

 

 

 

10,215

 

10,215

 

10,215

 

10,215

 

 

 

Deferred taxes

 

 

 

11,267

 

9,490

 

10,255

 

10,812

 

 

 

10,812

 

10,812

 

10,812

 

10,812

 

 

 

10,812

 

10,812

 

10,812

 

10,812

 

 

 

Total current assets

 

 

 

250,647

 

263,962

 

276,689

 

301,498

 

 

 

297,864

 

307,923

 

307,347

 

313,844

 

 

 

323,560

 

343,819

 

352,791

 

366,910

 

 

 

Property, plant and equipment, net

 

 

 

35,580

 

34,333

 

33,799

 

33,994

 

 

 

38,879

 

41,192

 

43,436

 

45,706

 

 

 

46,481

 

47,557

 

48,576

 

49,622

 

 

 

Net Software Development Costs

 

 

 

29,306

 

29,183

 

29,714

 

14,125

 

 

 

14,125

 

14,125

 

14,125

 

14,125

 

 

 

14,125

 

14,125

 

14,125

 

14,125

 

 

 

Deferred contract costs

 

 

 

7,712

 

6,273

 

5,435

 

5,324

 

 

 

5,324

 

5,324

 

5,324

 

5,324

 

 

 

5,324

 

5,324

 

5,324

 

5,324

 

 

 

Deferred taxes

 

 

 

 

 

 

7,722

 

 

 

7,722

 

7,722

 

7,722

 

7,722

 

 

 

7,722

 

7,722

 

7,722

 

7,722

 

 

 

Other assets

 

 

 

92,833

 

92,518

 

91,326

 

69,483

 

 

 

69,483

 

69,483

 

69,483

 

69,483

 

 

 

69,483

 

69,483

 

69,483

 

69,483

 

 

 

Total assets

 

 

 

416,078

 

426,269

 

436,963

 

432,146

 

 

 

433,397

 

445,769

 

447,437

 

456,204

 

 

 

466,695

 

488,030

 

498,021

 

513,186

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

 

 

52,441

 

53,391

 

51,802

 

48,950

 

 

 

44,780

 

48,490

 

47,621

 

47,348

 

 

 

46,035

 

49,921

 

48,952

 

48,780

 

 

 

Accrued compensation and benefits

 

 

 

25,771

 

28,390

 

29,417

 

26,684

 

 

 

25,077

 

27,154

 

24,763

 

24,621

 

 

 

26,854

 

29,121

 

26,516

 

26,423

 

 

 

Billings in excess of costs and estimated earnings

 

 

 

37,461

 

33,151

 

33,836

 

19,676

 

 

 

18,806

 

20,451

 

20,167

 

20,272

 

 

 

17,928

 

19,524

 

19,223

 

19,366

 

 

 

Notes payable & other (cap. lease obligations)

 

 

 

1,643

 

1,238

 

830

 

417

 

 

 

417

 

417

 

417

 

417

 

 

 

417

 

417

 

417

 

417

 

 

 

Income taxes payable

 

 

 

 

 

 

12,662

 

 

 

12,662

 

12,662

 

12,662

 

12,662

 

 

 

12,662

 

12,662

 

12,662

 

12,662

 

 

 

Deferred taxes

 

 

 

2,675

 

998

 

1,237

 

14,919

 

 

 

14,919

 

14,919

 

14,919

 

14,919

 

 

 

14,919

 

14,919

 

14,919

 

14,919

 

 

 

S corporation distribution payable

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total current liabilities

 

 

 

119,991

 

117,168

 

117,122

 

123,308

 

 

 

116,662

 

124,093

 

120,550

 

120,239

 

 

 

118,815

 

126,565

 

122,689

 

122,567

 

 

 

Long-term debt

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred taxes

 

 

 

11,202

 

12,752

 

11,810

 

1,617

 

 

 

1,617

 

1,617

 

1,617

 

1,617

 

 

 

1,617

 

1,617

 

1,617

 

1,617

 

 

 

Other liabilities

 

 

 

12,319

 

11,470

 

10,996

 

8,315

 

 

 

8,315

 

8,315

 

8,315

 

8,315

 

 

 

8,315

 

8,315

 

8,315

 

8,315

 

 

 

Total liabilities

 

 

 

143,512

 

141,390

 

139,928

 

133,240

 

 

 

126,594

 

134,025

 

130,482

 

130,171

 

 

 

128,747

 

136,497

 

132,621

 

132,499

 

 

 

Redeemable common stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional paid-in capital

 

 

 

31,976

 

36,514

 

39,130

 

44,756

 

 

 

41,511

 

33,748

 

25,986

 

20,811

 

 

 

20,811

 

20,811

 

20,811

 

20,811

 

 

 

Retained earnings

 

 

 

240,590

 

248,365

 

257,905

 

254,150

 

 

 

265,293

 

277,996

 

290,970

 

305,223

 

 

 

317,137

 

330,723

 

344,589

 

359,877

 

 

 

Total stockholders’ equity

 

 

 

272,566

 

284,879

 

297,035

 

298,906

 

 

 

306,803

 

311,744

 

316,955

 

326,034

 

 

 

337,948

 

351,533

 

365,400

 

380,687

 

 

 

Total liab & stockholders’ equity

 

 

 

416,078

 

426,269

 

436,963

 

432,146

 

 

 

433,397

 

445,769

 

447,437

 

456,204

 

 

 

466,695

 

488,030

 

498,021

 

513,186

 

 

 

 

 

 

 

 

 

 

 

 

 

20.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash Flow Statement

 

FY07

 

1Q08

 

2Q08

 

3Q08

 

4Q08

 

FY08

 

1Q09E

 

2Q09E

 

3Q09E

 

4Q09E

 

FY09E

 

1Q10E

 

2Q10E

 

3Q10E

 

4Q10E

 

FY10E

 

Cash flows from operating activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

(8,255

)

$

10,605

 

$

9,627

 

$

11,405

 

$

(1,760

)

$

29,877

 

$

12,143

 

$

13,678

 

$

13,923

 

$

15,185

 

$

54,930

 

$

12,851

 

$

14,527

 

$

14,813

 

$

16,239

 

$

58,430

 

Deferred taxes

 

 

 

4,195

 

3,327

 

(1,707

)

(20,089

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

 

5,039

 

4,799

 

4,271

 

(1,581

)

 

 

2,600

 

2,600

 

2,600

 

2,600

 

 

 

2,600

 

2,600

 

2,600

 

2,600

 

 

 

Other

 

 

 

3,600

 

2,154

 

(4,588

)

33,370

 

 

 

800

 

800

 

800

 

800

 

 

 

800

 

800

 

800

 

800

 

 

 

Funds from operations

 

 

 

23,439

 

19,907

 

9,381

 

9,940

 

 

 

15,543

 

17,078

 

17,323

 

18,585

 

 

 

16,251

 

17,927

 

18,213

 

19,639

 

 

 

(Increase) decrease in A/R

 

 

 

13,695

 

(3,425

)

(4,101

)

(2,026

)

 

 

16,375

 

(12,016

)

3,881

 

1,539

 

 

 

1,175

 

(12,826

)

4,313

 

1,378

 

 

 

(Increase) decrease in excess costs and earnings

 

 

 

(7,571

)

(2,543

)

2,593

 

19,026

 

 

 

(9,463

)

(3,512

)

(1,547

)

(2,399

)

 

 

4,756

 

(3,815

)

(1,578

)

(2,672

)

 

 

(Increase) decrease in prepaid other c/a

 

 

 

1,471

 

(8,031

)

4,070

 

1,434

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Increase) decrease in other assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Increase (decrease) in compensation

 

 

 

(3,678

)

2,619

 

1,027

 

(2,733

)

 

 

(1,607

)

2,077

 

(2,391

)

(142

)

 

 

2,233

 

2,267

 

(2,605

)

(93

)

 

 

Increase (decrease) in A/P

 

 

 

(1,984

)

950

 

(1,589

)

(2,852

)

 

 

(4,170

)

3,710

 

(868

)

(273

)

 

 

(1,313

)

3,886

 

(970

)

(172

)

 

 

Increase (decrease) in income tax payable

 

 

 

 

 

 

12,662

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Increase (decrease) in excess billings

 

 

 

(680

)

(2,871

)

1,523

 

(14,049

)

 

 

(870

)

1,644

 

(284

)

105

 

 

 

(2,343

)

1,596

 

(301

)

142

 

 

 

Increase (decrease) in other liabilities

 

 

 

2,176

 

(849

)

(474

)

(2,681

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other changes to working capital (plug)

 

 

 

(6,079

)

(1,253

)

369

 

(240

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Working capital changes

 

 

 

(2,650

)

(15,403

)

3,418

 

8,541

 

 

 

265

 

(8,096

)

(1,209

)

(1,171

)

 

 

4,508

 

(8,891

)

(1,141

)

(1,416

)

 

 

Net cash provided by operating activities

 

51,190

 

20,789

 

4,504

 

12,799

 

18,481

 

56,573

 

15,809

 

8,983

 

16,113

 

17,414

 

58,319

 

20,759

 

9,036

 

17,072

 

18,223

 

65,089

 

Capital expenditures, net

 

(17,893

)

(4,083

)

(3,055

)

(6,730

)

(1,581

)

(15,449

)

(4,518

)

(4,913

)

(4,845

)

(4,870

)

(19,145

)

(3,375

)

(3,676

)

(3,619

)

(3,646

)

(14,316

)

% of revenue

 

2.4

%

2.0

%

1.5

%

3.3

%

0.8

%

1.9

%

2.5

%

2.5

%

2.5

%

2.5

%

2.5

%

1.8

%

1.8

%

1.8

%

1.8

%

7.4

%

Acquisitions

 

 

 

 

 

10,572

 

29,885

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other investing activities (plug)

 

 

 

 

 

59

 

(2,815

)

 

 

(2,967

)

 

 

 

 

 

 

 

 

 

 

 

Net cash used by investing activities

 

 

 

(4,083

)

(3,053

)

3,901

 

25,489

 

 

 

(7,485

)

(4,913

)

(4,845

)

(4,870

)

 

 

(3,375

)

(3,676

)

(3,619

)

(3,646

)

 

 

Free Cash Flow (excluding acquisitions)

 

33,297

 

16,706

 

1,449

 

6,069

 

16,900

 

41,124

 

11,291

 

4,070

 

11,269

 

12,544

 

39,174

 

17,384

 

5,360

 

13,453

 

14,577

 

50,774

 

% of net income

 

-403.4

%

 

 

 

 

 

 

 

 

79.9

%

 

 

 

 

 

 

 

 

71.3

%

 

 

 

 

 

 

 

 

86.9

%

Increase (decrease) in debt

 

 

 

(401

)

(404

)

(408

)

(414

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Increase (decrease) in equity

 

 

 

(148,733

)

2,195

 

97

 

990

 

 

 

(3,246

)

(7,763

)

(7,763

)

(5,175

)

 

 

 

 

 

 

 

 

Other financing activities (incl. dividend)

 

 

 

(1,925

)

(2,149

)

(1,865

)

(1,860

)

 

 

(1,801

)

(1,775

)

(1,749

)

(1,732

)

 

 

(1,737

)

(1,742

)

(1,747

)

(1,752

)

 

 

Net cash provided from financing activities

 

 

 

(151,059

)

(358

)

(2,176

)

(1,284

)

 

 

(5,046

)

(9,537

)

(9,512

)

(6,907

)

 

 

(1,737

)

(1,742

)

(1,747

)

(1,752

)

 

 

Net increase (decrease) in cash and cash equivalents

 

38,635

 

(134,353

)

1,093

 

14,524

 

42,686

 

(76,050

)

3,278

 

(5,468

)

1,757

 

5,638

 

5,205

 

15,647

 

3,618

 

11,706

 

12,825

 

43,797

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Source: Maximus, Inc. and Stifel Nicolaus estimates

 

8



 

Commercial IT Services Companies

 

Stifel, Nicolaus & Company, Inc.

 

Valuation Data:

($ in millions, except per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity

 

Price/Earnings Ratio

 

PE/Growth (PEG)

 

Enterprise

 

Enterprise Value/

 

Cash Flow

 

 

 

 

 

Price

 

Annual

 

Annual

 

Market

 

CY

 

CY

 

CY

 

CY

 

Market

 

Trailing Twelve Months

 

Enterprise Value/

 

CY08 FCF

 

Ticker

 

Company

 

11/13/2008

 

High

 

Low

 

Value

 

2008

 

2009

 

2008

 

2009

 

Value

 

Revenue

 

EBIT

 

EBITDA

 

TTM FCF

 

CY08 FCF

 

CY09 FCF

 

Yield

 

ACN

 

Accenture, Ltd. (1) (3) (11)

 

$

29.37

 

$

43.04

 

$

24.76

 

$

23,788

 

10.7x

 

10.3x

 

0.3

 

2.8

 

$

20,173

 

0.80x

 

6.6x

 

5.7x

 

8.1x

 

7.9x

 

8.1x

 

10.7

%

ACS

 

Affiliated Comp. Services, Inc. (1) (7) (11)

 

41.40

 

57.40

 

36.84

 

4,061

 

11.3

 

10.2

 

1.3

 

0.9

 

5,997

 

0.96

 

8.6

 

5.5

 

10.4

 

12.6

 

13.7

 

11.7

 

BE

 

BearingPoint, Inc. (9) *

 

0.06

 

4.60

 

0.06

 

13

 

Neg

 

Neg

 

Neg

 

Neg

 

641

 

0.19

 

Neg

 

NM

 

Neg

 

Neg

 

NE

 

NE

 

CBR

 

CIBER, Inc. (1) (11)

 

4.62

 

8.97

 

3.57

 

279

 

8.5

 

8.4

 

0.6

 

3.8

 

421

 

0.35

 

7.2

 

5.4

 

8.7

 

7.4

 

12.4

 

20.4

 

CSC

 

CSC (1) (5) (11)

 

30.58

 

55.25

 

25.95

 

4,682

 

7.7

 

7.1

 

Neg

 

0.9

 

7,714

 

0.45

 

6.4

 

3.1

 

7.8

 

11.3

 

12.0

 

14.5

 

DTPI

 

Diamond Mgmt. & Tech. Consultants (1) (6) (11)

 

4.07

 

8.21

 

1.84

 

108

 

NM

 

NM

 

NM

 

NM

 

60

 

0.32

 

9.9

 

7.7

 

Neg

 

Neg

 

Neg

 

Neg

 

HCKT

 

The Hackett Group, Inc.

 

2.84

 

6.65

 

2.69

 

119

 

8.6

 

7.7

 

0.1

 

0.1

 

98

 

0.53

 

6.3

 

5.3

 

5.4

 

NE

 

NE

 

NE

 

HEW

 

Hewitt Associates Inc. (1) (4)

 

24.42

 

43.00

 

23.07

 

2,489

 

12.1

 

11.1

 

0.6

 

1.2

 

2,633

 

0.83

 

8.4

 

5.3

 

11.3

 

12.8

 

8.4

 

8.3

 

MMS

 

Maximus, Inc. (1) (10) (11)

 

31.02

 

47.50

 

25.94

 

581

 

10.5

 

9.7

 

0.2

 

1.2

 

460

 

0.62

 

5.3

 

4.7

 

12.7

 

12.9

 

10.2

 

6.2

 

NSTC

 

Ness Technologies, Inc.

 

4.76

 

13.00

 

4.51

 

188

 

4.8

 

5.1

 

0.0

 

Neg

 

206

 

0.32

 

5.2

 

3.7

 

8.5

 

NE

 

NE

 

NE

 

PER

 

Perot Systems Corp. (1) (8) (11)

 

12.45

 

18.82

 

11.05

 

1,526

 

12.8

 

11.9

 

0.5

 

1.6

 

1,461

 

0.52

 

8.0

 

4.9

 

8.4

 

10.3

 

12.0

 

9.3

 

PRFT

 

Perficient, Inc.

 

4.21

 

18.19

 

3.74

 

130

 

5.5

 

4.8

 

Neg

 

0.3

 

111

 

0.48

 

4.1

 

3.3

 

4.4

 

NE

 

NE

 

NE

 

UIS

 

Unisys Corp.

 

0.67

 

7.90

 

0.50

 

240

 

Neg

 

4.5

 

Neg

 

Neg

 

1,378

 

0.25

 

8.4

 

2.5

*

19.9

 

NE

 

NE

 

NE

 

 

 

Mean:

 

 

 

 

 

 

 

Total

 

9.3x

 

8.3x

 

0.5x

 

1.4x

 

Total

 

0.53x

 

7.0x

 

4.7x

 

9.6x

 

10.7x

 

11.0x

 

11.6

%

 

 

Median:

 

 

 

 

 

 

 

$

38,203

 

9.6

 

8.4

 

0.4

 

1.2

 

$

41,355

 

0.50

 

6.9

 

5.1

 

8.5

 

11.3

 

12.0

 

10.7

 

 

 

Mean: (Larger Caps) (2)

 

 

 

 

 

 

 

 

 

10.9x

 

9.2x

 

0.7x

 

1.5x

 

 

 

0.6x

 

7.7x

 

4.5x

 

11.0x

 

11.0x

 

10.8x

 

10.9

%

 

 

Median: (Larger Caps) (2)

 

 

 

 

 

 

 

 

 

11.3

 

10.2

 

0.6

 

1.2

 

 

 

0.7

 

8.2

 

5.1

 

9.4

 

11.3

 

12.0

 

10.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial Data:

($ in millions)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance Sheet Data

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trailing Twelve Months

 

 

 

Goodwill

 

Total

 

TTM Capex/

 

 

 

 

 

 

 

Returns

 

 

 

 

 

TTM

 

Revenue/EPS Growth

 

Gross

 

 

 

 

 

Net

 

Cash

 

as % of

 

Debt/

 

TTM

 

Total

 

LQA Rev. per

 

 

 

TTM

 

CY08

 

Ticker

 

Company

 

Revenue

 

CY08

 

CY09

 

Margin

 

EBIT

 

EBITDA

 

Income

 

Balance

 

Total Assets

 

Total Capital

 

Revenue

 

Employees

 

Employee

 

DSO

 

ROE/ROIC

 

ROE/ROIC

 

ACN

 

Accenture, Ltd. (1) (3) (11)

 

$

25,313.8

 

15.1 / 31.5

%

-1.8 / 3.6

%

28.4

%

12.0

%

13.9

%

8.3

%

$

3,623.0

 

6.7

%

0.3

%

1.3

%

186,805

 

140,490

 

62

 

74.7 / 72.5

%

86.9 / 73.6

%

ACS

 

Affiliated Comp. Services, Inc. (1) (7) (11)

 

6,271.9

 

7.2 / 8.4

 

6.9 / 10.9

 

53.5

 

11.2

 

17.4

 

5.7

 

434.8

 

49.5

 

50.0

 

4.9

 

63,000

 

101,870

 

80

 

15.6 / 10.4

 

15.4 / 10.4

 

BE

 

BearingPoint, Inc. (9) *

 

3,430.7

 

-2.9 / -82.2

 

0.9 / -96.7

 

16.2

 

Neg

 

0.3

 

Neg

 

350.9

 

27.1

 

176.3

 

1.0

 

15,900

 

223,075

 

72

 

53.1 / -15.3

 

 NE

 

CBR

 

CIBER, Inc. (1) (11)

 

1,201.5

 

11.9 / 15.4

 

0.7 / 2.2

 

27.1

 

4.9

 

6.5

 

2.6

 

39.3

 

56.2

 

28.2

 

1.3

 

8,500

 

141,161

 

80

 

6.7 / 6.1

 

7.1 / 6.3

 

CSC

 

CSC (1) (5) (11)

 

17,320.7

 

8.0 / -0.2

 

-21.0 / 8.2

 

20.3

 

6.9

 

14.5

 

3.7

 

741.6

 

25.5

 

39.7

 

4.5

 

91,000

 

186,316

 

92

 

16.7 / 8.0

 

16.0 / 7.9

 

DTPI

 

Diamond Mgmt. & Tech. Consultants (1) (6) (11)

 

190.0

 

-11.4 / -95.8

 

-1.6 / NM

 

31.1

 

3.2

 

4.1

 

1.5

 

47.1

 

0.0

 

0.0

 

1.4

 

582

 

278,392

 

 34

 

3.9 / 2.7

 

19.6 / -1.0

 

HCKT

 

The Hackett Group, Inc.

 

184.6

 

8.7 / 94.1

 

9.3 / 12.1

 

40.9

 

8.4

 

10.1

 

8.1

 

20.3

 

50.5

 

0.0

 

1.4

 

729

 

269,410

 

61

 

15.1 / 11.9

 

NE

 

HEW

 

Hewitt Associates Inc. (1) (4)

 

3,171.3

 

3.9 / 21.5

 

0.5 / 9.5

 

14.5

 

9.9

 

15.7

 

9.1

 

275.2

 

20.5

 

33.5

 

3.3

 

23,000

 

138,188

 

75

 

23.8 / 23.9

 

21.5 / 19.4

 

MMS

 

Maximus, Inc. (1) (10) (11)

 

745.1

 

0.9 / 46.3

 

-1.1 / 8.

2

27.1

 

11.6

 

13.2

 

7.3

 

121.0

 

14.9

 

0.0

 

2.1

 

6,000

 

126,046

 

80

 

16.3 / 20.5

 

13.8 / 18.4

 

NSTC

 

Ness Technologies, Inc.

 

641.1

 

22.5 / 280.8

 

11.5 / -6.1

 

29.4

 

6.2

 

8.7

 

4.7

 

64.7

 

38.7

 

16.9

 

2.0

 

7,800

 

87,480

 

143

 

7.4 / 6.4

 

NE

 

PER

 

Perot Systems Corp. (1) (8) (11)

 

2,828.0

 

6.8 / 23.8

 

4.8 / 7.6

 

16.8

 

6.5

 

10.6

 

4.0

 

246.0

 

36.5

 

12.2

 

1.7

 

24,000

 

118,500

 

62

 

9.0 / 10.5

 

9.2 / 9.6

 

PRFT

 

Perficient, Inc.

 

231.9

 

8.3 / -2.6

 

7.3 / 14.5

 

33.7

 

11.6

 

14.7

 

7.0

 

18.3

 

60.6

 

0.0

 

1.0

 

1,323

 

178,685

 

74

 

9.2 / 9.9

 

 NE

 

UIS

 

Unisys Corp.

 

5,570.1

 

-2.8 /-43.5

 

 -1.6 / -215.4

 

23.8

 

2.9

 

9.9

 

(1.0

)

471.4

 

5.4

 

80.5

 

3.4

 

31,000

 

172,903

 

68

 

-14.0 / 7.1

 

NE

 

 

 

Mean:

 

Total

 

 

 

 

 

28.9

%

7.9

%

11.6

%

5.1

%

 

 

30.4

%

21.8

%

2.3

%

 

 

 

 

76

 

 

 

 

 

 

 

Median:

 

$

67,101

 

 

 

 

 

27.7

 

7.7

 

11.9

 

5.2

 

 

 

31.0

 

14.5

 

1.8

 

 

 

 

 

74

 

 

 

 

 

 

 

Mean (excl. negatives):

 

 

 

 

 

 

 

28.9

%

7.9

%

11.6

%

5.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Median (excl. negatives):

 

 

 

 

 

 

 

27.7

 

7.7

 

11.9

 

5.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Notes:

* Not included in mean and median calculations

(1) Stifel Nicolaus Research estimates.

(2) Includes ACN, ACS, CSC, HEW, PER, and UIS.

(3) Accenture (ACN) ROIC is GROSS of cash and investments.

(4) Hewitt TTM EBIT and EBITDA exclude significant goodwill and asset impairment charges

(5) CSC net income and FCF exclude restructuring and impairment charges.

(6) DTPI FCF excludes ~$20M,  based on management’s estimate of cash needed to repurchase shares to offset dilutive equity comp.

(7) Affiliated Comp. Services EBIT, EBITDA, and NI exclude one-time  charges.

(8) PER TTM EBIT and NI exclude the $46M TRIAD termination benefit and $18M restructuring charge

(9) BE TTM EBIT and NI exclude lease and facilities restructuring charges

(10) MMS financials are on continuing operations basis.

(11) Reflects C3Q08 results.

 

Unless otherwise noted, all results reflect C2Q08 data.

 

Sources: Company data, Bloomberg Financial Markets, First Call estimates, FactSet Research Systems and Stifel Nicolaus Research estimates.

 

George A. Price, Jr.

 

Shlomo H. Rosenbaum

 

Richard M. Eskelsen

gaprice@stifel.com

 

shrosenbaum@stifel.com

 

eskelsenr@stifel.com

(443) 224-1323

 

(443) 224-1322

 

(443) 224-1366

 

9



 

Important Disclosures and Certifications

 

I, George Price, certify that the views expressed in this research report accurately reflect my personal views about the subject securities or issuers; and I, George Price, certify that no part of my compensation was, is, or will be directly or indirectly related to the specific recommendation or views contained in this research report.

 

I, Shlomo Rosenbaum, certify that the views expressed in this research report accurately reflect my personal views about the subject securities or issuers; and I, Shlomo Rosenbaum, certify that no part of my compensation was, is, or will be directly or indirectly related to the specific recommendation or views contained in this research report.

 

 

For a price chart with our ratings and target price changes for MMS go to http://sf.bluematrix.com/bluematrix/Disclosure?ticker=MMS

 

The rating and price target history for Maximus, Inc. and its securities prior to December 1, 2005 on the above price chart reflects the research analyst’s views while employed at the prior owner of part of the Stifel Nicolaus Capital Markets business.

 

Maximus, Inc. is a client of Stifel, Nicolaus & Company, Inc. or an affiliate or was a client of Stifel Nicolaus or an affiliate within the past 12 months.

 

Maximus, Inc. is provided with non-investment banking, securities related services by Stifel, Nicolaus & Company, Inc. or an affiliate or was provided with non-investment banking, securities related services by Stifel Nicolaus or an affiliate within the past 12 months.

 

Stifel, Nicolaus & Company, Inc. expects to receive or intends to seek compensation for investment banking services from Maximus, Inc. in the next 3 months.

 

Stifel, Nicolaus & Company, Inc. or an affiliate has received compensation for non-investment banking, securities related services from Maximus, Inc. in the past 12 months.

 

Stifel, Nicolaus & Company, Inc.’s research analysts receive compensation that is based upon (among other factors) Stifel Nicolaus’ overall investment banking revenues.

 

Our investment rating system is three tiered, defined as follows:

 

BUY -We expect this stock to outperform the S&P 500 by more than 10% over the next 12 months. For higher-yielding equities such as REITs and Utilities, we expect a total return in excess of 12% over the next 12 months.

 

HOLD -We expect this stock to perform within 10% (plus or minus) of the S&P 500 over the next 12 months. A Hold

 

10



 

rating is also used for those higher-yielding securities where we are comfortable with the safety of the dividend, but believe that upside in the share price is limited.

 

SELL -We expect this stock to underperform the S&P 500 by more than 10% over the next 12 months and believe the stock could decline in value.

 

Of the securities we rate, 38% are rated Buy, 57% are rated Hold, and 5% are rated Sell.

 

Within the last 12 months, Stifel, Nicolaus & Company, Inc. or an affiliate has provided investment banking services for 12%, 17% and 9% of the companies whose shares are rated Buy, Hold and Sell, respectively.

 

Additional Disclosures

 

STIFEL NICOLAUS ACTED AS FINANCIAL ADVISOR TO MAXIMUS, INC. IN CONNECTION WITH ITS SALE OF ITS CORRECTIONS SERVICES BUSINESS TO PROVIDENCE SERVICE CORPORATION.

 

Please visit the Research Page at www.stifel.com for the current research disclosures applicable to the companies mentioned in this publication that are within Stifel Nicolaus’ coverage universe. For a discussion of risks to target price please see our stand-alone company reports and notes for all Buy-rated stocks.

 

The information contained herein has been prepared from sources believed to be reliable but is not guaranteed by us and is not a complete summary or statement of all available data, nor is it considered an offer to buy or sell any securities referred to herein. Opinions expressed are subject to change without notice and do not take into account the particular investment objectives, financial situation or needs of individual investors. Employees of Stifel, Nicolaus & Company, Inc. or its affiliates may, at times, release written or oral commentary, technical analysis or trading strategies that differ from the opinions expressed within.

 

Stifel, Nicolaus & Company, Inc. is a multi-disciplined financial services firm that regularly seeks investment banking assignments and compensation from issuers for services including, but not limited to, acting as an underwriter in an offering or financial advisor in a merger or acquisition, or serving as a placement agent in private transactions. Moreover, Stifel Nicolaus and its affiliates and their respective shareholders, directors, officers and/or employees, may from time to time have long or short positions in such securities or in options or other derivative instruments based thereon.

 

These materials have been approved by Stifel Nicolaus Limited, authorized and regulated by the Financial Services Authority (UK), in connection with its distribution to professional clients and eligible counterparties in the European Economic Area. (Stifel Nicolaus Limited home office: London +44 20 7557 6030.) No investments or services mentioned are available in the European Economic Area to retail clients or to anyone in Canada other than a Designated Institution. This investment research report is classified as objective for the purposes of the FSA rules. Please contact a Stifel Nicolaus entity in your jurisdiction if you require additional information.

 

Additional Information Is Available Upon Request

 

© 2008 Stifel, Nicolaus & Company, Inc. One South Street Baltimore, MD 21202. All rights reserved.

 

11



 

Appendix 5

 

Commercial IT Services

Maximus, Inc.
MMS — NYSE
Hold




 

 

December 15, 2008

 

 

 

From

 

To

 

Changes

 

(Previous)

 

(Current)

 

Rating

 

 

Hold

 

FY09E EPS

 

$

3.11

 

$

3.04

 

(Net)

 

 

 

 

 

FY10E EPS

 

$

3.35

 

$

3.18

 

(Net)

 

 

 

 

 

Stock Data

 

 

 

 

 

Price (12/15/08):

 

 

 

$

33.25

 

52-Week Range:

 

 

 

$

45 – $26

 

Market Cap.($mm):

 

 

 

$

615.1

 

Shr.O/S-Diluted (mm):

 

 

 

18.5

 

Enterprise Val. ($mm):

 

 

 

$

509.1

 

Avg Daily Vol (3 Mo):

 

 

 

264,452

 

LT Debt/Total Cap.:

 

 

 

0.0

%

Net Cash/Share:

 

 

 

$

6.52

 

Dividend ($):

 

 

 

$

0.40

 

Yield (%):

 

 

 

1.2

%

Book Value/Share:

 

 

 

$

14.87

 

S&P Index:

 

 

 

879.02

 

 

Price is intraday 12-15-08.

 

EPS (Net)

 

2008A

 

2009E

 

2010E

 

1Q

 

$

0.59A

 

$

0.66

 

$

0.70

 

2Q

 

0.75A

 

0.75

 

0.79

 

3Q

 

0.81A

 

0.78

 

0.80

 

4Q

 

0.71A

 

0.86

 

0.88

 

FY Sep

 

$

2.86A

 

$

3.04

 

$

3.18

 

P/E

 

11.6x

 

10.9x

 

10.5x

 

 

F3Q07 per share results do not include legal settlement charges. 2007 EPS is proforma.

 

FY08 quarterly EPS estimates are pro forma from continuing operations, and exclude one-time, nonrecurring items; include $0.03 of pre-ASR interest income.

 

Revenue (Net)

 

$

807.9M

 

$

755.7M

 

$

788.1M

 

EV/Revenue

 

0.6x

 

0.7x

 

0.6x

 

 

FY08 revenue estimates are from continuing operations.

 

 

Pays To Settle TX/Accenture Arbitration; S&L Fiscal Crisis Looms; Maint. Hold

 

George A. Price

 

(443) 224-1323

 

gaprice@stifel.com

Shlomo Rosenbaum

 

(443) 224-1322

 

shrosenbaum@stifel.com

Richard Eskelsen

 

(443) 224-1366

 

eskelsenr@stifel.com

 

 

 

 

Company Update

 

·             Friday after the market close, MMS announced it had settled the outstanding arbitration matter with Accenture (ACN) and related outstanding contractual issues with the Texas Health and Human Services Commission (HHSC) stemming from the TX Integrated Eligibility contract.

 

·             MMS taking a pretax charge of $37.5M ($23.2M after-tax) in F4Q08, lowered previously reported F4Q08 and FY08 EPS from continuing operations, and lowered FY09 cash flow guidance. All in, consideration provided by MMS essentially totals $50M, higher than we would have thought.

 

·             Positively, this is one more issue MMS is now able to put behind it, and the financial impact appears manageable given what we view as MMS’ healthy balance sheet. Further, we believe some investors are looking at MMS as an “Obama stock”, given its healthcare focus and the expected stimulus plan that is expected to include significant funding for states.  MMS shares are up 6.1% versus S&P 500 down 9.1% since November 1, 2008.

 

·             However, we remain cautious on MMS shares for 2 primary reasons: (1) MMS continues to have to pay for execution-related issues, and given its track record, we suspect there are more to come, and (2) the state & local fiscal situation continues to deteriorate, and there is risk even to more insulated health and human services programs (MMS share price and earnings expectations tend to track with state revenue growth, though on a lagging basis). While we believe MMS has done a good job de-risking its business, we note 15% of revenue still comes from consulting, including a handful of ERP projects with recent execution issues.

 

·             MMS now trading at 11.0x our new CY09 estimate of $3.08 (up 5.3% YOY) and at 5.9x EV/TTM EBIT. While the PE is ahead of most commercial ITS stocks, the EV/TTM EBIT multiple is basically 1 turn below the commercial comp average of 6.8x. We note MMS’ FCF yield on our new CY09 FCF estimate is well below the group average of ~11%.  While we don’t view MMS’ valuation currently as expensive, we remain cautious on the name given increasingly difficult S&L fiscal situation. Maintain Hold.

 

All relevant disclosures and certifications appear on pages 12 - 14 of this report.

 

1



 

Investment Conclusions

 

Friday after the market close, MMS announced that it had settled the outstanding arbitration matter with Accenture (ACN) and related outstanding contractual issues with the Texas Health and Human Services Commission (HHSC) stemming from the TX Integrated Eligibility contract terminated in March 2007. MMS will take a pretax charge of $37.5M ($23.2M after-tax) in legal and settlement expense in F4Q08, lowered previously reported F4Q08 and FY08 EPS from continuing operations, and lowered FY09 cash flow guidance as a result of the payment. All in, consideration provided by MMS essentially totals $50M, more than we would have thought MMS would ultimately have to offer, given the company’s adamant stance on its performance.

 

Positively, this is one more issue that MMS is now able to put behind it, and the financial impact appears very manageable given what we view as MMS’ healthy balance sheet. Further, we believe that some investors are looking at MMS as an “Obama stock”, given its healthcare focus and the expected stimulus plan that is expected to include significant funding for states.

 

However, we remain cautious on MMS shares for 2 primary reasons: (1) MMS continues to have to pay for execution-related issues, and given its track record, we suspect there are more to come (for example, there is still an outstanding issue with CT, we believe), and (2) the state & local fiscal situation continues to deteriorate, which in really tough times does impact more insulated health and human services programs (MMS share price and earnings expectations tend to track with state revenue growth, though on a lagging basis). While MMS has done a good job de-risking its business, we note that 15% of revenue still comes from consulting, including a handful of ERP projects that have had execution issues recently. We also note that MMS expects a revenue headwind of $55M-$60M in FY09 from business that will not recur from FY08 (~7.7% of FY08 revenue on a continuing ops. basis), and approximately $70M worth of annual revenue is currently up for rebid in TX (work re-awarded to MMS after the TX IE contract termination).

 

MMS is now trading at 11.0x our new CY09 estimate of $3.08 (up 5.3% YOY) and at 5.9x EV/TTM EBIT. While the PE is ahead of most commercial ITS stocks, the EV/TTM EBIT multiple is basically 1 turn below the Commercial IT Services average of 6.8x. We also note that MMS’ FCF yield on our new CY09 FCF estimate is well below the group average of ~11%. While we do not view MMS’ valuation currently as expensive, we remain cautious on the name in the face of increasing difficulties in the S&L fiscal situation. Maintain Hold.

 

MMS Pays To Settle TX/ACN Contract Issues

 

After the close on Friday, MMS announced that it had settled the outstanding arbitration matter with Accenture (ACN, $28.59, Buy) and related outstanding contractual issues with the Texas Health and Human Services Commission (HHSC) stemming from the TX Integrated Eligibility contract terminated in March 2007. All in, consideration provided by MMS essentially totals $50M, comprised of (1) $27.5M in cash paid by MMS, (2) $12.5M in cash paid by MMS’ primary insurance carrier, and (3) $10M of in-kind services to be provided by MMS to TX HHSC, for which we understand there will be no associated profit or cash flow to MMS. While we note that cash outflows from MMS are only the $27.5M (~$23M after tax we believe), we view the other components as basically things that MMS was deemed responsible for, even if they will not result in a cash outflow from MMS. We also note that MMS is pursuing additional insurance coverage from its excess insurance carriers, though potential timing and magnitude of any additional coverage are not known at this time.

 

We also note that, according to the TX HHSC release on the settlement, the TX Access Alliance (ACN as prime contractor and MMS as subcontractor) will forgo $70.9M in payments for services provided to TX, will pay $20M in cash, and will provide a $10M credit against future work performed by MMS. Thus, while MMS (along with its primary insurance carrier) is paying out $40M in cash (total), only $20M apparently is going to TX. We assume the other $20M is going to ACN and nets against the A/R hit, which we assume is born by ACN as the prime contractor. ACN indicates the terms of the settlement are immaterial to its results.

 

We view the settlement as a minor inconvenience to MMS financially, given its $120M+ in cash on the balance sheet, and no debt. Still, some investors may find the terms of the settlement somewhat disappointing — having expected MMS to be paid as opposed to be paying — since MMS had been adamant in defending its work and position in the arbitration. Positively, this is one more issue that MMS is now able to put behind it, though given MMS’ track record

 

2



 

(not to mention the deteriorating S&L fiscal situation — discussed in more detail below) we are not so confident that there won’t be more issues to come. We believe MMS still has an outstanding issue pending with the state of Connecticut.

 

FY08 EPS Restated From Prior Results

 

MMS will take a pretax charge of $37.5M ($23.2M after-tax) in legal and settlement expense in F4Q08, given this is a subsequent event and the books are still technically open until the 10-K is filed. MMS would not break out the legal expense component of the charge. As a result of the settlement, F4Q08 GAAP loss is now $1.35 per share versus previously reported GAAP loss per share of $0.09, and earnings from continuing operations is now a loss per share of $0.80 versus the previously reported EPS from continuing operations of $0.45. MMS’ F4Q08 pro forma EPS from continuing operations, excluding nonrecurring items (including the TX/ACN settlement) remains $0.71, though we would view this number with increasing skepticism given the numerous charges and expenses MMS has incurred over the years due to performance and execution issues.

 

For full FY08 MMS now reports GAAP earnings per diluted share of $0.35 versus previously reported $1.55, and EPS from continuing operations of $1.48 versus previously reported $2.67. Again, pro forma EPS from continuing operations is unchanged at $2.83, though we view this number as $2.86 because we do not exclude the $0.03 per share in pre-ASR interest income (from F1Q08).

 

FY09 Cash Flow Guidance Reduced

 

As a result of the cash settlement payment, which is expected in F1Q09 (Dec), MMS lowered its FY09 cash flow guidance to $35M - $45M from continuing operations, versus prior guidance of $60M - $70M. However, we again note that this excludes $11M in payments due to recent divestitures, so reported cash flow will actually be lower (see our revised estimates below).

 

S&L Fiscal Situation Continues To Deteriorate

 

The Center on Budget and Policy Priorities (www.cbpp.org) recently indicated that 37 states are now facing mid-year budget shortfalls for current FY09 (June) totaling $31.2B. This is after 29 states closed a total of $48B in budget shortfalls when they enacted their FY09 budgets — i.e., things have gotten worse than expected in terms of state revenues. Further, 28 states now estimate a cumulative budget deficit in FY10 of over $60B. CBPP estimates this could go to a cumulative $100B deficit when all is said and done, worse than the last downturn. California, not surprisingly, tends to have the largest budget deficits of any single state. CA and NY, we note, have the largest projected FY10 budget gaps according to CBPP, at $19.5B and $12.5B, respectively ($32B of the current projected $60B). We point out that 3 of MMS’ top-5 contracts, we believe, are in these 2 states (CA Healthy Families and MediCal in CA, and MMS provides Medicaid enrollment broker services in NY).

 

Since states generally cannot deficit spend (unlike the Federal government), states must close these budget gaps via one or more means — use of reserve funds, tax increases, and spending cuts. States tend to use the first 2 first, holding off on the spending cuts until they really need to, and thus impacts to vendors like MMS tend to come later in the cycle. For example, MMS negatively preannounced in April 2003, well into the last downturn, citing issues such as (1) unexpected delays in contract signings (even where awards were made), (2) cuts in discretionary spending, (3) states grappling with FY04 budget deficits, and (4) uncertainty as to help from the federal government. However, it seems clear that the current recession is setting up to be much worse and longer than the last downturn (which lacked the same magnitude of issues in housing and credit markets, for example), which may accelerate these issues.

 

MMS Share Price And EPS Growth/Outlook Follow State Fiscal Situation And GDP

 

We highlight the 3 charts below, which illustrate a few things, in our opinion: (1) state tax revenue growth tends to lag the business cycle (GDP) by roughly a year, (2) MMS share prices tends to track state tax revenue growth over time (though we acknowledge several divergences, often due to company-specific issues, such as the declines in 2006 due

 

3



 

to the initial losses on the TX Integrated Eligibility contract), and (3) MMS forward EPS expectations (using 2-year forward FirstCall consensus estimates) rose through the last business cycle (and even into the early portion of the downturn) and then cracked as state trends deteriorated materially.

 

 

 

4



 

 

Source for graphs: Rockefeller Institute of Government, Factset, and Stifel Nicolaus.

 

On the last point, one could look at the chart and say that history might be repeating itself (i.e., MMS forward EPS expectations have increased substantially even as the economy and state fiscal conditions have begun to deteriorate). We must acknowledge that a good portion of the improvement in MMS’ EPS outlook is due to factors like getting past the TX issues, as well as positive steps by the company to improve profitability and de-risk its operations (e.g., shifted focus away from larger, riskier deals, divested troublesome operations, etc.). However, that being said, we still believe that obvious and logical dependencies are likely to hold true at some point — if states (and other municipalities) are facing tough fiscal times, companies that provide services to them are at risk. We’ve seen this before.

 

But Aren’t Health And Human Services More Insulated From Macro Conditions?...

 

Generally, yes, but to a point, in our opinion. To be sure, politicians and other government employees are generally loath to cut services for the poor and disadvantaged (e.g., Medicaid, SCHIP) in a downturn. Doing so is not very politically favorable. But that being said, when things get bad, almost everything is potentially on the table for cuts (again, we point to MMS preannouncing in the last downturn). We note the following comments from CBPP (from “State Budget Troubles Worsen”, by Elizabeth McNichol and Iris J. Lav, Center on Budget and Policy Priorities, December 10, 2008):

 

·        “... at least 17 states have implemented or are considering cuts that will affect low-income children’s or families’ eligibility for health insurance or reduce their access to health care services.” (in current slowdown)

 

·        “The experience of the last recession is instructive as to what kinds of actions states may take. Between 2002 and 2004 states reduced services significantly. For example, in the last recession, some 34 states cut eligibility for public health programs, causing well over 1 million people to lose health coverage, and at least 23 states cut eligibility for child care subsidies or otherwise limited access to child care.”

 

5



 

...And What About President Elect Obama’s Stimulus Plan With Funding For The States?

 

This is an uncertainty. Clearly, President-Elect Obama has indicated support for states in general and for health programs administered by the states, in what is expected to be a very large stimulus package that is expected to be enacted shortly after he takes office in January 2009. Even money given to the states for other things like infrastructure would likely help fiscal conditions overall, and thus alleviate some pressure on programs for which MMS provides services. In addition, President-Elect Obama and other Democrats have indicated that current health programs may be supported as a first step to more systemic improvements in health care coverage in the U.S. This could ultimately benefit companies like MMS. Also, federal funding for the State Children’s Health Insurance Plan (SCHIP) expires at the end of March 2009, and media reports indicate there is bipartisan support for not only extending, but possibly expanding, this program, which could also ultimately benefit companies like MMS.

 

It remains to be seen, however, how much money we are talking about for a stimulus package, how much goes to the states, and in what form and via what programs.

 

Estimates

 

General Assumptions:

 

·                  MMS has $55M-$60M of work from FY08 that does not recur in FY09 (7.4%-8.1% of FY08 revenue on continuing ops. basis), as projects wind down or MMS voluntarily does not rebid work on unacceptable terms.

·                  MMS has ~3.3% currency headwind in FY09, based on current FX average and spot rates.

·                  Before currency and nonrecurring revenue impacts, we view Operations growth ~10% and Consulting growth as ~1%-2%.

·                  MMS wins its 2 TX recompetes (~$70M of annual revenue, or ~9.4% of FY08 revenue on continuing ops. basis) on terms fairly comparable to current terms.

·                  Pro forma OPM from continuing operations falls from 11.7% to 11.1%, based on tighter state & local fiscal conditions and likely performance issues on ERP and other legacy consulting/integration contracts.

·                  Tax rate 37.5%.

·                  MMS continues to repurchase shares, using the remaining $31M of authorization through FY09 at an average price of $30 per share.

 

6



 

ESTIMATES

 

F1Q09

 

Current

 

Prior

 

Variance

 

YOY Change

 

Comment

Revenue ($M, as reported)

 

$

179.2

 

$

180.7

 

$

(1.5

)

-11.3

%

Includes impact of divestitures. Up 1.2% YOY on a continuing operations basis. Assumes some drop off in revenue, plus ~2.5% impact from currency.

Gross Margin

 

27.4

%

27.4

%

No change

 

+ 130 bps

 

Reflects divestiture of underperforming Systems business.

Operating Margin (excl. charges)

 

10.3

%

10.4

%

- 10 bps

 

+ 100 bps

 

Reflects divestiture of underperforming Systems business. Actually down 60 bps YOY on continuing ops. basis due to ERP cost overruns.

Diluted EPS (pro forma, cont. ops.)

 

$

0.66

 

$

0.67

 

$

(0.01

)

11.9

%

Up basically due to share repurchases. Using net income against F1Q08 share count, EPS would be down $0.02 YOY.

FCF ($M)

 

$

(15.9

)

$

11.3

 

$

(27.1

)

$

(32.6

)

Down largely due to anticipated cash payout of $27.5M net of insurance in F1Q09.

 

 

 

 

 

 

 

 

 

 

 

FY09

 

Current

 

Prior

 

Variance

 

YOY Change

 

Comment

Revenue ($M, as reported)

 

$

755.7

 

$

765.8

 

$

(10.1

)

-6.5

%

Includes impact of divestitures. Up 1.4% YOY on a continuing operations basis. Assumes ~1% of revenue from FY08 does not persist, plus ~3.3% currency headwind.

Gross Margin

 

28.0

%

28.0

%

No change

 

+ 170 bps

 

Reflects divestiture of underperforming Systems business.

Operating Margin (excl. charges)

 

11.1

%

11.1

%

No change

 

- 60 bps

 

On continuing ops. basis, excluding goodwill impairment, TX settlement, and other “nonrecurring” charges.

Diluted EPS (pro forma, cont. ops.)

 

$

3.04

 

$

3.11

 

$

(0.07

)

6.3

%

 

FCF ($M)

 

$

6.4

 

$

39.2

 

$

(32.8

)

$

(34.7

)

Down largely due to anticipated cash payout of $27.5M net of insurance in F1Q09. Includes anticipated $11M of payments made as result of divestitures.

 

 

 

 

 

 

 

 

 

 

 

FY10

 

Current

 

Prior

 

Variance

 

YOY Change

 

Comment

Revenue ($M, as reported)

 

$

788.1

 

$

818.0

 

$

(30.0

)

4.3

%

Assumes ~7% growth in Operations excluding currency and FY08 revenue that does not recur. Also now assume greater demand headwinds for Consulting segment (down 5.7% YOY versus prior -2.6%).

Gross Margin

 

27.7

%

27.7

%

No change

 

- 30 bps

 

State & local fiscal pressures.

Operating Margin (excl. charges)

 

10.8

%

10.8

%

No change

 

- 30 bps

 

State & local fiscal pressures.

Diluted EPS (pro forma)

 

$

3.18

 

$

3.35

 

$

(0.17

)

4.6

%

Lower revenue.

FCF ($M)

 

$

44.2

 

$

50.8

 

$

(6.6

)

$

37.8

 

Higher capex assumption. FCF ~80% of net income.

 

 

 

 

 

 

 

 

 

 

 

Calendar Year

 

Current

 

Prior

 

Variance

 

YOY Change

 

Comment

CY08 Revenue ($M, as reported)

 

$

785.2

 

$

786.7

 

$

(1.5

)

0.7

%

 

CY08 Pro forma EPS

 

$

2.93

 

$

2.94

 

$

(0.01

)

NM

 

 

CY09 Revenue ($M, as reported)

 

$

763.3

 

$

778.0

 

$

(14.6

)

-2.8

%

 

CY09 Pro forma EPS

 

$

3.08

 

$

3.18

 

$

(0.10

)

5.3

%

 

 

Source: Company data and Stifel Nicolaus.

 

Valuation

 

MMS is now trading at 11.0x our new CY09 estimate of $3.08 (up 5.3% YOY) and at 5.9x EV/TTM EBIT. While the PE is ahead of most commercial ITS stocks, the EV/TTM EBIT multiple is basically 1 turn below the Commercial IT Services average of 6.8x. We also note that MMS’ FCF yield on our new CY09 FCF estimate is well below the group average of ~11%. While we do not view MMS’ valuation currently as expensive, we remain cautious on the name in the face of increasing difficulties in the S&L fiscal situation.

 

We believe that some currently view MMS as an “Obama stock” in that the company focuses on core HHS services such as Medicaid and SCHIP that are more popular under a Democratic administration and that the company would benefit from the new administration directing fiscal aid to the states. We note that MMS shares have outperformed the S&P 500 since the beginning of November 2008 (MMS up 6.1% versus S&P 500 down 9.1% in that period). While we believe that the expected stimulus plan and potential reauthorization of SCHIP will ultimately benefit MMS (or at least relieve a lot of pressure effaced by MMS’ clients), the timing and magnitude of this are uncertain, and we believe the S&L fiscal situation is likely to get worse before it gets better. We remain concerned that the realities of a poor

 

7



 

economy, economic issues throughout the country (e.g., Detroit auto bailout, continuing issues in credit markets and housing, and a poor consumer outlook), and the magnitude of budgetary gaps for the states pose a risk to services even in more insulated areas like Medicaid and SCHIP. In addition, MMS faces currency headwinds in FY09, ~7.7% revenue headwind in FY09 from nonrecurring revenue, and recompetes include 2 TX contracts that account for ~9% of total revenue. Maintain Hold.

 

In our view, MMS is also very likely a sale candidate when credit markets come back and potential suitors become less focused on hoarding cash, but that it seems is likely to take some time as well.

 

Company Description

Founded in 1975, Maximus is a leader in providing program management support (including both IT services and business process outsourcing) and consulting services primarily to health and human services agencies in state and local governments. Maximus utilizes technology combined with its strong program management skills and understanding of government agencies’ business processes to result in an operation that is more efficient than governments could achieve on their own at similar costs. Maximus is based in McLean, Virginia.

 

8



 

Maximus, Inc.

Income Statement

($ in thousands, except per share)

 

Fiscal year ends September 30

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income Statement

 

2007

 

1Q08

 

2Q08

 

3Q08

 

4Q08

 

2008

 

1Q09E

 

2Q09E

 

3Q09E

 

4Q09E

 

2009E

 

1Q10E

 

2Q10E

 

3Q10E

 

4Q10E

 

2010E

 

Revenue (as reported)

 

$

738,646

 

$

201,950

 

$

210,584

 

$

206,324

 

$

189,069

 

$

807,927

 

$

179,199

 

$

192,436

 

$

190,950

 

$

193,157

 

$

755,742

 

$

186,796

 

$

200,727

 

$

199,004

 

$

201,537

 

$

788,064

 

Year-over-year % Change (as reported)

 

5.4

%

25.3

%

17.6

%

5.0

%

-6.3

%

9.4

%

-11.3

%

-8.6

%

-7.5

%

2.2

%

-6.5

%

4.2

%

4.3

%

4.2

%

4.3

%

4.3

%

Year-over-year % Change (continuing ops.)

 

 

 

34.4

%

25.7

%

11.4

%

8.8

%

19.0

%

1.2

%

1.5

%

0.8

%

2.2

%

1.4

%

 

 

 

 

 

 

 

 

 

 

Sequential % Change

 

5.4

%

0.0

%

4.3

%

-2.0

%

-8.4

%

9.4

%

-5.2

%

7.4

%

-0.8

%

1.2

%

-6.5

%

-3.3

%

7.5

%

-0.9

%

1.3

%

4.3

%

Salaries, wages and other

 

561,563

 

149,183

 

156,694

 

151,086

 

138,260

 

595,223

 

130,099

 

139,324

 

136,338

 

138,300

 

544,061

 

136,175

 

145,929

 

142,686

 

144,905

 

569,694

 

Gross Profit

 

177,083

 

52,767

 

53,890

 

55,238

 

50,809

 

212,704

 

49,101

 

53,112

 

54,612

 

54,857

 

211,681

 

50,622

 

54,798

 

56,318

 

56,632

 

218,370

 

Gross Margin

 

24.0

%

26.1

%

25.6

%

26.8

%

26.9

%

26.3

%

27.4

%

27.6

%

28.6

%

28.4

%

28.0

%

27.1

%

27.3

%

28.3

%

28.1

%

27.7

%

Selling Gen & Admin

 

131,752

 

33,033

 

35,019

 

35,213

 

29,126

 

132,391

 

29,760

 

31,616

 

32,589

 

30,722

 

124,687

 

31,021

 

32,978

 

33,964

 

32,054

 

130,018

 

Stock Option Expense

 

3,829

 

1,020

 

2,154

 

1,595

 

1,774

 

6,543

 

800

 

800

 

800

 

800

 

3,200

 

800

 

800

 

800

 

800

 

3,200

 

Consolidating Adjustment & Other

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Charges/Nonrecurring Items

 

44,638

 

2,200

 

931

 

3,737

 

44,327

 

51,195

 

 

 

 

 

 

 

 

 

 

 

Total Operating Expense

 

180,219

 

36,253

 

38,104

 

40,545

 

75,227

 

190,129

 

30,560

 

32,416

 

33,389

 

31,522

 

127,887

 

31,821

 

33,778

 

34,764

 

32,854

 

133,218

 

% of Revenue

 

24.4

%

18.0

%

18.1

%

19.7

%

39.8

%

23.5

%

17.1

%

16.8

%

17.5

%

16.3

%

16.9

%

17.0

%

16.8

%

17.5

%

16.3

%

16.9

%

Operating Income (GAAP)

 

(3,136

)

16,514

 

15,786

 

14,693

 

(24,418

)

22,575

 

18,541

 

20,696

 

21,223

 

23,335

 

83,795

 

18,801

 

21,020

 

21,554

 

23,778

 

85,153

 

% Change

 

11.0

%

-195.0

%

580.4

%

-248.0

%

-211.8

%

-819.9

%

12.3

%

31.1

%

44.4

%

-195.6

%

271.2

%

-16.7

%

13.4

%

4.1

%

12.0

%

1.6

%

Oper. Margin (GAAP)

 

-0.4

%

8.2

%

7.5

%

7.1

%

-12.9

%

2.8

%

10.3

%

10.8

%

11.1

%

12.1

%

11.1

%

10.1

%

10.5

%

10.8

%

11.8

%

10.8

%

Oper. Margin (Continuing Ops.)

 

 

 

10.9

%

11.7

%

14.3

%

-12.9

%

5.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Margin (excl. charges)

 

5.6

%

9.3

%

7.9

%

8.9

%

10.5

%

9.1

%

10.3

%

10.8

%

11.1

%

12.1

%

11.1

%

10.1

%

10.5

%

10.8

%

11.8

%

10.8

%

Investment Income

 

5,804

 

1,501

 

107

 

490

 

325

 

2,423

 

545

 

484

 

474

 

466

 

1,969

 

776

 

878

 

922

 

959

 

3,535

 

Minority Interest

 

451

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income Before Income Taxes

 

3,119

 

18,015

 

15,893

 

15,183

 

(24,093

)

24,998

 

19,086

 

21,180

 

21,696

 

23,801

 

85,764

 

19,576

 

21,898

 

22,476

 

24,737

 

88,688

 

Pretax Margin

 

0.4

%

8.9

%

7.5

%

7.4

%

-12.7

%

3.1

%

10.7

%

11.0

%

11.4

%

12.3

%

11.3

%

10.5

%

10.9

%

11.3

%

12.3

%

11.3

%

% Change

 

-22.7

%

-211.1

%

303.9

%

-268.1

%

-198.6

%

701.5

%

5.9

%

33.3

%

42.9

%

-198.8

%

243.1

%

-21.7

%

14.7

%

6.1

%

14.0

%

3.4

%

Provision for Income Taxes

 

11,374

 

7,410

 

6,266

 

5,379

 

(9,321

)

9,734

 

7,157

 

7,943

 

8,136

 

8,925

 

32,161

 

7,341

 

8,212

 

8,429

 

9,276

 

33,258

 

Tax Rate

 

364.7

%

41.1

%

39.4

%

35.4

%

38.7

%

38.9

%

37.5

%

37.5

%

37.5

%

37.5

%

37.5

%

37.5

%

37.5

%

37.5

%

37.5

%

37.5

%

Income from Continuing Ops.

 

(8,255

)

12,268

 

13,489

 

17,296

 

(14,772

)

28,281

 

11,929

 

13,238

 

13,560

 

14,876

 

53,602

 

12,235

 

13,687

 

14,048

 

15,460

 

55,430

 

Margin

 

-1.1

%

6.1

%

6.4

%

8.4

%

-7.8

%

3.5

%

6.7

%

6.9

%

7.1

%

7.7

%

7.1

%

6.6

%

6.8

%

7.1

%

7.7

%

7.0

%

Income from Discontinued Ops.

 

 

(1,663

)

(3,862

)

(5,891

)

(10,188

)

(21,604

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income

 

(8,255

)

10,605

 

9,627

 

11,405

 

(24,960

)

6,677

 

11,929

 

13,238

 

13,560

 

14,876

 

53,602

 

 

 

 

 

 

 

 

 

 

 

Net Margin

 

-1.1

%

5.3

%

4.6

%

5.5

%

-13.2

%

0.8

%

6.7

%

6.9

%

7.1

%

7.7

%

7.1

%

 

 

 

 

 

 

 

 

 

 

Earnings Per Share (GAAP)

 

$

(0.40

)

$

0.51

 

$

0.51

 

$

0.61

 

$

(1.35

)

$

0.35

 

$

0.66

 

$

0.75

 

$

0.78

 

$

0.86

 

$

3.04

 

$

0.70

 

$

0.79

 

$

0.80

 

$

0.88

 

$

3.18

 

% Change

 

NM

 

NM

 

NM

 

NM

 

NM

 

NM

 

29.4

%

47.1

%

27.9

%

NM

 

NM

 

103.0

%

18.6

%

7.8

%

13.8

%

4.4

%

Earnings Per Share (Continuing Ops.)

 

 

 

$

0.59

 

$

0.72

 

$

0.92

 

$

(0.80

)

$

1.47

 

$

0.66

 

$

0.75

 

$

0.78

 

$

0.86

 

$

3.04

 

$

0.70

 

$

0.79

 

$

0.80

 

$

0.88

 

$

3.18

 

% Change

 

 

 

 

 

 

 

 

 

 

 

 

 

11.9

%

4.2

%

-15.2

%

NM

 

106.8

%

6.1

%

5.3

%

2.6

%

2.3

%

4.6

%

Earnings Per Share (Continuing Ops., pro forma)

 

 

 

$

0.59

 

$

0.75

 

$

0.81

 

$

0.71

 

$

2.86

 

$

0.66

 

$

0.75

 

$

0.78

 

$

0.86

 

$

3.04

 

$

0.70

 

$

0.79

 

$

0.80

 

$

0.88

 

$

3.18

 

% Change

 

 

 

 

 

 

 

 

 

 

 

 

 

11.9

%

0.0

%

-3.7

%

21.1

%

6.3

%

6.1

%

5.3

%

2.6

%

2.3

%

4.6

%

Shares Outstanding (000s)

 

22,029

 

20,854

 

18,763

 

18,819

 

18,540

 

19,244

 

18,008

 

17,749

 

17,490

 

17,318

 

17,641

 

17,368

 

17,418

 

17,468

 

17,518

 

17,443

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Calendar Year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CY 08

 

CY 09

 

CY 010

 

EPS (Continuing Ops., pro forma)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

2.93

 

$

 3.08

 

$

3.26

 

% Change YOY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5.3

%

5.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ratios

 

2007

 

1Q08

 

2Q08

 

3Q08

 

4Q08

 

2008

 

1Q09E

 

2Q09E

 

3Q09E

 

4Q09E

 

2009E

 

1Q10E

 

2Q10E

 

3Q10E

 

4Q10E

 

2010E

 

A/R in Days Sales

 

85

 

75

 

75

 

77

 

76

 

71

 

76

 

75

 

78

 

81

 

83

 

75

 

74

 

77

 

80

 

82

 

A/P and Accrued Days Op. Exp.

 

28

 

26

 

25

 

25

 

26

 

24

 

25

 

25

 

25

 

26

 

26

 

24

 

24

 

24

 

25

 

25

 

Current Ratio

 

3.03

 

2.1

 

2.3

 

2.4

 

1.9

 

1.92

 

2.3

 

2.3

 

2.3

 

2.3

 

2.33

 

2.5

 

2.5

 

2.6

 

2.7

 

2.67

 

Return on Assets, avg

 

-1.5

%

8.7

%

9.1

%

9.1

%

-13.3

%

52.2

%

11.1

%

12.7

%

12.8

%

13.8

%

48.2

%

11.2

%

12.2

%

12.1

%

12.9

%

48.0

%

Return on Equity, avg.

 

-2.0

%

12.4

%

13.8

%

13.5

%

-20.6

%

19.4

%

17.1

%

18.5

%

18.7

%

20.0

%

18.6

%

15.9

%

17.2

%

16.9

%

17.9

%

16.9

%

NOPAT/Capital*

 

1.9

%

10.8

%

13.0

%

12.4

%

-18.3

%

16.6

%

14.2

%

16.6

%

16.7

%

18.0

%

15.6

%

14.1

%

15.2

%

15.0

%

15.9

%

15.0

%

Book Value, end

 

$

18.36

 

$

13.07

 

$

15.18

 

$

15.78

 

$

14.87

 

$

14.33

 

$

15.74

 

$

16.22

 

$

16.74

 

$

17.41

 

$

17.09

 

$

18.01

 

$

18.69

 

$

19.39

 

$

20.16

 

$

20.25

 

 

Some calculations may vary due to rounding.

Source: Maximus, Inc. data and Stifel Nicolaus estimates

 

 

12/15/2008

 

 

 

 

George A. Price, Jr.

Shlomo H. Rosenbaum

Richard M. Eskelsen

(443) 224-1323

(443) 224-1322

(443) 224-1366

gaprice@stifel.com

shrosenbaum@stifel.com

eskelsenr@stifel.com

 

9



 

Maximus, Inc.

Balance Sheet and Cash Flow

($ in thousands)

 

FY ends September 30

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance Sheet

 

FY07

 

1Q08

 

2Q08

 

3Q08

 

4Q08

 

FY08

 

1Q09E

 

2Q09E

 

3Q09E

 

4Q09E

 

FY09E

 

1Q10E

 

2Q10E

 

3Q10E

 

4Q10E

 

FY10E

 

Cash and short-term investments

 

 

 

$

62,654

 

$

63,747

 

$

78,271

 

$

120,957

 

 

 

$

97,094

 

$

96,523

 

93,045

 

$

93,382

 

 

 

$

113,524

 

$

120,711

 

$

125,107

 

$

130,624

 

 

 

Accounts receivable, net

 

 

 

119,267

 

122,692

 

126,793

 

128,819

 

 

 

111,502

 

117,600

 

120,935

 

126,625

 

 

 

114,153

 

120,436

 

123,825

 

129,880

 

 

 

Unbilled receivables

 

 

 

49,771

 

52,314

 

49,721

 

30,695

 

 

 

39,822

 

42,764

 

44,555

 

47,216

 

 

 

41,510

 

44,606

 

46,434

 

49,265

 

 

 

Prepaid and other current assets

 

 

 

7,688

 

15,719

 

11,649

 

10,215

 

 

 

10,215

 

10,215

 

10,215

 

10,215

 

 

 

10,215

 

10,215

 

10,215

 

10,215

 

 

 

Deferred taxes

 

 

 

11,267

 

9,490

 

10,255

 

25,750

 

 

 

13,250

 

13,250

 

13,250

 

13,250

 

 

 

13,250

 

13,250

 

13,250

 

13,250

 

 

 

Total current assets

 

 

 

250,647

 

263,962

 

276,689

 

316,436

 

 

 

271,882

 

280,351

 

282,000

 

290,688

 

 

 

292,652

 

309,218

 

318,831

 

333,234

 

 

 

Property, plant and equipment, net

 

 

 

35,580

 

34,333

 

33,799

 

33,994

 

 

 

38,841

 

41,052

 

43,226

 

45,455

 

 

 

47,524

 

49,943

 

52,318

 

54,756

 

 

 

Net Software Development Costs

 

 

 

29,306

 

29,183

 

29,714

 

14,125

 

 

 

14,125

 

14,125

 

14,125

 

14,125

 

 

 

14,125

 

14,125

 

14,125

 

14,125

 

 

 

Deferred contract costs

 

 

 

7,712

 

6,273

 

5,435

 

5,324

 

 

 

5,324

 

5,324

 

5,324

 

5,324

 

 

 

5,324

 

5,324

 

5,324

 

5,324

 

 

 

Deferred taxes

 

 

 

 

 

 

10,933

 

 

 

10,933

 

10,933

 

10,933

 

10,933

 

 

 

10,933

 

10,933

 

10,933

 

10,933

 

 

 

Other assets

 

 

 

92,833

 

92,518

 

91,326

 

69,483

 

 

 

69,483

 

69,483

 

69,483

 

69,483

 

 

 

69,483

 

69,483

 

69,483

 

69,483

 

 

 

Total assets

 

 

 

416,078

 

426,269

 

436,963

 

450,295

 

 

 

410,588

 

421,268

 

425,090

 

436,008

 

 

 

440,042

 

459,026

 

471,014

 

487,855

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

 

 

52,441

 

53,391

 

51,802

 

48,950

 

 

 

44,405

 

47,483

 

46,924

 

48,829

 

 

 

44,586

 

47,709

 

47,106

 

49,156

 

 

 

Accrued compensation and benefits

 

 

 

25,771

 

28,390

 

29,417

 

26,684

 

 

 

24,867

 

26,591

 

26,278

 

26,292

 

 

 

26,008

 

27,830

 

27,479

 

27,527

 

 

 

Billings in excess of costs and estimated earnings

 

 

 

37,461

 

33,151

 

33,836

 

19,676

 

 

 

18,649

 

20,026

 

19,872

 

20,101

 

 

 

17,364

 

18,659

 

18,499

 

18,734

 

 

 

Notes payable & other (cap. lease obligations)

 

 

 

1,643

 

1,238

 

830

 

417

 

 

 

417

 

417

 

417

 

417

 

 

 

417

 

417

 

417

 

417

 

 

 

Income taxes payable

 

 

 

 

 

 

4,011

 

 

 

4,011

 

4,011

 

4,011

 

4,011

 

 

 

4,011

 

4,011

 

4,011

 

4,011

 

 

 

Deferred taxes

 

 

 

2,675

 

998

 

1,237

 

64,919

 

 

 

24,919

 

24,919

 

24,919

 

24,919

 

 

 

24,919

 

24,919

 

24,919

 

24,919

 

 

 

S corporation distribution payable

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total current liabilities

 

 

 

119,991

 

117,168

 

117,122

 

164,657

 

 

 

117,268

 

123,448

 

122,421

 

124,569

 

 

 

117,305

 

123,544

 

122,431

 

124,764

 

 

 

Long-term debt

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred taxes

 

 

 

11,202

 

12,752

 

11,810

 

1,617

 

 

 

1,617

 

1,617

 

1,617

 

1,617

 

 

 

1,617

 

1,617

 

1,617

 

1,617

 

 

 

Other liabilities

 

 

 

12,319

 

11,470

 

10,996

 

8,315

 

 

 

8,315

 

8,315

 

8,315

 

8,315

 

 

 

8,315

 

8,315

 

8,315

 

8,315

 

 

 

Total liabilities

 

 

 

143,512

 

141,390

 

139,928

 

174,589

 

 

 

127,200

 

133,380

 

132,353

 

134,501

 

 

 

127,237

 

133,476

 

132,363

 

134,696

 

 

 

Redeemable common stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional paid-in capital

 

 

 

31,976

 

36,514

 

39,130

 

39,220

 

 

 

35,975

 

28,212

 

20,450

 

15,275

 

 

 

15,275

 

15,275

 

15,275

 

15,275

 

 

 

Retained earnings

 

 

 

240,590

 

248,365

 

257,905

 

236,486

 

 

 

247,414

 

259,677

 

272,288

 

286,232

 

 

 

297,530

 

310,275

 

323,376

 

337,885

 

 

 

Total stockholders’ equity

 

 

 

272,566

 

284,879

 

297,035

 

275,706

 

 

 

283,389

 

287,889

 

292,738

 

301,506

 

 

 

312,805

 

325,550

 

338,651

 

353,159

 

 

 

Total liab & stockholders’ equity

 

 

 

416,078

 

426,269

 

436,963

 

450,295

 

 

 

410,588

 

421,268

 

425,090

 

436,008

 

 

 

440,042

 

459,026

 

471,014

 

487,855

 

 

 

 

 

 

 

 

 

 

 

 

 

68.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash Flow Statement

 

FY07

 

1Q08

 

2Q08

 

3Q08

 

4Q08

 

FY08

 

1Q09E

 

2Q09E

 

3Q09E

 

4Q09E

 

FY09E

 

1Q10E

 

2Q10E

 

3Q10E

 

4Q10E

 

FY10E

 

Cash flows from operating activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

(8,255

)

$

10,605

 

$

9,627

 

$

11,405

 

$

(24,960

)

$

6,677

 

$

11,929

 

$

13,238

 

$

13,560

 

$

14,876

 

$

53,602

 

$

12,235

 

$

13,687

 

$

14,048

 

$

15,460

 

$

55,430

 

Deferred taxes

 

 

 

4,195

 

3,327

 

(1,707

)

(26,015

)

 

 

(27,500

)

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

 

5,039

 

4,799

 

4,271

 

(1,581

)

 

 

2,600

 

2,600

 

2,600

 

2,600

 

 

 

2,600

 

2,600

 

2,600

 

2,600

 

 

 

Other

 

 

 

3,600

 

2,154

 

(4,588

)

33,370

 

 

 

800

 

800

 

800

 

800

 

 

 

800

 

800

 

800

 

800

 

 

 

Funds from operations

 

 

 

23,439

 

19,907

 

9,381

 

(19,186

)

 

 

(12,171

)

16,638

 

16,960

 

18,276

 

 

 

15,635

 

17,087

 

17,448

 

18,860

 

 

 

(Increase) decrease in A/R

 

 

 

13,695

 

(3,425

)

(4,101

)

(2,026

)

 

 

17,317

 

(6,098

)

(3,335

)

(5,690

)

 

 

12,472

 

(6,283

)

(3,388

)

(6,055

)

 

 

(Increase) decrease in excess costs and earnings

 

 

 

(7,571

)

(2,543

)

2,593

 

19,026

 

 

 

(9,127

)

(2,942

)

(1,791

)

(2,661

)

 

 

5,706

 

(3,096

)

(1,828

)

(2,830

)

 

 

(Increase) decrease in prepaid other c/a

 

 

 

1,471

 

(8,031

)

4,070

 

1,434

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Increase) decrease in other assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Increase (decrease) in compensation

 

 

 

(3,678

)

2,619

 

1,027

 

(2,733

)

 

 

(1,817

)

1,724

 

(313

)

15

 

 

 

(284

)

1,822

 

(351

)

48

 

 

 

Increase (decrease) in A/P

 

 

 

(1,984

)

950

 

(1,589

)

(2,852

)

 

 

(4,545

)

3,078

 

(559

)

1,904

 

 

 

(4,243

)

3,123

 

(602

)

2,049

 

 

 

Increase (decrease) in income tax payable

 

 

 

 

 

 

4,011

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Increase (decrease) in excess billings

 

 

 

(680

)

(2,871

)

1,523

 

(14,049

)

 

 

(1,027

)

1,378

 

(155

)

230

 

 

 

(2,737

)

1,295

 

(160

)

236

 

 

 

Increase (decrease) in other liabilities

 

 

 

2,176

 

(849

)

(474

)

(2,681

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other changes to working capital (plug)

 

 

 

(6,079

)

(1,253

)

369

 

37,537

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Working capital changes

 

 

 

(2,650

)

(15,403

)

3,418

 

37,667

 

 

 

801

 

(2,860

)

(6,153

)

(6,203

)

 

 

10,913

 

(3,139

)

(6,330

)

(6,553

)

 

 

Net cash provided by operating activities

 

51,190

 

20,789

 

4,504

 

12,799

 

18,481

 

56,573

 

(11,370

)

13,777

 

10,807

 

12,073

 

25,287

 

26,548

 

13,948

 

11,118

 

12,308

 

63,921

 

Capital expenditures, net

 

(17,893

)

(4,083

)

(3,055

)

(6,730

)

(1,581

)

(15,449

)

(4,480

)

(4,811

)

(4,774

)

(4,829

)

(18,894

)

(4,670

)

(5,018

)

(4,975

)

(5,038

)

(19,702

)

% of revenue

 

2.4

%

2.0

%

1.5

%

3.3

%

0.8

%

1.9

%

2.5

%

2.5

%

2.5

%

2.5

%

2.5

%

2.5

%

2.5

%

2.5

%

2.5

%

2.5

%

Acquisitions

 

 

 

 

 

10,572

 

29,885

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other investing activities (plug)

 

 

 

 

 

59

 

(2,815

)

 

 

(2,967

)

 

 

 

 

 

 

 

 

 

 

 

Net cash used by investing activities

 

 

 

(4,083

)

(3,053

)

3,901

 

25,489

 

 

 

(7,447

)

(4,811

)

(4,774

)

(4,829

)

 

 

(4,670

)

(5,018

)

(4,975

)

(5,038

)

 

 

Free Cash Flow (excluding acquisitions)

 

33,297

 

16,706

 

1,449

 

6,069

 

16,900

 

41,124

 

(15,850

)

8,967

 

6,033

 

7,244

 

6,394

 

21,879

 

8,929

 

6,143

 

7,269

 

44,220

 

% of net income

 

-403.4

%

 

 

 

 

 

 

 

 

145.4

%

 

 

 

 

 

 

 

 

11.9

%

 

 

 

 

 

 

 

 

79.8

%

Increase (decrease) in debt

 

 

 

(401

)

(404

)

(408

)

(414

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Increase (decrease) in equity

 

 

 

(148,733

)

2,195

 

97

 

990

 

 

 

(3,246

)

(7,763

)

(7,763

)

(5,175

)

 

 

 

 

 

 

 

 

Other financing activities (incl. dividend)

 

 

 

(1,925

)

(2,149

)

(1,865

)

(1,860

)

 

 

(1,801

)

(1,775

)

(1,749

)

(1,732

)

 

 

(1,737

)

(1,742

)

(1,747

)

(1,752

)

 

 

Net cash provided from financing activities

 

 

 

(151,059

)

(358

)

(2,176

)

(1,284

)

 

 

(5,046

)

(9,537

)

(9,512

)

(6,907

)

 

 

(1,737

)

(1,742

)

(1,747

)

(1,752

)

 

 

Net increase (decrease) in cash and cash equivalents

 

38,635

 

(134,353

)

1,093

 

14,524

 

42,686

 

(76,050

)

(23,863

)

(571

)

(3,478

)

337

 

(27,575

)

20,142

 

7,188

 

4,396

 

5,517

 

37,243

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Source: Maximus, Inc. and Stifel Nicolaus estimates

 

10



 

Commercial IT Services Companies

 

Stifel, Nicolaus & Company, Inc.

 

Valuation Data:

($ in millions, except per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity

 

Price/Earnings Ratio

 

PE/Growth (PEG)

 

Enterprise

 

Enterprise Value/

 

Cash Flow

 

 

 

 

 

Price

 

Annual

 

Annual

 

Market

 

CY

 

CY

 

CY

 

CY

 

Market

 

Trailing Twelve Months

 

Enterprise Value/

 

CY09 FCF

 

Ticker

 

Company

 

12/15/2008

 

High

 

Low

 

Value

 

2008

 

2009

 

2008

 

2009

 

Value

 

Revenue

 

EBIT

 

EBITDA

 

TTM FCF

 

CY08 FCF

 

CY09 FCF

 

Yield

 

ACN

 

Accenture, Ltd. (1) (3)

 

$

 28.48

 

$

 43.04

 

$

24.76

 

$

23,067

 

10.3x

 

10.0x

 

0.3

 

2.7

 

$

 19,452

 

0.77x

 

6.4x

 

5.5x

 

7.8x

 

7.6x

 

7.8x

 

11.6

%

ACS

 

Affiliated Comp. Services, Inc. (1) (7)

 

39.16

 

57.40

 

34.84

 

3,841

 

10.7

 

9.6

 

1.3

 

0.9

 

5,777

 

0.92

 

8.2

 

5.3

 

10.1

 

12.2

 

13.2

 

11.3

 

CBR

 

CIBER, Inc. (1)

 

4.02

 

8.97

 

2.95

 

242

 

7.4

 

7.3

 

0.5

 

3.3

 

385

 

0.32

 

6.5

 

4.9

 

8.0

 

6.8

 

11.3

 

13.9

 

CSC

 

CSC (1) (5)

 

31.31

 

50.52

 

23.93

 

4,794

 

7.9

 

7.3

 

Neg

 

0.9

 

7,825

 

0.45

 

6.5

 

3.1

 

7.9

 

11.5

 

12.2

 

13.2

 

DTPI

 

Diamond Mgmt. & Tech. Consultants (1) (6)

 

4.02

 

7.45

 

1.84

 

106

 

NM

 

NM

 

NM

 

NM

 

59

 

0.31

 

9.7

 

7.5

 

Neg

 

Neg

 

Neg

 

Neg

 

HCKT

 

The Hackett Group, Inc.

 

2.67

 

6.65

 

2.07

 

111

 

8.3

 

7.4

 

0.1

 

0.1

 

85

 

0.45

 

5.1

 

4.3

 

3.8

 

NE

 

NE

 

NE

 

HEW

 

Hewitt Associates Inc. (1) (4)

 

26.57

 

43.00

 

22.78

 

2,608

 

13.2

 

10.4

 

0.6

 

0.4

 

2,868

 

0.89

 

9.3

 

5.7

 

13.6

 

15.3

 

11.2

 

9.8

 

MMS

 

Maximus, Inc. (1) (9)

 

33.96

 

45.07

 

25.94

 

630

 

11.6

 

11.0

 

0.3

 

2.1

 

509

 

0.68

 

5.9

 

5.2

 

14.0

 

59.4

 

11.5

 

7.4

 

NSTC

 

Ness Technologies, Inc. (1)

 

4.25

 

13.00

 

3.54

 

169

 

4.4

 

4.9

 

0.0

 

Neg

 

177

 

0.27

 

5.0

 

3.3

 

8.6

 

NE

 

NE

 

NE

 

PER

 

Perot Systems Corp. (1) (8)

 

12.43

 

18.82

 

10.71

 

1,524

 

12.8

 

11.9

 

0.5

 

1.6

 

1,459

 

0.52

 

8.0

 

4.9

 

8.4

 

10.3

 

12.0

 

8.0

 

PRFT

 

Perficient, Inc.

 

4.86

 

17.08

 

2.31

 

148

 

6.7

 

6.8

 

Neg

 

Neg

 

132

 

0.56

 

5.6

 

4.3

 

5.6

 

NE

 

NE

 

NE

 

UIS

 

Unisys Corp. (10)

 

0.59

 

5.11

 

0.38

 

213

 

Neg

 

4.5

 

Neg

 

Neg

 

781

 

0.14

 

4.9

 

1.2

*

4.7

 

NE

 

NE

 

NE

 

 

 

Mean:

 

 

 

 

 

 

 

Total

 

9.3x

 

8.3x

 

0.4x

 

1.5x

 

Total

 

0.52x

 

6.8x

 

4.6x

 

8.4x

 

17.6x

 

11.3x

 

10.7

%

 

 

Median:

 

 

 

 

 

 

 

$

37,454

 

9.3

 

7.4

 

0.4

 

1.2

 

$

39,509

 

0.48

 

6.5

 

4.9

 

8.0

 

11.5

 

11.5

 

11.3

 

 

 

Mean: (Larger Caps) (2)

 

 

 

 

 

 

 

 

 

11.0x

 

9.8x

 

0.7x

 

1.3x

 

 

 

0.71x

 

7.7x

 

4.9x

 

9.6x

 

11.4x

 

11.3x

 

10.8

%

 

 

Median: (Larger Caps) (2)

 

 

 

 

 

 

 

 

 

10.7

 

10.0

 

0.6

 

0.9

 

 

 

0.77

 

8.0

 

5.3

 

8.4

 

11.5

 

12.0

 

11.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial Data:

($ in millions)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance Sheet Data

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trailing Twelve Months

 

 

 

Goodwill

 

Total

 

TTM Capex/

 

 

 

 

 

 

 

Returns

 

 

 

 

 

TTM

 

Revenue/EPS Growth

 

Gross

 

 

 

 

 

Net

 

Cash

 

as % of

 

Debt/

 

TTM

 

Total

 

LQA Rev. per

 

 

 

TTM

 

CY09

 

Ticker

 

Company

 

Revenue

 

CY08

 

CY09

 

Margin

 

EBIT

 

EBITDA

 

Income

 

Balance

 

Total Assets

 

Total Capital

 

Revenue

 

Employees

 

Employee

 

DSO

 

ROE/ROIC

 

ROE/ROIC

 

ACN

 

Accenture, Ltd. (1) (3)

 

$

25,313.8

 

15.1 / 31.5

%

-1.8 / 3.6 

%

28.4

%

12.0

%

13.9

%

8.3

%

$

 3,623.0

 

6.7

%

0.3

%

1.3

%

186,805

 

140,490

 

62

 

74.7 / 72.5

%

101.9 / 78.4

%

ACS

 

Affiliated Comp. Services, Inc. (1) (7)

 

6,271.9

 

7.2 / 8.4

 

6.9 / 10.9

 

53.5

 

11.2

 

17.4

 

5.7

 

434.8

 

49.5

 

50.0

 

4.9

 

63,000

 

101,870

 

80

 

15.6 / 10.4

 

15.0 / 11.3

 

CBR

 

CIBER, Inc. (1)

 

1,201.5

 

11.9 / 15.4

 

0.7 / 2.2

 

27.1

 

4.9

 

6.5

 

2.6

 

39.3

 

56.2

 

28.2

 

1.3

 

8,500

 

141,161

 

80

 

6.7 / 6.1

 

6.8 / 6.3

 

CSC

 

CSC (1) (5)

 

17,320.7

 

8.0 / -0.2

 

-21.0 / 8.2

 

20.3

 

6.9

 

14.5

 

3.7

 

741.6

 

25.5

 

39.7

 

4.5

 

91,000

 

186,316

 

92

 

11.5 / 8.0

 

10.7 / 8.1

 

DTPI

 

Diamond Mgmt. & Tech. Consultants (1) (6)

 

190.0

 

-11.4 / -95.8

 

-1.6 / NM

 

31.1

 

3.2

 

4.1

 

1.5

 

47.1

 

0.0

 

0.0

 

1.4

 

582

 

278,392

 

34

 

3.9 / 2.7

 

4.0 / 7.8

 

HCKT

 

The Hackett Group, Inc.

 

188.2

 

7.6 / 88.2

 

5.0 / 12.5

 

41.4

 

8.8

 

10.4

 

9.3

 

26.1

 

49.3

 

0.0

 

1.0

 

747

 

269,922

 

59

 

17.9 / 13.4

 

NE

 

HEW

 

Hewitt Associates Inc. (1) (4)

 

3,227.6

 

5.3 / 22.0

 

1.7 / 26.1

 

38.8

 

9.6

 

15.5

 

6.4

 

541.5

 

19.1

 

55.2

 

3.6

 

23,000

 

143,396

 

72

 

25.7 / 20.1

 

30.5 / 26.0

 

MMS

 

Maximus, Inc. (1) (9)

 

745.1

 

0.7 / 45.7

 

-2.8 / 5.3

 

27.1

 

11.6

 

13.2

 

7.3

 

121.0

 

14.9

 

0.0

 

2.1

 

6,000

 

126,046

 

80

 

16.5 / 19.8

 

18.1 / 23.9

 

NSTC

 

Ness Technologies, Inc. (1)

 

666.5

 

19.6 / 273.1

 

7.5 / -10.3

 

28.9

 

5.3

 

7.9

 

2.7

 

81.7

 

38.2

 

17.8

 

2.1

 

8,300

 

66,837

 

175

 

4.4 / 5.8

 

NE

 

PER

 

Perot Systems Corp. (1) (8)

 

2,828.0

 

6.8 / 23.8

 

4.8 / 7.6

 

16.8

 

6.5

 

10.6

 

4.0

 

246.0

 

36.5

 

12.2

 

1.7

 

24,000

 

118,500

 

62

 

9.0 / 10.5

 

9.1 / 10.4

 

PRFT

 

Perficient, Inc.

 

237.1

 

5.9/ -6.4

 

-0.4 / -2.7

 

33.0

 

10.0

 

13.1

 

5.8

 

15.6

 

61.2

 

0.0

 

0.8

 

1,327

 

175,753

 

76

 

7.7 / 8.6

 

NE

 

UIS

 

Unisys Corp. (10)

 

5,489.4

 

-5.9 / -60.9

 

-4.5 / -244.4

 

23.9

 

2.9

 

11.8

 

(1.1

)

493.8

 

5.5

 

73.6

 

3.6

 

31,000

 

169,342

 

63

 

-15.1 / 11.0

 

NE

 

 

 

Mean:

 

Total

 

 

 

 

 

30.9

%

7.7

%

11.6

%

4.7

%

 

 

30.2

%

23.1

%

2.4

%

 

 

 

 

78

 

 

 

 

 

 

 

Median:

 

$

63,680

 

 

 

 

 

28.7

 

7.9

 

12.4

 

4.9

 

 

 

31.0

 

15.0

 

1.9

 

 

 

 

 

80

 

 

 

 

 

 

 

Mean (excl. negatives):

 

 

 

 

 

 

 

30.9

%

7.7

%

11.6

%

5.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Median (excl. negatives):

 

 

 

 

 

 

 

28.7

 

7.9

 

12.4

 

5.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Notes:

* Not included in mean and median calculations

(1)          Stifel Nicolaus Research estimates.

(2)          Includes ACN, ACS, CSC, HEW, PER, and UIS.

(3)          Accenture (ACN) ROIC is GROSS of cash and investments.

(4)          Hewitt TTM EBIT and EBITDA exclude significant goodwill and asset impairment charges

(5)          CSC net income and FCF exclude restructuring and impairment charges.

(6)          DTPI FCF excludes ~$20M, based on management’s estimate of cash needed to repurchase shares to offset dilutive equity comp.

(7)          Affiliated Comp. Services EBIT, EBITDA, and NI exclude one-time charges.

(8)          PER TTM EBIT and NI exclude the $46M TRIAD termination benefit and $18M restructuring charge

(9)          MMS financials are on continuing operations basis.

(10)    Reflects C2Q08 data.

Unless otherwise noted, all results reflect C3Q08 data.

Sources: Company data, Bloomberg Financial Markets, First Call estimates, FactSet Research Systems and Stifel Nicolaus Research estimates.

 

 

George A. Price, Jr.

Shlomo H. Rosenbaum

 

Richard M. Eskelsen

 

gaprice@stifel. com

shrosenbaum@stifel. com

 

eskelsenr@stifel. com

 

(443) 224-1323

(443) 224-1322

 

(443) 224-1366

 

11



 

Important Disclosures and Certifications

 

I, George Price, certify that the views expressed in this research report accurately reflect my personal views about the subject securities or issuers; and I, George Price, certify that no part of my compensation was, is, or will be directly or indirectly related to the specific recommendation or views contained in this research report.

 

I, Shlomo Rosenbaum, certify that the views expressed in this research report accurately reflect my personal views about the subject securities or issuers; and I, Shlomo Rosenbaum, certify that no part of my compensation was, is, or will be directly or indirectly related to the specific recommendation or views contained in this research report.

 

 

For a price chart with our ratings and target price changes for MMS go to
http://sf.bluematrix.com/bluematrix/Disclosure?ticker=MMS

 

 

For a price chart with our ratings and target price changes for ACN go to
http://sf.bluematrix.com/bluematrix/Disclosure?ticker=ACN

 

12



 

Maximus, Inc. is a client of Stifel, Nicolaus & Company, Inc. or an affiliate or was a client of Stifel Nicolaus or an affiliate within the past 12 months.

 

Maximus, Inc. is provided with non-investment banking, securities related services by Stifel, Nicolaus & Company, Inc. or an affiliate or was provided with non-investment banking, securities related services by Stifel Nicolaus or an affiliate within the past 12 months.

 

Stifel, Nicolaus & Company, Inc. expects to receive or intends to seek compensation for investment banking services from Maximus, Inc. in the next 3 months.

 

Stifel, Nicolaus & Company, Inc. or an affiliate has received compensation for non-investment banking, securities related services from Maximus, Inc. in the past 12 months.

 

Stifel, Nicolaus & Company, Inc.’s research analysts receive compensation that is based upon (among other factors) Stifel Nicolaus’ overall investment banking revenues.

 

Our investment rating system is three tiered, defined as follows:

 

BUY - -We expect this stock to outperform the S&P 500 by more than 10% over the next 12 months. For higher-yielding equities such as REITs and Utilities, we expect a total return in excess of 12% over the next 12 months.

 

HOLD - -We expect this stock to perform within 10% (plus or minus) of the S&P 500 over the next 12 months. A Hold rating is also used for those higher-yielding securities where we are comfortable with the safety of the dividend, but believe that upside in the share price is limited.

 

SELL - -We expect this stock to underperform the S&P 500 by more than 10% over the next 12 months and believe the stock could decline in value.

 

Of the securities we rate, 38% are rated Buy, 57% are rated Hold, and 5% are rated Sell.

 

Within the last 12 months, Stifel, Nicolaus & Company, Inc. or an affiliate has provided investment banking services for 12%, 17% and 9% of the companies whose shares are rated Buy, Hold and Sell, respectively.

 

Additional Disclosures

 

STIFEL NICOLAUS ACTED AS FINANCIAL ADVISOR TO MAXIMUS, INC. IN CONNECTION WITH ITS SALE OF ITS CORRECTIONS SERVICES BUSINESS TO PROVIDENCE SERVICE CORPORATION.

 

STIFEL, NICOLAUS & COMPANY, INC. PROVIDED FINANCIAL ADVISORY SERVICES TO GESTALT, LLC IN CONNECTION WITH ITS PENDING ACQUISITION BY ACCENTURE LTD.

 

Please visit the Research Page at www.stifel.com for the current research disclosures applicable to the companies mentioned in this publication that are within Stifel Nicolaus’ coverage universe. For a discussion of risks to target price please see our stand-alone company reports and notes for all Buy-rated stocks.

 

The information contained herein has been prepared from sources believed to be reliable but is not guaranteed by us and is not a complete summary or statement of all available data, nor is it considered an offer to buy or sell any securities referred to herein. Opinions expressed are subject to change without notice and do not take into account the particular investment objectives, financial situation or needs of individual investors. Employees of Stifel, Nicolaus & Company, Inc. or its affiliates may, at times, release written or oral commentary, technical analysis or trading strategies that differ from the opinions expressed within.

 

Stifel, Nicolaus & Company, Inc. is a multi-disciplined financial services firm that regularly seeks investment banking assignments and compensation from issuers for services including, but not limited to, acting as an underwriter in an offering or financial advisor in a merger or acquisition, or serving as a placement agent in private transactions. Moreover, Stifel Nicolaus and its affiliates and their respective shareholders, directors, officers and/or employees, may from time to time have long or short positions in such securities or in options or other derivative instruments based thereon.

 

These materials have been approved by Stifel Nicolaus Limited, authorized and regulated by the Financial Services Authority (UK), in connection with its distribution to professional clients and eligible counterparties in the European Economic Area. (Stifel Nicolaus Limited home office: London +44 20 7557 6030.) No investments or services

 

13



 

mentioned are available in the European Economic Area to retail clients or to anyone in Canada other than a Designated Institution. This investment research report is classified as objective for the purposes of the FSA rules. Please contact a Stifel Nicolaus entity in your jurisdiction if you require additional information.

 

Additional Information Is Available Upon Request

 

© 2008 Stifel, Nicolaus & Company, Inc. One South Street Baltimore, MD 21202. All rights reserved.

 

14